{"version": "v1.0", "data": [{"id": "10907391_3_0", "context": "Physicians should be aware that PLP can occur after initiation of paclitaxel.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Treatment] paclitaxel [Effect] PLP"}, {"id": "18957000_3_1", "context": "Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] heparin [Effect] thrombocytopenia"}, {"id": "6405633_1_2", "context": "Treatment of lithium tremor with metoprolol.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] Treatment of [Treatment] metoprolol"}, {"id": "4044222_1_3", "context": "A 54-year-old man, treated with amiodarone, developed thyrotoxicosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 54-year-old man [Treatment] amiodarone [Effect] thyrotoxicosis"}, {"id": "12962465_2_4", "context": "Gynaecomastia is a rarely reported adverse drug reaction due to isoniazid therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse drug reaction [Treatment] isoniazid therapy [Effect] Gynaecomastia"}, {"id": "15112258_6_5", "context": "The authors performed a literature search using PubMed and the search terms \"gemcitabine\" and \"radiation recall\" to find prior cases of radiation recall attributed to gemcitabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attributed [Subject] prior cases [Treatment] gemcitabine [Effect] radiation recall"}, {"id": "1893404_1_6", "context": "Carbamazepine-induced Diabetes mellitus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Carbamazepine [Effect] Diabetes mellitus"}, {"id": "15827071_5_7", "context": "She displayed symptoms of ST 8 days after the introduction of linezolid.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] displayed [Subject] She [Treatment] 8 days after the introduction of linezolid [Effect] symptoms of ST"}, {"id": "9819544_2_8", "context": "Naproxen is a commonly used nonsteroidal anti-inflammatory drug (NSAID) whose side effects include tinnitus and transient hearing loss.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] include [Treatment] Naproxen [Effect] tinnitus and transient hearing loss"}, {"id": "3159106_3_9", "context": "The allopurinol hypersensitivity syndrome is a rare adverse drug reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse [Treatment] allopurinol [Effect] hypersensitivity syndrome"}, {"id": "8452107_2_10", "context": "The pulmonary toxicity is probably induced by piritrexim.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] piritrexim [Effect] pulmonary toxicity"}, {"id": "15944830_1_11", "context": "BACKGROUND: Interferon (IFN)-associated retinopathy is typically characterized by retinal hemorrhages and cotton wool spots at the posterior fundus, but visual function is usually maintained.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Interferon (IFN) [Effect] retinopathy is typically characterized by retinal hemorrhages and cotton wool spots at the posterior fundus"}, {"id": "7986915_2_12", "context": "We describe a patient with a liver abscess due to Entamoeba histolytica, in whom metronidazole therapy (total dose, 21 g over 14 days) was complicated by reversible deafness, tinnitus, and ataxia and who relapsed 5 months later with a splenic abscess.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicated [Subject] a patient with a liver abscess due to Entamoeba histolytica [Treatment] metronidazole therapy (total dose, 21 g over 14 days) [Effect] reversible deafness, tinnitus, and ataxia and who relapsed 5 months later with a splenic abscess"}, {"id": "18159131_4_13", "context": "We present a Japanese male patient who underwent a living-donor kidney transplantation having received tacrolimus, mycophenolate mofetil, and prednisolone for immunosuppression.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] received [Subject] a Japanese male patient who underwent a living-donor kidney transplantation; immunosuppression [Treatment] tacrolimus, mycophenolate mofetil, and prednisolone"}, {"id": "6430252_1_14", "context": "Gold nephropathy due to auranofin obscured by tolmetin pseudoproteinuria.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] auranofin [Effect] Gold nephropathy"}, {"id": "2690546_3_15", "context": "We report three cases of amiodarone-induced torsades de pointe.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] three cases [Treatment] amiodarone [Effect] torsades de pointe"}, {"id": "11720625_1_16", "context": "Torsades de pointes due to drug interaction between disopyramide and clarithromycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Treatment] drug interaction between disopyramide and clarithromycin [Effect] Torsades de pointes"}, {"id": "12053072_2_17", "context": "We describe a patient who developed HUS after treatment with mitomycin C (total dose 144 mg/m2) due to a carcinoma of the ascending colon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] mitomycin C (total dose 144 mg/m2) [Effect] HUS"}, {"id": "23006440_5_18", "context": "In this case, 5-FU increased PHT, which in turn may have increased the PB concentration, suggesting that when fluoropyrimidine antitumor agents are administered to patients receiving PHT in combination with other drugs, some measures should be taken in consideration of secondary effects of antitumor agents on other drugs that may possibly interact with PHT, including frequent monitoring of blood drug concentration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] interact [Subject] patients [Treatment] 5-FU increased PHT, which in turn may have increased the PB concentration [Effect] secondary effects of antitumor agents on other drugs"}, {"id": "16181292_2_19", "context": "Severe loss of vision after removal of cataract caused by intravitreal triamcinolone in combination with photodynamic therapy for exudative age-related macular degeneration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] intravitreal triamcinolone; photodynamic [Effect] Severe loss of vision"}, {"id": "10715308_12_20", "context": "The CATAPULT I study shows that tirapazamine enhances the activity of cisplatin in patients with advanced NSCLC and confirms that hypoxia is an exploitable therapeutic target in human malignancies.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] enhances [Subject] patients with advanced NSCLC [Treatment] tirapazamine [Effect] enhances the activity of cisplatin"}, {"id": "9619226_1_21", "context": "Cardiac arrest associated with sulprostone use during caesarean section.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] sulprostone [Effect] Cardiac arrest"}, {"id": "11807466_1_22", "context": "Linear IgA bullous dermatosis occurring after carbamazepine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Treatment] carbamazepine [Effect] Linear IgA bullous dermatosis"}, {"id": "12053072_1_23", "context": "Erythropoietin is beneficial in mitomycin-induced hemolytic-uremic syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] beneficial [Treatment] Erythropoietin [Adverse event] induced [Treatment] mitomycin [Effect] hemolytic-uremic syndrome"}, {"id": "8305778_9_24", "context": "Hypothyroidism, occurring in up to 11 percent of patients treated with amiodarone, can also alter drug metabolism and sensitize the central nervous system, thus increasing the potential for toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] 11 percent of patients [Treatment] amiodarone [Effect] Hypothyroidism"}, {"id": "3513544_2_25", "context": "We report the first case of herpes esophagitis in a renal transplant patient treated with Cyclosporine A while on chronic steroid therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a renal transplant patient [Treatment] Cyclosporine A while on chronic steroid therapy [Effect] herpes esophagitis"}, {"id": "1827039_1_26", "context": "Severe hepatocellular dysfunction following cyproterone acetate therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] cyproterone acetate [Effect] Severe hepatocellular dysfunction"}, {"id": "11672959_2_27", "context": "It is thought that the clinico-pathological features and chronology of this case bore the hallmarks of the so-called \"3-week sulphasalazine syndrome\", a rare, but often fatal, immunoallergic reaction to sulphasalazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] immunoallergic reaction [Treatment] sulphasalazine [Effect] 3-week sulphasalazine syndrome"}, {"id": "6405633_2_28", "context": "Two patients with bipolar affective disorder and a history of bronchospastic phenomena experienced tremor during lithium carbonate therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] Two patients with bipolar affective disorder and a history of bronchospastic phenomena [Treatment] lithium carbonate therapy [Effect] tremor"}, {"id": "6344831_1_29", "context": "Acute renal failure most likely was secondary to the nephrotoxic effect of captopril on chronically hypoperfused kidneys.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] nephrotoxic effect [Subject] chronically hypoperfused kidneys [Treatment] captopril [Effect] Acute renal failure"}, {"id": "2154663_3_30", "context": "We report a case of radiotherapy-enhanced aminoglutethimide skin toxicity in a patient with metastatic breast cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Subject] a patient with metastatic breast cancer [Treatment] radiotherapy-enhanced aminoglutethimide [Effect] skin toxicity"}, {"id": "25540831_8_31", "context": "Clinicians should also be aware of the possibility of serotonin syndrome when encountering a patient taking serotonergic drugs who presents with characteristic symptoms of serotonin syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] a patient [Treatment] serotonergic drugs [Effect] serotonin syndrome"}, {"id": "946400_3_32", "context": "Such a rapid and relentless progression of methyldopa-induced liver injury is undoubtedly rare, but it may be prevented by careful supervision of patients who exhibit liver function abnormalities early in the course of therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] methyldopa [Effect] liver injury"}, {"id": "6507240_2_33", "context": "In eight patients, a mean decrease in serum Na+ of 8.25 +/- 3.2 mEq/L was observed after a single 200 mg intravenous dose of lorcainide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Subject] eight patients [Treatment] a single 200 mg intravenous dose of lorcainide [Effect] mean decrease in serum Na+ of 8.25 +/- 3.2 mEq/L"}, {"id": "2234880_1_34", "context": "Nitrendipine-induced gingival hyperplasia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Nitrendipine [Effect] gingival hyperplasia"}, {"id": "3501467_1_35", "context": "Extensive immunological investigations were performed in a patient with definite seronegative rheumatoid arthritis who developed hypogammaglobulinemia in the course of gold therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with definite seronegative rheumatoid arthritis [Treatment] gold therapy [Effect] hypogammaglobulinemia"}, {"id": "12763355_4_36", "context": "When SASP was changed to 5-aminosalicylic acid (5-ASA), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] he [Treatment] SASP was changed to 5-aminosalicylic acid (5-ASA) [Effect] weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance. [Potential therapeutic event] resolved [Treatment] SASP was changed to 5-aminosalicylic acid (5-ASA)"}, {"id": "17697264_2_37", "context": "One case of tacrolimus-induced hepatic VOD developing after lung transplantation (LT) has been recently reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] tacrolimus; after lung transplantation (LT) [Effect] hepatic VOD"}, {"id": "16948177_4_38", "context": "We describe a case of an NHL patient who received rituximab and developed symptomatic, biopsy-proven multinodular bronchiolitis obliterans with organizing pneumonia (BOOP).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] an NHL patient [Treatment] rituximab [Effect] symptomatic, biopsy-proven multinodular bronchiolitis obliterans with organizing pneumonia (BOOP)"}, {"id": "11720625_4_39", "context": "We describe a case of TdP caused by a drug interaction in a 76-year-old woman taking long-term disopyramide after she was given clarithromycin concomitantly for chronic bronchitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] 76-year-old woman [Treatment] long-term disopyramide; clarithromycin [Effect] TdP"}, {"id": "14971874_2_40", "context": "Thus, clinical recognition of sleep disordered breathing should be taken into account when rheumatoid arthritis patients are to be treated with infliximab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] rheumatoid arthritis patients [Treatment] infliximab [Effect] sleep disordered breathing"}, {"id": "18006091_2_41", "context": "We present a case of a sustained monomorphic ventricular tachycardia following adenosine infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] adenosine infusion [Effect] sustained monomorphic ventricular tachycardia"}, {"id": "11008259_1_42", "context": "Provocation of non-convulsive status epilepticus by tiagabine in three adolescent patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Provocation [Subject] three adolescent patients [Treatment] tiagabine [Effect] non-convulsive status epilepticus"}, {"id": "19260037_5_43", "context": "We recommend that a TMA in association with quinine be consistently referred to as quinine-associated thrombotic microangiopathy (quinine-TMA) to better distinguish this entity from idiopathic TTP.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] quinine [Effect] quinine-associated thrombotic microangiopathy (quinine-TMA)"}, {"id": "6625005_3_44", "context": "The authors describe a case of oral-facial dyskinesia that occurred after discontinuation of amoxapine, and antidepressant which may also have neuroleptic effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] discontinuation of amoxapine, and antidepressant which may also have neuroleptic effects [Effect] oral-facial dyskinesia"}, {"id": "19934385_3_45", "context": "A 34-year-old HIV-infected man who had recently initiated efavirenz-based antiretroviral therapy was diagnosed with disseminated Histoplasma capsulatum infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] initiated [Subject] A 34-year-old HIV-infected man [Treatment] initiated efavirenz-based antiretroviral therapy"}, {"id": "2154663_1_46", "context": "Aminoglutethimide was discontinued until completion of radiotherapy, and the rash resolved.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] and [Treatment] Aminoglutethimide was discontinued until completion of radiotherapy [Effect] the rash resolved"}, {"id": "15941649_4_47", "context": "We explored ophthalmic and neurologic findings in two children who have been exposed prenatally to VGB.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] explored [Subject] two children [Treatment] exposed prenatally to VGB; VGB [Effect] ophthalmic and neurologic findings"}, {"id": "2572964_2_48", "context": "Two cases are described of chronic schizophrenic patients maintained on depot neuroleptics, who developed severe extrapyramidal symptoms following a period of heavy betel nut consumption.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two cases [Treatment] heavy betel nut consumption; depot neuroleptics [Effect] severe extrapyramidal symptoms"}, {"id": "160443_1_49", "context": "Five personal observations of an acute amnestic episode in younger individuals after intake of clioquinol are described together with three observations from the medical literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] younger individuals [Treatment] intake of clioquinol [Effect] acute amnestic episode"}, {"id": "6344831_2_50", "context": "In a patient with severe renovascular hypertension, nonoliguric acute renal failure developed after she received captopril treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient with severe renovascular hypertension [Treatment] captopril [Effect] nonoliguric acute renal failure"}, {"id": "1834424_1_51", "context": "A 30-year-old pharmacist suffered from acute allergic contact dermatitis due to 4-chloro-7-nitrobenzofurazan (NBD-Cl).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suffered [Subject] A 30-year-old pharmacist [Treatment] 4-chloro-7-nitrobenzofurazan (NBD-Cl) [Effect] acute allergic contact dermatitis"}, {"id": "15760792_1_52", "context": "CONCLUSION: This rare case of PTU-induced ANCA-associated vasculitis manifested with ototoxicity in combination with systemic involvement.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] PTU [Effect] ANCA-associated vasculitis manifested with ototoxicity in combination with systemic involvement"}, {"id": "7887138_1_53", "context": "A 15-year follow-up of phenytoin-induced unilateral gingival hyperplasia: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] phenytoin [Effect] unilateral gingival hyperplasia"}, {"id": "8627446_2_54", "context": "We describe two patients with rheumatoid factor-positive, polyarticular-onset juvenile rheumatoid arthritis in whom accelerated nodulosis developed during methotrexate therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two patients with rheumatoid factor-positive, polyarticular-onset juvenile rheumatoid arthritis [Treatment] methotrexate therapy [Effect] accelerated nodulosis"}, {"id": "10465148_6_55", "context": "The clinical data suggest that anterior lumbosacral radiculopathy is also a type of neurologic complication associated with intrathecal methotrexate treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] intrathecal methotrexate [Effect] anterior lumbosacral radiculopathy"}, {"id": "24927617_5_56", "context": "At admission simvastatin and all antiviral drugs were discontinued because toxicity due to a drug-drug interaction was suspected.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] simvastatin and all antiviral drugs [Effect] toxicity"}, {"id": "6614033_1_57", "context": "A major limitation in the use of amphotericin B is its potential to cause nephrotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] amphotericin B [Effect] nephrotoxicity"}, {"id": "2461837_2_58", "context": "We report a case of hyperpigmentation due to bleomycin treatment in a patient with acquired immune deficiency syndrome (AIDS).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] a patient with acquired immune deficiency syndrome (AIDS) [Treatment] bleomycin [Effect] hyperpigmentation"}, {"id": "8551001_2_59", "context": "Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with autoimmune hepatitis [Treatment] Azathioprine [Effect] myelosuppression"}, {"id": "8645078_2_60", "context": "Captopril-associated \"pseudocholangitis'.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Captopril [Effect] pseudocholangitis"}, {"id": "6628806_1_61", "context": "A case of toxic hepatitis caused by combination therapy with methotrexate and etretinate in the treatment of severe psoriasis is presented in a 47-year-old woman.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] psoriasis; a 47-year-old woman [Treatment] combination therapy with methotrexate and etretinate [Effect] toxic hepatitis"}, {"id": "1988604_2_62", "context": "Thrombin is highly effective for stopping intractable arterial hemorrhage during stereotactic brain biopsy; however, it is a vasospastic agent and may have been responsible for the cerebral infarctions in one patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] stopping [Treatment] Thrombin [Effect] highly effective [Adverse event] responsible [Subject] one patient [Treatment] Thrombin [Effect] cerebral infarctions"}, {"id": "12439602_2_63", "context": "Carboplatin hypersensitivity presenting as coronary vasospasm - a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presenting [Treatment] Carboplatin [Effect] coronary vasospasm"}, {"id": "23471710_1_64", "context": "Severe hypoglycemia from Helicobacter pylori triple-drug therapy and insulin detemir drug interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] Helicobacter pylori triple-drug therapy and insulin detemir drug interaction [Effect] Severe hypoglycemia"}, {"id": "18765315_3_65", "context": "The aim of this study was to describe the occurrence of acute coronary syndromes in 3 cases of rituximab infusions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurrence [Treatment] rituximab infusions [Effect] acute coronary syndromes"}, {"id": "12196060_12_66", "context": "Acute pharmacokinetic and pharmacodynamic interactions between phenytoin and isradipine were probably responsible for the lethargy, dysarthria, ataxia, and weakness our patient developed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] responsible [Treatment] Acute pharmacokinetic and pharmacodynamic interactions between phenytoin and isradipine [Effect] the lethargy, dysarthria, ataxia, and weakness"}, {"id": "11819156_2_67", "context": "A patient suffering from a rare enzyme deficiency developed a malignant neuroleptic syndrome after having been treated with one single dose of haloperidol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] A patient suffering from a rare enzyme deficiency [Treatment] one single dose of haloperidol [Effect] malignant neuroleptic syndrome"}, {"id": "8645078_3_68", "context": "Captopril is known to be associated with dermatologic, hematologic, and pulmonary adverse effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Captopril [Effect] dermatologic, hematologic, and pulmonary adverse effects"}, {"id": "16446228_1_69", "context": "Here, we present a case of sirolimus-associated interstitial pneumonitis in a cardiac transplant recipient that resolved completely with withdrawal of the drug and treatment with corticosteroids.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Subject] a case of sirolimus-associated interstitial pneumonitis in a cardiac transplant recipient [Treatment] withdrawal of the drug and treatment with corticosteroids [Adverse event] associated [Treatment] sirolimus [Effect] interstitial pneumonitis"}, {"id": "3586163_1_70", "context": "Other upper tract neoplasms after cyclophosphamide are reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] cyclophosphamide [Effect] upper tract neoplasms"}, {"id": "647693_1_71", "context": "Four patients receiving high-dose tamoxifen for greater than 1 year have demonstrated similar retinal changes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] Four patients [Treatment] high-dose tamoxifen for greater than 1 year [Effect] retinal changes"}, {"id": "12390172_3_72", "context": "Retinal dysfunction and anterior segment deposits in a patient treated with rifabutin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] patient [Treatment] rifabutin [Effect] Retinal dysfunction and anterior segment deposits"}, {"id": "11590881_1_73", "context": "Carbamazepine induced right bundle branch block in a Greenlandic patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] Greenlandic patient [Treatment] Carbamazepine [Effect] right bundle branch block"}, {"id": "17068466_2_74", "context": "RESULTS: Both cases presented here describe corneal ulcers that persisted and showed signs of worsening during weeks of frequent topical dosing with moxifloxacin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] worsening [Subject] Both cases [Treatment] weeks of frequent topical dosing with moxifloxacin [Effect] corneal ulcers that persisted"}, {"id": "8844232_2_75", "context": "We describe a case of poisoning with 3,4-methylenedioxymet-amphetamine Ecstasy that presented with all the features suggestive of a fatal outcome, including a creatinine phosphokinase level markedly higher than any previously reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] a case [Treatment] 3,4-methylenedioxymet-amphetamine Ecstasy [Effect] poisoning; creatinine phosphokinase level markedly higher"}, {"id": "14964753_7_76", "context": "Ramipril-induced cutaneous vasculitis is particularly rare and our case was atypical because the patient had tolerated lisinopril before.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] the patient had tolerated lisinopril before [Treatment] Ramipril [Effect] cutaneous vasculitis"}, {"id": "11978156_6_77", "context": "To date, this is the first reported case of what appears to be isolated thrombocytopenia associated with lansoprazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] lansoprazole [Effect] isolated thrombocytopenia"}, {"id": "1628669_1_78", "context": "A 7-year-old girl developed diabetes mellitus and exocrine pancreatic insufficiency after 3.5 years of almost continuous treatment with azathioprine and/or prednisone for idiopathic auto-immune haemolytic anaemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 7-year-old girl [Treatment] 3.5 years of almost continuous treatment with azathioprine and/or prednisone [Effect] diabetes mellitus and exocrine pancreatic insufficiency"}, {"id": "10485779_2_79", "context": "The human immunodeficiency virus protease inhibitor ritonavir is a potent inhibitor of the cytochrome P450 3A4 enzyme, and ritonavir's concomitant administration with the substrates of this enzyme may lead to dangerous drug interactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] lead [Treatment] ritonavir's concomitant administration with the substrates of this enzyme [Effect] drug interactions"}, {"id": "10510017_3_80", "context": "There remains a paucity of information pertaining to alternative anticoagulation strategies for use during cardiopulmonary bypass concomitant with heparin-induced thrombocytopenia, especially in children.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] children [Treatment] heparin [Effect] thrombocytopenia"}, {"id": "8308511_1_81", "context": "Unintended exposure to acyclovir early in pregnancy, which is not uncommon, may cause excessive maternal and physician anxiety.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Unintended exposure to acyclovir [Effect] excessive maternal and physician anxiety"}, {"id": "14964753_6_82", "context": "The ACE inhibitors can cause various skin side effects; however, it rarely causes cutaneous vasculitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] ACE inhibitors [Effect] skin side effects"}, {"id": "10633877_2_83", "context": "Salicylate intoxication was excluded, and theophylline was finally incriminated.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] incriminated [Treatment] theophylline"}, {"id": "15028328_4_84", "context": "We present a case of stroke after PPA ingestion that occurred 4 months after the recall in an 8-year-old boy on chronic peritoneal dialysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] an 8-year-old boy on chronic peritoneal dialysis [Treatment] PPA [Effect] stroke"}, {"id": "15028328_1_85", "context": "Cerebral infarcts in a pediatric patient secondary to phenylpropanolamine, a recalled medication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Subject] pediatric patient [Treatment] phenylpropanolamine [Effect] Cerebral infarcts"}, {"id": "16164579_2_86", "context": "To our knowledge, our report is one of the first on shock and angio-oedema from irbesartan.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] irbesartan [Effect] shock and angio-oedema"}, {"id": "15944830_2_87", "context": "Clinical course of macular edema in two cases of interferon-associated retinopathy observed by optical coherence tomography.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] two cases [Treatment] interferon [Effect] macular edema; retinopathy"}, {"id": "16939867_3_88", "context": "This report describes a 13-year-old female with a right frontal high-grade glioma and complex partial seizures who developed localized purpura after 23 months of lamotrigine monotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 13-year-old female with a right frontal high-grade glioma and complex partial seizures [Treatment] 23 months of lamotrigine monotherapy [Effect] localized purpura"}, {"id": "9491301_2_89", "context": "Patient 1 presented bilateral ballism 1 week after intravenous heroin injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] Patient 1 [Treatment] intravenous heroin injection [Effect] bilateral ballism"}, {"id": "3718111_1_90", "context": "He became hyperkalemic on rechallenge with timolol and normokalemic following its withdrawal.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] He [Treatment] timolol [Effect] hyperkalemic"}, {"id": "11247558_1_91", "context": "Ischaemic colitis in a patient taking meloxicam.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] a patient [Treatment] meloxicam [Effect] Ischaemic colitis"}, {"id": "17937473_2_92", "context": "Leflunomide-associated infections in rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Leflunomide [Effect] infections"}, {"id": "11903249_1_93", "context": "Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] two cases [Treatment] interferon alfa and ribavirin treatment of hepatitis C virus infection [Effect] Cutaneous sarcoidosis"}, {"id": "7632529_2_94", "context": "Acute renal failure in a child associated with acyclovir.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a child [Treatment] acyclovir [Effect] Acute renal failure"}, {"id": "18622319_4_95", "context": "Bevacizumab is a recently developed monoclonal antibody against vascular endothelial growth factor receptor used to inhibit angiogenesis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] inhibit [Treatment] Bevacizumab is a recently developed monoclonal antibody"}, {"id": "7387219_3_96", "context": "Two patients with rheumatoid arthritis developed evidence of hepatotoxicity while receiving D-penicillamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two patients with rheumatoid arthritis [Treatment] D-penicillamine [Effect] hepatotoxicity"}, {"id": "17310853_1_97", "context": "Fatal venous thrombembolism complicating imatinib therapy in a patient with metastatic gastrointestinal stromal tumor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicating [Subject] a patient with metastatic gastrointestinal stromal tumor [Treatment] imatinib [Effect] Fatal venous thrombembolism"}, {"id": "19296063_2_98", "context": "However, acute cardiomyopathy and pericarditis secondary to methylphenidate use has been rarely reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] use [Treatment] methylphenidate [Effect] acute cardiomyopathy and pericarditis"}, {"id": "7897759_2_99", "context": "Propoxyphene-induced wide QRS complex dysrhythmia responsive to sodium bicarbonate--a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Propoxyphene [Effect] wide QRS complex dysrhythmia"}, {"id": "24927617_11_100", "context": "Simvastatin plasma concentration increased 30 times in this patient and statin induced muscle toxicity is related to the concentration of the statin in blood.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] Simvastatin plasma concentration increased 30 times in this patient [Treatment] statin [Effect] muscle toxicity"}, {"id": "11171531_3_101", "context": "Poorly controlled hypertension in a painter with chronic lead toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] a painter [Treatment] lead [Effect] Poorly controlled hypertension"}, {"id": "9695308_4_102", "context": "It was concluded that ANCA is closely related to the pathogenesis of crescentic glomerulonephritis and that treatment with PTU appeared to induce ANCA.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Treatment] PTU [Effect] ANCA"}, {"id": "12561997_1_103", "context": "Gelatinous transformation of bone marrow following chemotherapy for myeloma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] chemotherapy [Effect] Gelatinous transformation of bone marrow"}, {"id": "15279668_2_104", "context": "We discuss a case with significant progressive peripheral neurological deterioration following administration of both fludarabine and cytarabine as part of the FLA (fludarabine and cytarabine) regime.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a case [Treatment] fludarabine and cytarabine; FLA (fludarabine and cytarabine) regime [Effect] significant progressive peripheral neurological deterioration"}, {"id": "7174620_2_105", "context": "The course of delirium due to lithium intoxication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] lithium intoxication [Effect] delirium"}, {"id": "21350204_10_106", "context": "Preadmission warfarin use was not associated with any secondary intracerebral hemorrhage (OR, 1.2; 95% CI, 0.7 to 2.2), symptomatic intracerebral hemorrhage (OR, 1.1; 95% CI, 0.5 to 2.3), or gastrointestinal hemorrhage (OR, 1.1; 95% CI, 0.2 to 5.6).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Preadmission warfarin [Effect] any secondary intracerebral hemorrhage (OR, 1.2; 95% CI, 0.7 to 2.2), symptomatic intracerebral hemorrhage (OR, 1.1; 95% CI, 0.5 to 2.3), or gastrointestinal hemorrhage (OR, 1.1; 95% CI, 0.2 to 5.6)"}, {"id": "16507380_11_107", "context": "In this case of a possible drug-drug interaction between IFN alfa 11 MU TIW and gemfibrozil 600 mg BID in a patient undergoing treatment for IFN-induced hypertriglyceridemia, the Naranjo Adverse Drug Reactions (ADR) Probability Scale score was 7 (ie, ADR possibly related to treatment).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Probability [Subject] a patient undergoing treatment for IFN-induced hypertriglyceridemia [Treatment] IFN alfa 11 MU TIW; gemfibrozil 600 mg BID [Effect] Naranjo Adverse Drug Reactions"}, {"id": "11554897_5_108", "context": "Stupor from lamotrigine toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] lamotrigine [Effect] Stupor"}, {"id": "2417800_2_109", "context": "Autopsy findings were consistent with bleomycin and oxygen-induced pulmonary damage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] bleomycin and oxygen [Effect] pulmonary damage"}, {"id": "9426968_2_110", "context": "We report a case of vitiligo that occurred during the second month of interferon alpha 2a therapy for chronic active hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] during the second month of interferon alpha 2a therapy [Effect] vitiligo"}, {"id": "16244351_2_111", "context": "Vardenafil is a new oral phosphodiesterase inhibitor used for erectile dysfunction.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used for [Treatment] Vardenafil is a new oral phosphodiesterase inhibitor"}, {"id": "17959575_16_112", "context": "CONCLUSION: A patient with CHF and ESRD developed myoclonic muscle spasms after receiving dobutamine by continuous i.v.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A patient with CHF and ESRD [Treatment] dobutamine by continuous i.v [Effect] myoclonic muscle spasms"}, {"id": "2568058_1_113", "context": "Nail-changes induced by penicillamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] penicillamine [Effect] Nail-changes"}, {"id": "18562412_4_114", "context": "The fourth patient showed RLS symptoms that were initially caused by a 20-mg daily olanzapine dosage and were later mitigated when olanzapine was reduced and ropinirole was administered.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] The fourth patient [Treatment] 20-mg daily olanzapine dosage [Effect] RLS symptoms"}, {"id": "9819544_1_115", "context": "Naproxen-associated sudden sensorineural hearing loss.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Naproxen [Effect] sudden sensorineural hearing loss"}, {"id": "15719254_3_116", "context": "Retinoic acid may increase the risk of bone marrow transplant nephropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increase [Treatment] Retinoic acid [Effect] bone marrow transplant nephropathy"}, {"id": "15827071_13_117", "context": "A review of published case reports showed a short time to onset of symptoms following the introduction of linezolid, generally within 1-3 days.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] introduction of linezolid, generally within 1-3 days [Effect] a short time to onset of symptoms"}, {"id": "10465148_2_118", "context": "Intrathecal chemotherapy with methotrexate or cytosine arabinoside is the standard approach to prophylaxis and treatment of central nervous system leukemia in children.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] children [Treatment] Intrathecal chemotherapy with methotrexate or cytosine arabinoside"}, {"id": "15827071_10_119", "context": "The following day, the patient developed anxiety, panic attacks, tremors, tachycardia, and hypertension that persisted throughout linezolid treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] patient [Treatment] linezolid [Effect] anxiety, panic attacks, tremors, tachycardia, and hypertension"}, {"id": "9527943_1_120", "context": "Effect of beta-blockade on symptomatic dexamethasone-induced hypertrophic obstructive cardiomyopathy in premature infants: three case reports and literature review.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] premature infants [Treatment] dexamethasone [Effect] hypertrophic obstructive cardiomyopathy [Potential therapeutic event] Effect [Subject] premature infants [Treatment] beta-blockade"}, {"id": "7235792_1_121", "context": "Although transient increases in ectopy after bretylium therapy have been described, presumably due to catecholamine release, the occurrence of life-threatening ventricular arrhythmia leading to cardiac arrest has not previously been emphasized.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] bretylium [Effect] transient increases in ectopy; life-threatening ventricular arrhythmia leading to cardiac arrest"}, {"id": "16531969_4_122", "context": "We report three cases of IFN beta induced hepatitis in MS and discuss the pathology findings and possible mechanisms of drug-induced liver injury.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] three cases [Treatment] IFN beta [Effect] hepatitis in MS"}, {"id": "14530108_2_123", "context": "RTA is one type of nephrotoxicity induced by FK506, and it is reversible in mild cases when appropriately treated.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] FK506 [Effect] RTA; nephrotoxicity"}, {"id": "11984077_2_124", "context": "The most common side effects associated with amifostine are nausea, vomiting, hypotension, hypocalcemia and allergic reactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] amifostine [Effect] nausea, vomiting, hypotension, hypocalcemia; allergic reactions."}, {"id": "16449538_5_125", "context": "Nonconvulsive status epilepticus due to ifosfamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] ifosfamide [Effect] Nonconvulsive status epilepticus"}, {"id": "16122280_3_126", "context": "Clinical experience in infectious patients has shown that oral telithromycin 800mg once daily for 5-10 days is effective for the treatment of community-acquired upper and lower respiratory tract infections.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] infectious patients [Treatment] oral telithromycin 800mg once daily for 5-10 days"}, {"id": "2549018_2_127", "context": "Five patients receiving fluoxetine for the treatment of obsessive compulsive disorder or major depression developed akathisia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Five patients [Treatment] fluoxetine [Effect] akathisia"}, {"id": "14723711_6_128", "context": "This fourth type of cutaneous minocycline hyperpigmentation may be a variant of Type I, but based on clinical, pathological and microanalytical differences, appears to be a new entity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] be [Treatment] minocycline [Effect] hyperpigmentation"}, {"id": "12196060_1_129", "context": "Phenytoin/isradipine interaction causing severe neurologic toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causing [Treatment] Phenytoin/isradipine interaction [Effect] neurologic toxicity"}, {"id": "3609047_3_130", "context": "We report a case of torsade de pointes following a single oral dose of amiodarone (1400 mg or 30 mg kg-1) administered after short intravenous loading for prevention of paroxysmal atrial flutter.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] a single oral dose of amiodarone (1400 mg or 30 mg kg-1) [Effect] torsade de pointes"}, {"id": "14660304_2_131", "context": "Traditionally, children with acute lymphoblastic leukemia receive prednisone, as part of multiagent remission-induction chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receive [Subject] children with acute lymphoblastic leukemia [Treatment] prednisone"}, {"id": "15760792_3_132", "context": "Propylthiouracil-induced sensorineural hearing loss associated with antineutrophil cytoplasmic antibodies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Propylthiouracil [Effect] sensorineural hearing loss associated with antineutrophil cytoplasmic antibodies"}, {"id": "9466030_1_133", "context": "Acute respiratory depression as a complication of nebulised morphine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] nebulised morphine [Effect] Acute respiratory depression"}, {"id": "7420580_2_134", "context": "We report on a patient with an embryonal teratocarcinoma of the testicle who had the syndrome of inappropriate secretion of antidiuretic hormone after receiving a high dose of vinblastine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] a patient with an embryonal teratocarcinoma of the testicle [Treatment] a high dose of vinblastine [Effect] syndrome of inappropriate secretion of antidiuretic hormone"}, {"id": "8864370_4_135", "context": "Methotrexate-induced liver cirrhosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Methotrexate [Effect] liver cirrhosis"}, {"id": "17195428_2_136", "context": "A case of oculogyric crisis induced by metoclopramide is described in this paper.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] metoclopramide [Effect] oculogyric crisis"}, {"id": "12806509_1_137", "context": "Early-onset acute transverse myelitis following hepatitis B vaccination and respiratory infection: case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] case [Treatment] hepatitis B vaccination [Effect] Early-onset acute transverse myelitis"}, {"id": "2429270_5_138", "context": "The pro-arrhythmic effects of procainamide may be explained on the basis of both its vagolytic action on the atrioventricular node as well as by prolongation of refractoriness in the accessory pathway.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] procainamide [Effect] pro-arrhythmic effects"}, {"id": "12661801_3_139", "context": "We present the management of agranulocytosis and neutropenic sepsis secondary to carbimazole with recombinant human granulocyte colony stimulating factor (G-CSF).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] carbimazole with recombinant human granulocyte colony stimulating factor (G-CSF) [Effect] agranulocytosis and neutropenic sepsis"}, {"id": "16459502_1_140", "context": "Cutaneous mycobacterial infection post intravesical BCG installation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] post [Treatment] intravesical BCG installation [Effect] Cutaneous mycobacterial infection"}, {"id": "19690222_2_141", "context": "On day 4, following 3 doses of dalteparin, the patient developed acute respiratory distress attributable to a massive right hemothorax confirmed by computed tomography pulmonary angiography (CTPA) and intercostal drainage of 1500 mL of frank blood.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] the patient [Treatment] 3 doses of dalteparin [Effect] acute respiratory distress attributable to a massive right hemothorax"}, {"id": "23774436_2_142", "context": "A 4-month regimen of gatifloxacin with rifampin, isoniazid, and pyrazinamide is being evaluated for the treatment of tuberculosis in a phase 3 randomized controlled trial (OFLOTUB).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] gatifloxacin; rifampin; isoniazid; pyrazinamide"}, {"id": "9619226_2_143", "context": "We postulate that the bolus of sulprostone resulted in possible coronary spasm that resulted in cardiac arrest.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Treatment] sulprostone [Effect] coronary spasm that resulted in cardiac arrest"}, {"id": "12661801_1_144", "context": "A 72-year-old woman with a history of thyrotoxicosis presented with sore throat and fever two weeks after starting carbimazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] 72-year-old woman with a history of thyrotoxicosis [Treatment] two weeks after starting carbimazole [Effect] sore throat and fever"}, {"id": "8700794_5_145", "context": "Without other causes for the hyponatremia, she was diagnosed with the syndrome of inappropriate antidiuretic hormone, presumably caused by desmopressin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] diagnosed [Subject] she [Treatment] desmopressin [Effect] hyponatremia; syndrome of inappropriate antidiuretic hormone"}, {"id": "15279668_1_146", "context": "Fatal peripheral neuropathy following FLA chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] FLA chemotherapy [Effect] Fatal peripheral neuropathy"}, {"id": "19249953_1_147", "context": "Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] potential sitagliptin-lovastatin interaction [Effect] Rhabdomyolysis"}, {"id": "8305778_3_148", "context": "A 78-year-old man with a history of congestive heart failure and coronary artery disease began taking amiodarone to suppress sustained ventricular tachycardia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] suppress [Subject] A 78-year-old man with a history of congestive heart failure and coronary artery disease [Treatment] amiodarone"}, {"id": "8645078_1_149", "context": "A patient with severe cholestatic jaundice induced by captopril is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] A patient [Treatment] captopril [Effect] severe cholestatic jaundice"}, {"id": "14723711_3_150", "context": "Three distinct types of minocycline-induced cutaneous pigmentation have been described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] minocycline [Effect] cutaneous pigmentation"}, {"id": "18765315_4_151", "context": "The occurrence of symptoms that could be ascribed to an acute coronary syndrome should always be taken seriously during the first rituximab infusion and investigated aggressively.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] first rituximab infusion [Effect] acute coronary syndrome"}, {"id": "12635752_1_152", "context": "Antithyroid treatment with propylthiouracil (PTU) resulted in elevated hepatic enzymes and after the 12th week of pregnancy treatment was changed to carbimazole (CBZ).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Subject] 12th week of pregnancy [Treatment] propylthiouracil (PTU) [Effect] elevated hepatic enzymes [Potential therapeutic event] changed [Subject] 12th week of pregnancy [Treatment] carbimazole (CBZ)"}, {"id": "9695308_2_153", "context": "Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with propylthiouracil therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] propylthiouracil therapy [Effect] Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis"}, {"id": "12399645_2_154", "context": "ADH hypersecretion in relation to plasma osmolality was reversed by mizoribin withdrawal, suggesting that bredinin might adversely induce SIADH.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] reversed [Subject] plasma osmolality [Treatment] mizoribin withdrawal [Adverse event] induce [Treatment] bredinin [Effect] adversely induce SIADH"}, {"id": "10510017_1_155", "context": "Heparin-induced thrombocytopenia is a rare and serious complication of anticoagulation therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] anticoagulation therapy [Effect] thrombocytopenia"}, {"id": "18991509_1_156", "context": "Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] an HIV type 1-infected patient [Treatment] receiving therapy with ritonavir-lopinavir; epidural triamcinolone injections [Effect] Iatrogenic Cushing syndrome"}, {"id": "18622319_2_157", "context": "Otolaryngologists should be made aware of a newer cause of nasal septal perforations resulting from the more recent antiangiogenic therapy used to treat malignancies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] the more recent antiangiogenic therapy [Effect] nasal septal perforations"}, {"id": "7459812_2_158", "context": "Following several of these courses of therapy, respiratory distress occurred 9 to 12 days after the chlorambucil was given.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] the chlorambucil [Effect] respiratory distress"}, {"id": "19648225_2_159", "context": "Possible mechanisms for damage to the urothelium by ketamine are suggested.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] by [Treatment] ketamine [Effect] damage to the urothelium"}, {"id": "19217693_2_160", "context": "Persistent hypoglycemia in a patient with diabetes taking etanercept for the treatment of psoriasis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] a patient with diabetes [Treatment] etanercept [Effect] Persistent hypoglycemia"}, {"id": "15965422_1_161", "context": "Cutaneous necrosis after injection of polyethylene glycol-modified interferon alfa.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] injection of polyethylene glycol-modified interferon alfa [Effect] Cutaneous necrosis"}, {"id": "3586163_3_162", "context": "We report an unusual case of simultaneous transitional cell carcinoma of the renal pelvis and distal ureter without transitional cell carcinoma of the bladder occurring after chronic cyclophosphamide therapy for nonHodgkin's lymphoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] chronic cyclophosphamide therapy [Effect] simultaneous transitional cell carcinoma of the renal pelvis and distal ureter without transitional cell carcinoma of the bladder"}, {"id": "18359591_1_163", "context": "In the present paper, we describe two patients with active UC who developed a severe systemic CMV infection during a treatment with an oral microemulsion form of cyclosporine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment [Subject] two patients with active UC [Treatment] oral microemulsion form of cyclosporine [Effect] severe systemic CMV infection"}, {"id": "9681092_5_164", "context": "Prior to surgery, the patient received droperidol, an agent known to prolong the QT interval.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] received [Subject] the patient [Treatment] droperidol; Prior to surgery"}, {"id": "20110001_4_165", "context": "OBJECTIVE: We report a case of cutaneous KS lesions in a patient affected by CML treated with imatinib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated with [Subject] a patient affected by CML [Treatment] imatinib [Effect] cutaneous KS lesions"}, {"id": "17907595_6_166", "context": "The FK 506 dose was constant within 21 days after discontinuing phenytoin in Patient 1 who had 36 days of phenytoin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] discontinuing [Subject] Patient 1 [Treatment] phenytoin [Effect] The FK 506 dose was constant within 21 days"}, {"id": "11597289_14_167", "context": "In patients receiving antithrombin III and concomitant heparin, a significantly increased bleeding incidence was observed (23.8% for antithrombin III group vs 13.5% for placebo group; P<.001).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increased [Subject] patients [Treatment] antithrombin III and concomitant heparin [Effect] bleeding incidence"}, {"id": "968449_2_168", "context": "Bone marrow chromosomes were studied in 2 patients with polycythaemia vera (PV) at the time of diagnosis and several times subsequently during therapy with chlorambucil.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] therapy [Subject] 2 patients with polycythaemia vera (PV) [Treatment] chlorambucil"}, {"id": "2429270_4_169", "context": "Procainamide-induced incessant supraventricular tachycardia in the Wolff-Parkinson-White syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Procainamide [Effect] incessant supraventricular tachycardia"}, {"id": "19249953_10_170", "context": "To our knowledge, however, this is the first case report of a possible sitagliptin-lovastatin interaction that may have caused rhabdomyolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] sitagliptin-lovastatin interaction [Effect] rhabdomyolysis"}, {"id": "897744_2_171", "context": "A drug addict with staphylococcal endocarditis treated with methicillin, who developed massive proteinuria and acute nephritic syndrome is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A drug addict [Treatment] methicillin [Effect] massive proteinuria and acute nephritic syndrome"}, {"id": "7035691_3_172", "context": "Although inhibition of the angiotensin-converting enzyme is considered to be efficient treatment for hypertension associated with chronic renal failure, care should be taken when captopril is administered initially to a patient with decreased renal function, under the conditions of sodium and water depletion.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] a patient with decreased renal function [Treatment] captopril"}, {"id": "7907218_1_173", "context": "Two patients with extrapyramidal side effects after the use of fluphenazine decanoate were evaluated by means of IBZM-SPECT.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] Two patients [Treatment] fluphenazine decanoate [Effect] extrapyramidal side effects"}, {"id": "10348150_2_174", "context": "The clinical course suggests that the interstitial pneumonitis was induced by hydroxyurea.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] hydroxyurea [Effect] interstitial pneumonitis"}, {"id": "2196696_1_175", "context": "Disulfiram-induced hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Disulfiram [Effect] hepatitis"}, {"id": "15112258_13_176", "context": "The majority of radiation recall reactions attributed to gemcitabine are reported to affect internal tissue or organs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attributed [Treatment] gemcitabine [Effect] radiation recall reactions"}, {"id": "18487000_2_177", "context": "The known side effects of sibutramine, ie, hypertension and tachycardia, depend on its adrenergic and serotoninergic effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] sibutramine [Effect] hypertension and tachycardia"}, {"id": "20979526_8_178", "context": "Because at the end of the first month the patient's platelet counts were normal and the thrombocytopenia developed after the co-medication with conventional drugs, it was suspected that the thrombocytopenia might not be attributed to the use of FHP.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attributed [Treatment] FHP [Effect] thrombocytopenia"}, {"id": "12625995_3_179", "context": "Two cases of childhood-onset schizophrenia associated with clozapine-induced akathisia responsive to beta-blocker treatment are described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] Two cases of childhood-onset schizophrenia [Treatment] clozapine [Effect] akathisia responsive [Potential therapeutic event] associated [Subject] Two cases of childhood-onset schizophrenia [Treatment] beta-blocker treatment"}, {"id": "11688826_2_180", "context": "Syndrome of inappropriate secretion of ADH (SIADH) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a pulmonary adenocarcinoma patient with a malignant pleural effusion [Treatment] cisplatin [Effect] Syndrome of inappropriate secretion of ADH (SIADH)"}, {"id": "12546343_2_181", "context": "He had an immediate hypersensitivity reaction during the initiation of the MTX infusion with diffuse urticaria, facial swelling, cough, and chest tightness.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] MTX infusion [Effect] hypersensitivity reaction; with diffuse urticaria, facial swelling, cough, and chest tightness"}, {"id": "20110001_1_182", "context": "CONCLUSIONS: We present a case of a patient with CML who developed KS 12 months after starting treatment with imatinib 400 mg/d.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] 12 months; imatinib 400 mg/d [Effect] KS"}, {"id": "16531969_2_183", "context": "Grade 3 hepatotoxicity (AST and ALT > 5 to 20 upper limit normal) or higher has been observed in as many as 1.4% of MS patients on IFN beta.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Subject] 1.4% of MS patients [Treatment] IFN beta [Effect] Grade 3 hepatotoxicity"}, {"id": "17329303_6_184", "context": "The second patient was a girl of 6, already on risperidone for ADHD and borderline intellectual functioning when referred.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] on [Subject] a girl of 6 [Treatment] risperidone"}, {"id": "12196060_2_185", "context": "To report a young man on phenytoin who developed acute neurologic symptoms after isradipine was introduced to his treatment regimen and discuss the possible causes of this drug interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a young man [Treatment] phenytoin; isradipine [Effect] acute neurologic symptoms"}, {"id": "16446228_2_186", "context": "Reversible sirolimus-associated pneumonitis after heart transplantation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] sirolimus [Effect] pneumonitis"}, {"id": "2063999_2_187", "context": "We report a girl with the Rett syndrome who had acute encephalopathy probably induced by calcium hopantenate (HOPA).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a girl [Treatment] calcium hopantenate (HOPA) [Effect] Rett syndrome; acute encephalopathy"}, {"id": "11126885_7_188", "context": "Only after three subsequent episodes of severe, symptomatic thrombocytopenia over the next four weeks did he say, upon repeat questioning, that he had continued to take quinine for night leg cramps.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] take [Subject] he; night leg cramps [Treatment] continued to take quinine [Effect] symptomatic thrombocytopenia"}, {"id": "10327035_1_189", "context": "An episode of subacute encephalopathy after the infusion of a moderate dose of methotrexate (1500 mg/m2) (MTX) is reported in a young adult with metastastic gastric cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a young adult with metastastic gastric cancer [Treatment] a moderate dose of methotrexate (1500 mg/m2) (MTX) [Effect] subacute encephalopathy"}, {"id": "24927617_1_190", "context": "Rhabdomyolysis in a hepatitis C virus infected patient treated with telaprevir and simvastatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] hepatitis C virus infected patient [Treatment] telaprevir and simvastatin [Effect] Rhabdomyolysis"}, {"id": "15779196_1_191", "context": "Four days after intravenous Zoledronic acid, the patient presented to emergency room with complaints of carpopedal spasm and bronchospasm.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complaints [Subject] patient [Treatment] Four days after intravenous Zoledronic acid [Effect] carpopedal spasm and bronchospasm"}, {"id": "7117795_3_192", "context": "Ulcerating enteritis associated with flucytosine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] flucytosine therapy [Effect] Ulcerating enteritis"}, {"id": "15681911_2_193", "context": "OBJECTIVES: To describe clinical and pathologic findings in patients noted to develop lower gastrointestinal symptoms when exposed to rofecoxib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] patients [Treatment] rofecoxib [Effect] lower gastrointestinal symptoms"}, {"id": "15338554_5_194", "context": "Our findings suggest that significant progression of marrow reticulin fibrosis during imatinib therapy can be an indicator for a return or progression of CML and, in some patients with CML, imatinib may promote cytogenetic clonal evolution, resulting in a poor response to treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] imatinib [Effect] significant progression of marrow reticulin fibrosis"}, {"id": "8840640_2_195", "context": "Metabolic acidosis induced by cetrimide-chlorhexidine solution in hydatid cyst surgery.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] cetrimide-chlorhexidine solution [Effect] Metabolic acidosis"}, {"id": "7685228_1_196", "context": "Reversal of gold-induced neutropenia with granulocyte colony-stimulating factor (G-CSF).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] granulocyte colony-stimulating factor [Treatment] gold; granulocyte colony-stimulating factor (G-CSF) [Effect] neutropenia"}, {"id": "946400_2_197", "context": "Methyldopa-induced liver injury.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Methyldopa [Effect] liver injury"}, {"id": "14971874_1_198", "context": "After infliximab treatment, additional sleep studies revealed an increase in the number of apneic events and SaO2 dips suggesting that TNFalpha plays an important role in the pathophysiology of sleep apnea.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increase [Treatment] infliximab [Effect] increase in the number of apneic events and SaO2 dips"}, {"id": "6507240_4_199", "context": "One patient developed severe hyponatremia with serum Na+ of 108 mEq/L when hydrochlorothiazide was given to control hypertension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] One patient [Treatment] hydrochlorothiazide [Effect] severe hyponatremia with serum Na+ of 108 mEq/L"}, {"id": "1624172_3_200", "context": "Thyroid dysfunction has been reported in patients with malignant disease treated with recombinant alpha interferon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Subject] patients with malignant disease [Treatment] recombinant alpha interferon [Effect] Thyroid dysfunction"}, {"id": "15112258_9_201", "context": "The authors also determined that their case of myositis developing in the rectus abdominus muscle of a patient with pancreatic adenocarcinoma was the manifestation of radiation recall, thereby bringing the number of patients who developed radiation recall to gemcitabine and were discussed in the current study to 13.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with pancreatic adenocarcinoma [Treatment] gemcitabine [Effect] myositis developing in the rectus abdominus muscle; radiation recall"}, {"id": "11126885_8_202", "context": "Even after a strict warning, he took another quinine tablet that evening, which triggered his fifth episode of severe thrombocytopenia, and confirmed the etiology of quinine-induced thrombocytopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] triggered [Treatment] quinine tablet [Effect] severe thrombocytopenia"}, {"id": "968449_4_203", "context": "Case 1 presented after 25 months of myelosuppressive therapy a deletion of chromosome no. 12, del (12) (p11), in 60% of the diploid cells.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] Case 1 [Treatment] 25 months of myelosuppressive therapy [Effect] a deletion of chromosome no. 12, del (12) (p11), in 60% of the diploid cells"}, {"id": "1893404_2_204", "context": "Diabetes Mellitus was observed in a patient given carbamazepine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] given [Subject] a patient [Treatment] carbamazepine [Effect] Diabetes Mellitus"}, {"id": "25295553_3_205", "context": "Anxiety is common in patients with schizophrenia and pregabalin has been suggested as an off-label add-on treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] patients with schizophrenia [Treatment] pregabalin has been suggested as an off-label add-on treatment"}, {"id": "8996514_2_206", "context": "Large cerebral infarction during praziquantel therapy in neurocysticercosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] praziquantel [Effect] Large cerebral infarction"}, {"id": "18556970_2_207", "context": "We report a 13 year-old male who developed life-threatening anaphylaxis early in the course of Increlex therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 13 year-old male [Treatment] Increlex [Effect] anaphylaxis"}, {"id": "16531969_1_208", "context": "Drug induced liver injury secondary to interferon-beta (IFN-beta) in multiple sclerosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] interferon-beta (IFN-beta) [Effect] liver injury"}, {"id": "9925865_1_209", "context": "CONCLUSION: Lipoid pneumonia as a result of mineral oil aspiration still occurs in the pediatric population.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Subject] pediatric [Treatment] mineral oil aspiration [Effect] Lipoid pneumonia"}, {"id": "21350204_12_210", "context": "The results from the present study suggest that tissue plasminogen activator treatment appears to be safe in patients with acute ischemic stroke taking warfarin with an international normalized ratio <1.7 and may reduce the risk of poor functional outcome.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] appears [Subject] patients with acute ischemic stroke [Treatment] taking warfarin with an international normalized ratio <1.7; tissue plasminogen activator treatment [Effect] may reduce the risk of poor functional outcome"}, {"id": "17157086_4_211", "context": "Because of chronic asthma, she had been receiving a leukotriene receptor antagonist (montelukast) for 5 years before the current presentation; 1 week before onset she had had 1 week of treatment with two dietary supplements for weight control; one of these included Garcinia Cambogia, a possible cause of two recent cases of hepatitis in the USA; in addition, both formulas contained a citrus derivative that interferes cytochrome functions.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receiving [Subject] she [Treatment] a leukotriene receptor antagonist (montelukast) for 5 years [Adverse event] cause [Subject] two recent cases [Treatment] Garcinia Cambogia [Effect] hepatitis"}, {"id": "2204409_1_212", "context": "An episode of leukoencephalopathy is reported in a 13-year-old girl who, after standard radiotherapy for a posterior fossa medulloblastoma, received 8 treatments with a protocol containing a 4-hour infusion of 500 mg/m2 methotrexate and 12 mg intrathecal methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] 13-year-old girl who [Treatment] standard radiotherapy for a posterior fossa medulloblastoma, received 8 treatments with a protocol containing a 4-hour infusion of 500 mg/m2 methotrexate and 12 mg intrathecal methotrexate [Effect] leukoencephalopathy"}, {"id": "11514944_1_213", "context": "BACKGROUND: Accutane a teratogenic prescription drug licensed to treat severe, recalcitrant nodular acne.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treat [Treatment] Accutane"}, {"id": "12452753_5_214", "context": "OBJECTIVE: To report the safe use of fluorouracil in a patient with breast cancer who had allergic reactions to capecitabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] safe [Subject] a patient with breast cancer who had allergic reactions to capecitabine [Treatment] fluorouracil"}, {"id": "7797283_1_215", "context": "Esophageal candidiasis following omeprazole therapy: a report of two cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] two cases [Treatment] omeprazole [Effect] Esophageal candidiasis"}, {"id": "11059196_2_216", "context": "We describe a 10-year-old boy with ulcerative colitis who developed acute pancreatitis while on long-term treatment with 5-aminosalicylic acid.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 10-year-old boy with ulcerative colitis [Treatment] long-term treatment with 5-aminosalicylic acid [Effect] acute pancreatitis"}, {"id": "22010004_8_217", "context": "The mechanism of niacin-induced coagulopathy is theorized to be related to diminished coagulation factors, and limited data suggest that this may be more pronounced with extended-release niacin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] niacin [Effect] coagulopathy"}, {"id": "16449538_6_218", "context": "OBJECTIVE: To report 2 cases of nonconvulsive status epilepticus (NCSE) following infusion of ifosfamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] infusion of ifosfamide [Effect] nonconvulsive status epilepticus (NCSE)"}, {"id": "24679099_8_219", "context": "We conclude that the observed toxicity with jaundice was probably caused by an interaction of this popular Chinese formula and temozolomide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] temozolomide [Effect] toxicity with jaundice"}, {"id": "14723711_2_220", "context": "Pigmentary disorders are recognized adverse effects of the semi-synthetic tetracycline derivative antibiotic, minocycline.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse [Treatment] semi-synthetic tetracycline derivative antibiotic, minocycline [Effect] Pigmentary disorders"}, {"id": "25295553_2_221", "context": "Pregabalin is an antiepileptic drug with anti-anxiety properties and is approved for treatment of generalized anxiety disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Pregabalin is an antiepileptic drug with anti-anxiety properties"}, {"id": "16615675_4_222", "context": "We report a case of chronic use of HCQ associated with torsade de pointes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] chronic use of HCQ [Effect] torsade de pointes"}, {"id": "17959575_18_223", "context": "PURPOSE: The occurrence of myoclonus associated with continuous i.v. infusion of dobutamine in a patient with end-stage renal disease (ESRD) is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Subject] a patient with end-stage renal disease (ESRD) [Treatment] continuous i.v. infusion of dobutamine [Effect] myoclonus"}, {"id": "15235919_3_224", "context": "The case concerns the sudden death of a 29-year-old male during clozapine therapy started 2 weeks before.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a 29-year-old male [Treatment] clozapine [Effect] sudden death"}, {"id": "12806509_2_225", "context": "In this paper, we report a case of 3 years-old boy who developed acute onset tetraparesia following a viral respiratory infecction and hepatitis B vaccination.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 3 years-old boy [Treatment] hepatitis B vaccination [Effect] acute onset tetraparesia"}, {"id": "9925865_6_226", "context": "Treatment of ELP in children is generally supportive, with the symptoms and roentgenographic abnormalities resolving within months after stopping the use of mineral oil.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] after [Treatment] stopping the use of mineral oil [Effect] symptoms and roentgenographic abnormalities resolving"}, {"id": "17710018_3_227", "context": "PET scintigraphy of etoposide-induced pulmonary toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] etoposide [Effect] pulmonary toxicity"}, {"id": "11807466_2_228", "context": "We report a patient who experienced LABD shortly after starting carbamazepine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient [Treatment] starting carbamazepine therapy [Effect] experienced LABD shortly"}, {"id": "1759924_1_229", "context": "Fulminant metoclopramide induced neuroleptic malignant syndrome rapidly responsive to intravenous dantrolene.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Fulminant metoclopramide [Effect] neuroleptic malignant syndrome"}, {"id": "19648225_1_230", "context": "Can ketamine prescribed for pain cause damage to the urinary tract?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] ketamine [Effect] damage to the urinary tract"}, {"id": "1450506_3_231", "context": "Sixteen hours after the first administration of IFN, IFN was suspended by the symptoms of congestive heart failure (CHF).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suspended [Treatment] IFN [Effect] congestive heart failure (CHF)"}, {"id": "2924444_8_232", "context": "We believe this is the first report of myocardial infarction due to coronary spasm, demonstrated by angiography associated with L-thyroxine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] L-thyroxine [Effect] myocardial infarction; coronary spasm"}, {"id": "17952482_1_233", "context": "A 58-year-old woman with rheumatoid arthritis (RA) developed fever, skin eruptions, leukocytopenia, and thrombocytopenia, 3 weeks after treatment with sulfasalazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 58-year-old woman with rheumatoid arthritis (RA) [Treatment] 3 weeks after treatment with sulfasalazine [Effect] fever, skin eruptions, leukocytopenia, and thrombocytopenia"}, {"id": "3449312_1_234", "context": "Gold-induced aplastic anemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Gold [Effect] aplastic anemia"}, {"id": "15176542_1_235", "context": "One patient developed large intramural esophageal hematoma as a complication of heparin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] One patient [Treatment] a complication of heparin therapy [Effect] large intramural esophageal hematoma"}, {"id": "6478628_1_236", "context": "Mammary gigantism is a rare complication of D-penicillamine treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication of [Treatment] D-penicillamine treatment [Effect] Mammary gigantism"}, {"id": "9681092_8_237", "context": "Cyclobenzaprine shares anticholinergic effects, tachycardia, and dysrhythmic potential with the tricyclic antidepressants (TCAs).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] potential [Treatment] Cyclobenzaprine; with the tricyclic antidepressants (TCAs) [Effect] anticholinergic effects, tachycardia, and dysrhythmic"}, {"id": "15235919_2_238", "context": "The autopsy findings and a detailed medical history supported the conclusion that clozapine-induced hypersensitivity myocarditis was the most likely cause of death.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] clozapine [Effect] hypersensitivity myocarditis; death"}, {"id": "9466030_3_239", "context": "PURPOSE: To present a case of respiratory depression following the administration of nebulised morphine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] nebulised morphine [Effect] respiratory depression"}, {"id": "11554897_3_240", "context": "METHODS: A 55-year-old woman became stuporous after overdose with lamotrigine (LTG) and valproic acid (VPA) tablets.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] became [Subject] A 55-year-old woman [Treatment] overdose with lamotrigine (LTG) and valproic acid (VPA) tablets [Effect] stuporous"}, {"id": "16099004_1_241", "context": "Recrudescence of imported falciparum malaria after quinine therapy: potential drug interaction with phenytoin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] quinine; phenytoin [Effect] Recrudescence of imported falciparum malaria"}, {"id": "11978156_1_242", "context": "CONCLUSIONS: Clinicians should be aware of the possible association of thrombocytopenia with lansoprazole and discontinue the drug if thrombocytopenia becomes apparent.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] lansoprazole [Effect] thrombocytopenia"}, {"id": "3549808_1_243", "context": "One of the subjects who was using extemporaneous topical minoxidil had hypertension and arteriosclerotic disease and the other died of a myocardial infarction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] One of the subjects [Treatment] extemporaneous topical minoxidil [Effect] hypertension and arteriosclerotic disease [Adverse event] died [Subject] the other [Treatment] extemporaneous topical minoxidil [Effect] died of a myocardial infarction"}, {"id": "12390172_1_244", "context": "CONCLUSION: Long-term treatment with rifabutin may have a reversible and previously undescribed side-effect on retinal function.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] have [Treatment] rifabutin [Effect] side-effect on retinal function"}, {"id": "6628806_2_245", "context": "Toxic hepatitis due to combination therapy with methotrexate and etretinate in psoriasis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] methotrexate and etretinate [Effect] Toxic hepatitis"}, {"id": "19934385_2_246", "context": "To report the results of therapeutic drug monitoring of lopinavir/ritonavir and itraconazole concentrations in an HIV-infected male who was treated for histoplasmosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] an HIV-infected male [Treatment] lopinavir/ritonavir and itraconazole concentrations"}, {"id": "11476690_1_247", "context": "Ulcer became worse after tobramycin and gentamycin treatment for 2 days.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] tobramycin and gentamycin [Effect] Ulcer became worse"}, {"id": "12149193_3_248", "context": "Thalidomide has proven activity in refractory multiple myeloma (MM), and although single-agent thalidomide has minimal prothrombogenic activity, its combination with cytotoxic chemotherapy is associated with a significantly increased risk of DVT.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] single-agent thalidomide; combination with cytotoxic chemotherapy [Effect] significantly increased risk of DVT"}, {"id": "2357706_3_249", "context": "These cases indicate that sulpiride can cause tardive dyskinesia and that this drug should be administered with caution.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] sulpiride [Effect] tardive dyskinesia"}, {"id": "7789881_4_250", "context": "Well-differentiated endometrial adenocarcinoma of the secretory type (FIGO Grade 1) with minimal myometrial invasion occurred in a postmenopausal patient on tamoxifen therapy 5 years after mastectomy for breast carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] a postmenopausal patient [Treatment] tamoxifen therapy 5 years after mastectomy for breast carcinoma. [Effect] Well-differentiated endometrial adenocarcinoma of the secretory type (FIGO Grade 1) with minimal myometrial invasion"}, {"id": "2104570_1_251", "context": "Secondary hematologic neoplasm after intravesical chemotherapy for superficial bladder carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] intravesical chemotherapy [Effect] Secondary hematologic neoplasm"}, {"id": "15463865_1_252", "context": "Ciprofloxacin-induced renal insufficiency in cystic fibrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Ciprofloxacin [Effect] renal insufficiency"}, {"id": "15701285_3_253", "context": "While the introduction of carmustine wafers (Gliadel wafers) into the tumor resection cavity has been shown to be a beneficial therapy for malignant glioma, it is recognized that clinically significant cerebral edema is a potential adverse effect.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse [Treatment] the introduction of carmustine wafers (Gliadel wafers) into the tumor resection cavity [Effect] significant cerebral edema"}, {"id": "11573852_5_254", "context": "Didanosine also has a potential for inducing seizures.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] inducing [Treatment] Didanosine [Effect] seizures"}, {"id": "12880504_2_255", "context": "Obsessive-compulsive symptoms suddenly emerged 10 days after starting risperidone and resolved within 3 days of discontinuation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] emerged [Treatment] risperidone [Effect] Obsessive-compulsive symptoms"}, {"id": "15362597_1_256", "context": "Refractory hypoglycemia from ciprofloxacin and glyburide interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] ciprofloxacin and glyburide interaction [Effect] Refractory hypoglycemia"}, {"id": "18556970_1_257", "context": "Anaphylactic reaction to recombinant insulin-like growth factor-I.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] recombinant insulin-like growth factor-I [Effect] Anaphylactic reaction"}, {"id": "21350204_1_258", "context": "Subtherapeutic warfarin is not associated with increased hemorrhage rates in ischemic strokes treated with tissue plasminogen activator.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Subtherapeutic warfarin; treated with tissue plasminogen activator [Effect] increased hemorrhage rates"}, {"id": "10510017_2_259", "context": "Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] management [Subject] Pediatric [Treatment] Danaparoid (orgaran) [Adverse event] induced [Subject] Pediatric [Treatment] heparin [Effect] thrombocytopenia"}, {"id": "17426073_4_260", "context": "Teicoplanin-induced agranulocytosis that followed vancomycin-induced agranulocytosis suggests a possible cross-reactivity between the 2 drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Teicoplanin; followed vancomycin [Effect] agranulocytosis"}, {"id": "946400_1_261", "context": "A 55-year-old woman developed symptoms suggestive of hepatitis 12 weeks after first receiving methyldopa for hypertension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 55-year-old woman [Treatment] methyldopa [Effect] hepatitis"}, {"id": "644545_1_262", "context": "Cyclophosphamide can rarely cause interstitial pneumonitis and fibrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Cyclophosphamide [Effect] interstitial pneumonitis and fibrosis"}, {"id": "7117795_1_263", "context": "Flucytosine-associated diarrhea has been previously described in 6%-10% of patients receiving the drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] 6%-10% of patients [Treatment] Flucytosine [Effect] diarrhea"}, {"id": "4051280_1_264", "context": "IV propranolol was used as the initial treatment for his hyperadrenergic state, resulting in a decrease in heart rate but a paroxsymal increase in blood pressure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Subject] his hyperadrenergic state [Treatment] IV propranolol [Effect] decrease in heart rate but a paroxsymal increase in blood pressure"}, {"id": "7789881_3_265", "context": "We believe that this is the first report of secretory carcinoma of the endometrium associated with tamoxifen use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] tamoxifen [Effect] secretory carcinoma of the endometrium"}, {"id": "3513544_1_266", "context": "Herpes simplex esophagitis in a renal transplant patient treated with cyclosporine A: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] renal transplant patient [Treatment] cyclosporine [Effect] Herpes simplex esophagitis"}, {"id": "12763355_3_267", "context": "This clinical course suggests that the sensorimotor polyneuropathy may have been caused by 5-ASA.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] 5-ASA [Effect] sensorimotor polyneuropathy"}, {"id": "18622319_1_268", "context": "Spontaneous nasal septal perforation with antiangiogenic bevacizumab therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] antiangiogenic bevacizumab therapy [Effect] Spontaneous nasal septal perforation"}, {"id": "10442258_3_269", "context": "There are a few case reports on hair loss associated with tricyclic antidepressants and serotonin selective reuptake inhibitors (SSRIs), but none deal specifically with paroxetine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] tricyclic antidepressants and serotonin selective reuptake inhibitors [Effect] hair loss"}, {"id": "11903249_2_270", "context": "There have been more than 20 observations of the appearance or aggravation of this granulomatosis with interferon alfa and more recently with the combination of interferon alfa plus ribavirin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] interferon alfa and more recently with the combination of interferon alfa plus ribavirin [Effect] more than 20 observations of the appearance or aggravation of this granulomatosis"}, {"id": "20065266_2_271", "context": "CONCLUSION: A 37-year-old African- American man with G6PD deficiency developed hemolytic anemia, hepatitis, orthostatic hypotension, and aseptic meningitis simultaneously after using trimethoprim-sulfamethoxazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 37-year-old African- American man with G6PD deficiency [Treatment] trimethoprim-sulfamethoxazole [Effect] hemolytic anemia, hepatitis, orthostatic hypotension, and aseptic meningitis"}, {"id": "20009973_1_272", "context": "All-trans retinoic acid-induced focal myositis, synovitis, and mononeuritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] All-trans retinoic acid [Effect] focal myositis, synovitis, and mononeuritis"}, {"id": "2417800_4_273", "context": "Oxygen potentiation of bleomycin-induced pulmonary toxicity is discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Oxygen potentiation of bleomycin [Effect] pulmonary toxicity"}, {"id": "11554897_1_274", "context": "CONCLUSIONS: LTG overdose may result in a severe but reversible encephalopathy, a previously undescribed phenomenon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] LTG overdose [Effect] reversible encephalopathy"}, {"id": "14712320_7_275", "context": "In this report, we describe a case of rhabdomyolysis and acute renal failure secondary to the interaction between danazol and simvastatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] interaction between danazol and simvastatin [Effect] rhabdomyolysis and acute renal failure"}, {"id": "14660304_1_276", "context": "Infectious toxicity of dexamethasone during all remission-induction chemotherapy: report of two cases and literature review.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] two cases [Treatment] dexamethasone; all remission-induction chemotherapy [Effect] Infectious toxicity"}, {"id": "19531696_3_277", "context": "A 56-year-old white male had been receiving chronic warfarin therapy for 11 years after mechanical heart valve replacement.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receiving [Subject] A 56-year-old white male [Treatment] chronic warfarin therapy for 11 years after mechanical heart valve replacement"}, {"id": "12962465_3_278", "context": "Isoniazid associated, painful, bilateral gynaecomastia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Isoniazid [Effect] painful, bilateral gynaecomastia"}, {"id": "2924444_5_279", "context": "Electrocardiographic findings and laboratory data indicated a diagnosis of acute myocardial infarction due to the L-thyroxine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Treatment] the L-thyroxine therapy. [Effect] acute myocardial infarction"}, {"id": "20154441_1_280", "context": "Combining methylephedrine and Chinese herbal drugs might carry a risk of stroke.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] carry [Treatment] Combining methylephedrine and Chinese herbal drugs [Effect] risk of stroke"}, {"id": "18025525_11_281", "context": "Coadministration of 200 mg bid voriconazole with 400 mg (or higher) qd efavirenz is contraindicated due to the clinically significant effect of efavirenz on voriconazole pharmacokinetics.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] contraindicated [Treatment] Coadministration of 200 mg bid voriconazole with 400 mg (or higher) qd efavirenz; efavirenz on voriconazole [Effect] clinically significant effect"}, {"id": "22010004_12_282", "context": "An interaction between niacin and warfarin likely elevated the INR in this patient because of synergistic coagulopathy and pharmacokinetic effects of niacin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] elevated [Subject] this patient [Treatment] interaction between niacin and warfarin [Effect] elevated the INR"}, {"id": "12692521_2_283", "context": "We present two cases in which both patients suffered with CLS, which we believe was caused following administration of granulocyte colony-stimulating factor, to our knowledge not described in the intensive care patient previously.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] administration [Subject] two cases in which both patients suffered with CLS [Treatment] granulocyte colony-stimulating factor [Effect] CLS"}, {"id": "12452753_1_284", "context": "Capecitabine was discontinued and the allergic reactions resolved after the woman took diphenhydramine for 1 week.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] took [Subject] woman [Treatment] diphenhydramine for 1 week [Effect] Capecitabine was discontinued and the allergic reactions resolved"}, {"id": "18812562_5_285", "context": "Intravenous fluconazole 400 mg, followed by 100 mg every 24 hours according to impaired renal function, was immediately started; to avoid further nephrotoxicity, immunosuppressant therapy was switched from cyclosporine plus mycophenolate mofetil to oral everolimus 0.75 mg every 12 hours.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] avoid [Treatment] Intravenous fluconazole 400 mg, followed by 100 mg every 24 hours; immunosuppressant therapy was switched from cyclosporine plus mycophenolate mofetil to oral everolimus 0.75 mg every 12 hours"}, {"id": "1827039_2_286", "context": "We report 3 patients with severe hepatocellular damage due to CPA therapy, 2 with fatal fulminant hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] 3 patients [Treatment] CPA [Effect] severe hepatocellular damage [Adverse event] due [Subject] 2 [Treatment] CPA [Effect] fatal fulminant hepatitis"}, {"id": "12702914_2_287", "context": "Soon after introduction of insulin therapy, she developed severe anasarca, including marked peripheral oedema, ascites and pleural effusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] she [Treatment] insulin [Effect] anasarca, including marked peripheral oedema, ascites and pleural effusion"}, {"id": "15053046_3_288", "context": "We describe a continuous ambulatory peritoneal dialysis (CAPD) patient that developed vancomycin-induced agranulocytosis during treatment for methicillin-resistant Staphylococcus aureus (MRSA)-associated external cuff infection and pneumonia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a continuous ambulatory peritoneal dialysis (CAPD) patient [Treatment] vancomycin [Effect] agranulocytosis"}, {"id": "17667887_8_289", "context": "In both cases, we believe that serotonin syndrome was produced by a combination of an antidepressant and an atypical antipsychotic.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] produced [Subject] In both cases [Treatment] a combination of an antidepressant and an atypical antipsychotic [Effect] serotonin syndrome"}, {"id": "3620420_6_290", "context": "Cyclosporin side effects included hirsutism, hypertension, increased blood levels of urea and creatinine, and abnormalities in liver function tests.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effects [Treatment] Cyclosporin [Effect] hirsutism, hypertension, increased blood levels of urea and creatinine, and abnormalities in liver function tests."}, {"id": "17329303_7_291", "context": "She displayed severe hyperactivity, agitation and irritability upon switching to methylphenidate medication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] displayed [Treatment] switching to methylphenidate [Effect] hyperactivity, agitation and irritability"}, {"id": "11573852_8_292", "context": "To date, only three cases of seizures associated with amphotericin B have been reported in the literature, but healthcare providers should be aware of the potential for this rare adverse effect.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] three cases [Treatment] amphotericin B [Effect] seizures"}, {"id": "16355099_1_293", "context": "Heparin-induced thrombocytopenia complicated with massive thrombosis of the inferior vena cava after filter placement.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Heparin [Effect] thrombocytopenia complicated with massive thrombosis of the inferior vena cava after filter placement"}, {"id": "17473920_1_294", "context": "Pharmacokinetics of methadone in human-immunodeficiency-virus-infected patients receiving nevirapine once daily.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receiving [Subject] human-immunodeficiency-virus-infected patients [Treatment] methadone; nevirapine once daily"}, {"id": "3449312_2_295", "context": "Three patients receiving gold salt treatment for rheumatoid arthritis developed severe aplastic anemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Three patients [Treatment] gold salt [Effect] severe aplastic anemia"}, {"id": "12092878_2_296", "context": "A case of anaphylactoid reaction due solely to the use of Gelofusine in a patient with non-haemorrhagic hypovolaemia is presented, with a discussion on the management and the use of allergy identification jewellery.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reaction [Subject] patient with non-haemorrhagic hypovolaemia [Treatment] Gelofusine [Effect] anaphylactoid"}, {"id": "6344831_3_297", "context": "Nonoliguric acute renal failure after captopril therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] captopril [Effect] Nonoliguric acute renal failure"}, {"id": "19217693_3_298", "context": "We report a patient with type 2 diabetes mellitus who, while treated with the antitumor necrosis factor-alpha blocking agent etanercept for severe plaque psoriasis, experienced persistent hypoglycemia requiring the lowering and eventual elimination of his previous insulin regimen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] a patient with type 2 diabetes mellitus [Treatment] the antitumor necrosis factor-alpha blocking agent etanercept; previous insulin regimen [Effect] persistent hypoglycemia"}, {"id": "12540009_4_299", "context": "We report the first case of doxycycline-induced hypoglycemia in a young nondiabetic man.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a young nondiabetic man [Treatment] doxycycline [Effect] hypoglycemia"}, {"id": "11573852_7_300", "context": "The time course of events suggested that amphotericin B was the cause of the seizures in this AIDS patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] AIDS patient [Treatment] amphotericin B [Effect] seizures"}, {"id": "897744_1_301", "context": "Focal glomerulonephritis and interstitial nephritis in methicillin-treated, heroin-related infective endocarditis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] heroin [Effect] infective endocarditis [Adverse event] treated [Treatment] methicillin [Effect] Focal glomerulonephritis and interstitial nephritis"}, {"id": "1834424_2_302", "context": "Allergic contact dermatitis from 4-chloro-7-nitrobenzofurazan.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] 4-chloro-7-nitrobenzofurazan [Effect] Allergic contact dermatitis"}, {"id": "16816519_2_303", "context": "We describe a 5-year-old girl showed recovery of vincristine induced cranial polyneuropathy with pyridoxine and pyridostigmine treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] with [Subject] a 5-year-old girl [Treatment] pyridoxine and pyridostigmine treatment [Effect] recovery of vincristine induced cranial polyneuropathy"}, {"id": "9925865_3_304", "context": "Lipoid pneumonia: a silent complication of mineral oil aspiration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] mineral oil aspiration [Effect] Lipoid pneumonia"}, {"id": "10610018_1_305", "context": "Elevated serum triglycerides with clozapine resolved with risperidone in four patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Subject] four patients [Treatment] risperidone [Adverse event] with [Treatment] clozapine [Effect] Elevated serum triglycerides"}, {"id": "8162401_3_306", "context": "Seizures associated with fluoxetine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] fluoxetine therapy [Effect] Seizures"}, {"id": "18006091_1_307", "context": "Sustained monomorphic ventricular tachycardia after adenosine infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] adenosine infusion. [Effect] Sustained monomorphic ventricular tachycardia"}, {"id": "7632529_1_308", "context": "A 9-year-old boy developed acute renal failure following intravenous acyclovir (30 mg/kg per day) administered for 6 days to treat herpetic encephalitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 9-year-old boy [Treatment] intravenous acyclovir [Effect] acute renal failure"}, {"id": "18476934_3_309", "context": "We report a 4-year-old girl who presented with acute bilateral blindness, a focal seizure and hypertension 10 days after commencing oxybutynin to treat enuresis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 4-year-old girl [Treatment] oxybutynin [Effect] acute bilateral blindness, a focal seizure and hypertension"}, {"id": "16580907_1_310", "context": "Severe arrhythmia as a result of the interaction of cetirizine and pilsicainide in a patient with renal insufficiency: first case presentation showing competition for excretion via renal multidrug resistance protein 1 and organic cation transporter 2.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Subject] a patient with renal insufficiency [Treatment] interaction of cetirizine and pilsicainide [Effect] Severe arrhythmia"}, {"id": "10465148_4_311", "context": "Reported are three children who developed progressive paraparesis after intrathecal methotrexate administration followed by complete or partial recovery.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] three children [Treatment] intrathecal methotrexate [Effect] paraparesis"}, {"id": "11428480_3_312", "context": "We observed ventricular fibrillation in 2 patients who presented to the emergency department with pre-excited atrial fibrillation and were given 12 mg of adenosine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] given [Subject] 2 patients who presented to the emergency department with pre-excited atrial fibrillation [Treatment] 12 mg of adenosine [Effect] ventricular fibrillation"}, {"id": "17083890_5_313", "context": "During administration of chemotherapy, the patient progressively developed a complex association of Beau's lines, transverse melanonychia, Muehrcke's lines, and diffuse hyperpigmentation of the skin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] patient [Treatment] chemotherapy [Effect] a complex association of Beau's lines, transverse melanonychia, Muehrcke's lines, and diffuse hyperpigmentation of the skin"}, {"id": "17083890_1_314", "context": "Distinct patterns of chromonychia, Beau's lines, and melanoderma seen with vincristine, adriamycin, dexamethasone therapy for multiple myeloma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] seen [Treatment] vincristine, adriamycin, dexamethasone [Effect] Distinct patterns of chromonychia, Beau's lines, and melanoderma"}, {"id": "10633877_3_315", "context": "Theophylline intoxication mimicking diabetic ketoacidosis in a child.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a child [Treatment] Theophylline [Effect] Theophylline intoxication"}, {"id": "18492617_3_316", "context": "We describe a patient who, after receiving his first dose of pregabalin to relieve neuropathic pain, presented with a negative myoclonus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] a patient [Treatment] pregabalin [Effect] negative myoclonus"}, {"id": "12452753_2_317", "context": "CONCLUSIONS: The use of fluorouracil treatment with careful monitoring can be considered in a patient with mild allergic reactions to capecitabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] can be considered [Subject] a patient with mild allergic reactions to capecitabine [Treatment] fluorouracil treatment with careful monitoring"}, {"id": "16313549_1_318", "context": "Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] patients with multiple myeloma [Treatment] bisphosphonate treatment [Effect] Symptomatic hypocalcaemia and renal impairment"}, {"id": "9681211_1_319", "context": "Although this G-CSF-driven leucocytosis was alarming it did not appear to have adversely affected the patient's prognosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] driven [Treatment] G-CSF [Effect] leucocytosis"}, {"id": "4018433_1_320", "context": "A case of pyridoxine-dependent seizures is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] dependent [Subject] A case [Treatment] pyridoxine [Effect] seizures"}, {"id": "2417800_1_321", "context": "A case of a 53-year-old man who developed acute pneumonitis after bleomycin and moderate oxygen administration is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A case of a 53-year-old man [Treatment] bleomycin and moderate oxygen [Effect] acute pneumonitis"}, {"id": "14530108_1_322", "context": "Renal tubular acidosis secondary to FK506 in living donor liver transplantation: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Subject] a case [Treatment] FK506 [Effect] Renal tubular acidosis"}, {"id": "20020238_3_323", "context": "Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] hepatitis C patients [Treatment] pegylated interferon and ribavirin [Effect] Retinopathy"}, {"id": "16615675_1_324", "context": "After excluding other causes of long QT syndrome, the HCQ was suspected as the cause of her ventricular tachycardia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suspected [Subject] her [Treatment] HCQ [Effect] ventricular tachycardia"}, {"id": "10907391_2_325", "context": "Phantom limb pain as a manifestation of paclitaxel neurotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] manifestation [Treatment] paclitaxel [Effect] Phantom limb pain"}, {"id": "3159106_1_326", "context": "A case of allopurinol hypersensitivity, possibly the first in a black African, is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Subject] a black African [Treatment] allopurinol [Effect] hypersensitivity"}, {"id": "14964753_5_327", "context": "Ramipril was stopped and he required a course of steroids after which the rash improved slowly.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] improved [Subject] he [Treatment] a course of steroids [Effect] the rash improved slowly"}, {"id": "15961942_1_328", "context": "Late development of diabetes mellitus after interferon-alfa and ribavirin therapy for chronic hepatitis C: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] interferon-alfa; ribavirin [Effect] diabetes mellitus"}, {"id": "9517515_2_329", "context": "Second cancers including various types of hematological malignancy have been reported in patients with hairy cell leukemia treated with chemotherapy or interferon alfa.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Subject] patients with hairy cell leukemia [Treatment] chemotherapy or interferon alfa [Effect] Second cancers including various types of hematological malignancy"}, {"id": "8840640_1_330", "context": "A patient with a large hydatid cyst of the left lobe of the liver developed metabolic acidosis following rather liberal use of cetrimide-chlorhexidine solution as a scolicidal agent.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient with a large hydatid cyst of the left lobe of the liver [Treatment] rather liberal use of cetrimide-chlorhexidine solution as a scolicidal agent [Effect] metabolic acidosis"}, {"id": "8329789_12_331", "context": "INTERVENTIONS AND RESULTS: Cardiac complications were observed in five pediatric patients who received between 4.6 and 40.8 mg/kg/d of amphotericin B.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] received [Subject] five pediatric patients [Treatment] between 4.6 and 40.8 mg/kg/d of amphotericin B [Effect] Cardiac complications"}, {"id": "16521231_2_332", "context": "In this case report, we have described a patient with Crohn's disease who developed subfulminant hepatitis B after the fourth infusion of infliximab due to an unrecognized HBs-antigen carrier state.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with Crohn's disease [Treatment] fourth infusion of infliximab [Effect] subfulminant hepatitis B"}, {"id": "12149193_4_333", "context": "We analyzed the incidence of DVT in 232 MM patients who received a combination of chemotherapy and thalidomide on 2 protocols that differed only by the inclusion of doxorubicin in one.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] incidence [Subject] 232 MM patients [Treatment] chemotherapy; thalidomide [Effect] DVT"}, {"id": "17109650_2_334", "context": "Valvular heart disease in a patient taking benfluorex.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] a patient [Treatment] benfluorex [Effect] Valvular heart disease"}, {"id": "18562412_3_335", "context": "The fifth patient exhibited paraesthesia and agitation caused by olanzapine that was misdiagnosed as psychotic agitation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] The fifth patient [Treatment] olanzapine [Effect] paraesthesia and agitation"}, {"id": "8329789_11_336", "context": "Hydrocortisone may decrease the incidence of mortality associated with cardiac arrhythmias in children receiving amphotericin B overdoses.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] decrease [Subject] cardiac arrhythmias in children [Treatment] Hydrocortisone [Adverse event] receiving [Subject] cardiac arrhythmias in children [Treatment] amphotericin B overdoses [Effect] incidence of mortality"}, {"id": "8700794_1_337", "context": "A review of the literature found 11 children and 2 adults in whom intranasal desmopressin was associated with hyponatremia, all of whom experienced seizures or altered mental status.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] 11 children and 2 adults [Treatment] intranasal desmopressin [Effect] hyponatremia; seizures or altered mental status"}, {"id": "7387219_1_338", "context": "Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] D-penicillamine [Effect] Hepatotoxicity"}, {"id": "8627446_1_339", "context": "Accelerated nodulosis during methotrexate therapy for juvenile rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] methotrexate [Effect] Accelerated nodulosis"}, {"id": "8305778_6_340", "context": "Amiodarone is a Class III antiarrhythmic with an adverse-effect profile involving many different organ systems.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse-effect [Treatment] Amiodarone [Effect] an adverse-effect profile involving many different organ systems"}, {"id": "17083890_2_341", "context": "Nail and skin alterations associated with the use of chemotherapy have been described in the last decade involving various combinations of two different types of nail changes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] chemotherapy [Effect] Nail and skin alterations"}, {"id": "7117795_2_342", "context": "This report describes a case of flucytosine-associated ulcerating enteritis in which the small bowel x-ray demonstrated severe luminal narrowing, ulceration, and marked separation of loops of bowel.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] flucytosine [Effect] ulcerating enteritis in which the small bowel x-ray demonstrated severe luminal narrowing, ulceration, and marked separation of loops of bowel"}, {"id": "968449_1_343", "context": "Chromosome abnormalities after chlorambucil therapy of polycythaemia vera.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] chlorambucil therapy [Effect] Chromosome abnormalities"}, {"id": "15944830_6_344", "context": "With the use of optical coherence tomography (OCT), two patients with IFN-associated retinopathy who had developed macular edema and reduced visual acuity during the clinical course of IFN therapy were observed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] IFN [Effect] retinopathy; macular edema and reduced visual acuity"}, {"id": "16244351_1_345", "context": "Atrial fibrillation after vardenafil therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] vardenafil therapy [Effect] Atrial fibrillation"}, {"id": "16122280_19_346", "context": "In phase III clinical trials, the telithromycin 800 mg once-daily dose has been shown to provide close to the maximum antimicrobial activity against S. pneumoniae, Haemophilus influenzae and Staphylococcus aureus in patients with community-acquired pneumonia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] provide [Subject] patients with community-acquired pneumonia [Treatment] telithromycin 800 mg once-daily dose"}, {"id": "11247558_4_347", "context": "We suggest that meloxicam might have intestinal toxic effects when taken in high doses, because of reduced COX-2 selectivity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] have [Treatment] meloxicam [Effect] intestinal toxic effects"}, {"id": "3152997_1_348", "context": "Atrial fibrillation following methylprednisolone pulse therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] methylprednisolone pulse therapy [Effect] Atrial fibrillation"}, {"id": "2113320_2_349", "context": "Subglottic stenosis in Wegener's granulomatosis: development during cyclophosphamide treatment with response to carbon dioxide laser therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] cyclophosphamide treatment with response to carbon dioxide laser therapy [Effect] Subglottic stenosis in Wegener's granulomatosis"}, {"id": "18492617_2_350", "context": "Pregabalin-induced cortical negative myoclonus in a patient with neuropathic pain.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with neuropathic pain [Treatment] Pregabalin [Effect] cortical negative myoclonus"}, {"id": "12663440_12_351", "context": "We conclude that quinine does not improve the survival of adult patients with de novo AML, even though it improves CR rate in a small subgroup of patients defined by rhodamine 123 efflux.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] improves [Subject] a small subgroup of patients defined by rhodamine 123 efflux [Treatment] quinine [Effect] improves CR rate [Potential therapeutic event] improve [Subject] adult patients [Treatment] quinine"}, {"id": "14530108_4_352", "context": "The mechanism of RTA induced by FK506 has not yet been clearly elucidated.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] FK506 [Effect] RTA"}, {"id": "17301517_2_353", "context": "The risk of new-onset diabetic ketoacidosis in patients with diabetic risk factors who are taking perospirone hydrochloride or other atypical antipsychotics should be kept in mind.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Subject] patients with diabetic risk factors [Treatment] perospirone hydrochloride or other atypical antipsychotics [Effect] new-onset diabetic ketoacidosis"}, {"id": "18487000_1_354", "context": "Severe symptomatic hyponatremia during sibutramine therapy: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] sibutramine [Effect] Severe symptomatic hyponatremia"}, {"id": "15779196_2_355", "context": "Zoledronic acid-induced severe hypocalcaemia in a prostate cancer patient with extensive osteoblastic bone metastases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] prostate cancer patient with extensive osteoblastic bone metastases [Treatment] Zoledronic acid [Effect] severe hypocalcaemia"}, {"id": "12149193_9_356", "context": "MM patients treated with thalidomide and doxorubicin have a high risk of developing DVT.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] have [Subject] MM patients [Treatment] thalidomide and doxorubicin [Effect] a high risk of developing DVT"}, {"id": "19653965_1_357", "context": "These two cases highlight the importance of considering lopinavir/ritonavir induced arrhythmias when dealing with HIV-positive individuals.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] HIV-positive individuals [Treatment] lopinavir/ritonavir [Effect] arrhythmias"}, {"id": "11200291_1_358", "context": "Atrial fibrillation occurring in a patient taking etanercept plus methotrexate for rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] a patient [Treatment] etanercept plus methotrexate for rheumatoid arthritis [Effect] Atrial fibrillation"}, {"id": "17083890_4_359", "context": "We describe a 52-year-old male diagnosed with stage III multiple myeloma, who was treated with 5-monthly cycles of VAD (vincristine, adriamycin and dexamathasone).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] a 52-year-old male [Treatment] 5-monthly cycles of VAD (vincristine, adriamycin and dexamathasone)"}, {"id": "15965422_4_360", "context": "We review the literature on previously reported cases of cutaneous necrosis after injection of standard interferon alfa or pegylated interferon alfa-2b and discuss the different pathophysiologic mechanisms that might be involved.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] standard interferon alfa; pegylated interferon alfa-2b [Effect] cutaneous necrosis"}, {"id": "21350204_9_361", "context": "Our cohort included 1739 patients with acute ischemic stroke treated with intravenous tissue plasminogen activator of whom 125 (7.2%) were receiving warfarin before admission and had an international normalized ratio <1.7.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] 1739 patients [Treatment] intravenous tissue plasminogen activator [Potential therapeutic event] receiving [Subject] 125 (7.2%) [Treatment] warfarin before admission"}, {"id": "7495990_1_362", "context": "Used injudiciously, naloxone can lead to withdrawal syndrome, return of severe pain, and other adverse effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] lead [Treatment] Used injudiciously, naloxone [Effect] withdrawal syndrome, return of severe pain, and other adverse effects"}, {"id": "8700794_3_363", "context": "When vague symptoms develop during desmopressin therapy, hyponatremia must be considered as part of the differential diagnosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] desmopressin [Effect] vague symptoms; hyponatremia"}, {"id": "2104570_4_364", "context": "Intravesical chemotherapy may be associated with a risk of secondary malignancy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Intravesical chemotherapy [Effect] secondary malignancy"}, {"id": "17329303_9_365", "context": "In all the cases described here, it is only with the discontinuation of methylphenidate that the adverse reactions resolved and readministration of methylphenidate in two patients did not produce any adverse effect after a drug-free interval.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resolved [Treatment] discontinuation of methylphenidate [Effect] adverse reactions [Adverse event] produce [Subject] two patients [Treatment] methylphenidate [Effect] adverse effect after a drug-free interval"}, {"id": "897744_3_366", "context": "Discontinuation of methicillin therapy and appropriate antibiotic treatment of endocarditis led to clinical improvement, emphasizing the need to promptly discontinue potential nephrotoxic agents when abnormalities in renal function appear.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] appear [Treatment] methicillin [Effect] abnormalities in renal function"}, {"id": "8864370_2_367", "context": "CONCLUSIONS: This study confirmed that in most patients MTX-induced liver cirrhosis is not aggressive.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] most patients [Treatment] MTX [Effect] liver cirrhosis is not aggressive"}, {"id": "24679099_4_368", "context": "We report the case of severe liver toxicity with jaundice during radiochemotherapy with temozolomide likely due to interaction with a popular Chinese herbal formula after surgery for glioblastoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] temozolomide; a popular Chinese herbal formula [Effect] severe liver toxicity with jaundice"}, {"id": "11978156_3_369", "context": "He was started on oral lansoprazole 60 mg twice daily and, on hospital day 2, his platelet count decreased to 102 x 10(3)/mm(3); on hospital day 3, the platelet count was 36 x 10(3)/mm(3).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] on [Subject] He [Treatment] oral lansoprazole 60 mg twice daily [Effect] platelet count decreased"}, {"id": "8207519_1_370", "context": "She received an accidental 450-mg bolus injection of morphine intrathecally and developed hypertension, status epilepticus, intracerebral hemorrhage, and respiratory failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] She [Treatment] 450-mg bolus injection of morphine [Effect] hypertension, status epilepticus, intracerebral hemorrhage, and respiratory failure"}, {"id": "2357706_4_371", "context": "We describe six patients who developed tardive dyskinesia after treatment with sulpiride for depression or gastrointestinal symptoms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] six patients [Treatment] sulpiride [Effect] tardive dyskinesia"}, {"id": "15827071_4_372", "context": "A 38-year-old white female with cystic fibrosis treated with venlafaxine 300 mg/day for one year was prescribed linezolid 600 mg intravenously every 12 hours for treatment of methicillin-resistant Staphylococcus aureus (MRSA) pulmonary infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] A 38-year-old white female [Treatment] venlafaxine 300 mg/day for one year [Potential therapeutic event] treatment [Subject] A 38-year-old white female [Treatment] linezolid 600 mg intravenously every 12 hours"}, {"id": "7448830_1_373", "context": "Hepatotoxicity of hycanthone in patients with metastatic breast cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Subject] patients with metastatic breast cancer [Treatment] hycanthone [Effect] Hepatotoxicity"}, {"id": "16237130_2_374", "context": "The authors report five additional cases of capecitabine-induced multifocal leukoencephalopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] capecitabine [Effect] multifocal leukoencephalopathy"}, {"id": "7545251_1_375", "context": "Chlormadinone acetate withdrawal syndrome under combined androgen blockade for advanced prostate cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] under [Treatment] Chlormadinone acetate; androgen blockade"}, {"id": "18562412_2_376", "context": "Restless legs syndrome and periodic limb movements during sleep probably associated with olanzapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] olanzapine [Effect] Restless legs syndrome; periodic limb movements during sleep"}, {"id": "8329789_8_377", "context": "Evaluation of the literature provides substantial evidence for the use of hydrocortisone in prevention of cardiac arrhythmias.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prevention [Treatment] hydrocortisone"}, {"id": "14530108_6_378", "context": "We report a case of RTA secondary to FK506 administration in liver transplantation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Subject] a case of RTA [Treatment] FK506 administration in liver transplantation [Effect] RTA"}, {"id": "17959575_1_379", "context": "Myoclonus associated with continuous dobutamine infusion in a patient with end-stage renal disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a patient with end-stage renal disease [Treatment] continuous dobutamine infusion [Effect] Myoclonus"}, {"id": "6614033_2_380", "context": "Amphotericin B nephrotoxicity in humans decreased by salt repletion.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] decreased [Subject] humans [Treatment] salt repletion [Effect] Amphotericin B nephrotoxicity in humans decreased"}, {"id": "8638872_2_381", "context": "Only a few reports of overt jaundice are associated with streptokinase.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] streptokinase [Effect] overt jaundice"}, {"id": "12885108_1_382", "context": "Possible heart failure exacerbation associated with rosiglitazone: case report and literature review.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] rosiglitazone [Effect] heart failure exacerbation"}, {"id": "11388112_2_383", "context": "We report the first case of polymorphic ventricular tachycardia with normal QT interval associated with the oral use of levofloxacin in the absence of other etiologies known to cause these arrhythmias.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] the first case [Treatment] oral use of levofloxacin [Effect] polymorphic ventricular tachycardia with normal QT interval; arrhythmias"}, {"id": "8104147_2_384", "context": "Reversible leukopenia was documented in an 81-year-old woman treated with adjunctive ibopamine 100 mg t.i.d. for chronic congestive heart failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] documented [Subject] an 81-year-old woman [Treatment] adjunctive ibopamine 100 mg t.i.d. [Effect] Reversible leukopenia"}, {"id": "12702914_4_385", "context": "We conjectured that the side effects of insulin, such as anti-natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, hyperinsulinaemia and hypoalbuminaemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effects [Treatment] insulin [Effect] anti-natriuresis and increased vascular permeability"}, {"id": "278642_1_386", "context": "Acute myelogenous leukemia in patients receiving chlorambucil as long-term adjuvant chemotherapy for stage II breast cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] patients [Treatment] receiving chlorambucil as long-term adjuvant chemotherapy [Effect] Acute myelogenous leukemia"}, {"id": "7889679_1_387", "context": "We report a case of generalized cutaneous sclerosis associated with muscle and oesophageal involvement in a patient exposed to herbicides containing bromocil, diuron and aminotriazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exposed to [Treatment] herbicides containing bromocil, diuron and aminotriazole [Effect] generalized cutaneous sclerosis associated with muscle and oesophageal involvement"}, {"id": "19097599_1_388", "context": "Only 3 cases of imatinib-induced tumor lysis syndrome have been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] imatinib [Effect] tumor lysis syndrome"}, {"id": "14964753_2_389", "context": "A 61-year-old patient who had been treated with lisinopril in the past without any problems was commenced on ramipril for left ventricular dysfunction.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] commenced [Subject] A 61-year-old patient who had been treated with lisinopril in the past without any problems [Treatment] ramipril"}, {"id": "9760614_2_390", "context": "However, repeated intracameral tPA injections may cause unwanted complications such as vitreous hemorrhage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] repeated intracameral tPA injections [Effect] unwanted complications such as vitreous hemorrhage"}, {"id": "9934637_3_391", "context": "In this article, we present the case of a vitiligo patient who was admitted to our facility with an intense burn after the topical use of 8-methoxypsoralen solution as a suntanning agent.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a vitiligo patient [Treatment] topical use of 8-methoxypsoralen solution as a suntanning agent [Effect] intense burn"}, {"id": "7474364_3_392", "context": "The frequency and relationship of granulocytopenia caused by sustained-release procainamide in patients with tachyarrhythmias are briefly discussed, and prior reported cases are reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] patients with tachyarrhythmias [Treatment] procainamide [Effect] granulocytopenia"}, {"id": "11642488_1_393", "context": "Cicatricial entropion associated with chronic dipivefrin application.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] chronic dipivefrin application [Effect] Cicatricial entropion"}, {"id": "7174620_1_394", "context": "Nine delirious patients suffering from lithium intoxication were examined with the Mini-Mental State Exam (MMS) to describe the clinical course of the disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suffering from [Subject] Nine delirious patients [Treatment] lithium [Effect] lithium intoxication"}, {"id": "19423476_1_395", "context": "Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab: case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a chronic lymphocytic leukemia patient [Treatment] alemtuzumab [Effect] Cryptococcus neoformans fatal sepsis"}, {"id": "6597713_2_396", "context": "Cholestyramine induced hyperchloremic metabolic acidosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Cholestyramine [Effect] hyperchloremic metabolic acidosis."}, {"id": "11406880_2_397", "context": "Methadone is recommended as being free of some of the neuropsychological side effects noticed with morphine, which are attributed to active metabolites.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] noticed [Treatment] morphine [Effect] neuropsychological side effects"}, {"id": "16948177_3_398", "context": "This is the first reported case of BOOP associated with single-agent rituximab, and along with two other patients we describe, as well as two prior reports of BOOP in NHL patients receiving rituximab-based combinations, strengthens the possibility of a causal relationship.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] single-agent rituximab [Effect] BOOP"}, {"id": "14530108_5_399", "context": "The treatment for acidosis and hyperkalaemia should be started as soon as RTA is diagnosed, and the dosage of FK506 should also be reduced if possible.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] FK506 [Effect] acidosis and hyperkalaemia; RTA"}, {"id": "11518127_1_400", "context": "A 62-year-old woman treated with pranlukast for 2 months developed interstitial pneumonitis with a high fever.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 62-year-old woman [Treatment] treated with pranlukast for 2 months [Effect] interstitial pneumonitis with a high fever"}, {"id": "11359026_2_401", "context": "Neurotoxicity of valacyclovir in peritoneal dialysis: a pharmacokinetic study.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Neurotoxicity [Treatment] valacyclovir in peritoneal dialysis [Effect] Neurotoxicity"}, {"id": "20065266_3_402", "context": "He had been taking trimethoprim-sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] He [Treatment] trimethoprim-sulfamethoxazole for approximately eight days [Effect] headaches, dizziness, difficulty with speech, weakness, and itching on the trunk of his body and legs; maculopapular rash"}, {"id": "10970989_2_403", "context": "We present an AIDS patient with severe and prolonged lactic acidosis on stavudine and lamivudine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] present [Subject] an AIDS patient [Treatment] stavudine and lamivudine [Effect] severe and prolonged lactic acidosis"}, {"id": "15235919_1_404", "context": "Sudden cardiac death due to hypersensitivity myocarditis during clozapine treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] clozapine [Effect] Sudden cardiac death due to hypersensitivity myocarditis"}, {"id": "11171531_2_405", "context": "It also highlights a current major etiologic question, that is, whether and to what degree lead exposure contributes to the development of hypertension, and raises the issue of whether lead-induced hypertension constitutes a subset of hypertension that is especially amenable to therapy with dietary calcium.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] contributes [Treatment] lead exposure [Effect] hypertension"}, {"id": "15489872_1_406", "context": "We report an allogeneic bone marrow transplant recipient who developed CMV infection refractory to sequential therapy with ganciclovir, foscarnet, and cidofovir.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] refractory [Subject] allogeneic bone marrow transplant recipient [Treatment] sequential therapy with ganciclovir, foscarnet, and cidofovir"}, {"id": "11518127_2_407", "context": "Acute interstitial pneumonia induced by ONO-1078 (pranlukast), a leukotriene receptor antagonist.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ONO-1078 (pranlukast) [Effect] Acute interstitial pneumonia"}, {"id": "20020238_2_408", "context": "CONCLUSION: Significant ocular complications such as an irreversible decrease of visual acuity may develop in patients treated with pegylated interferon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] patients [Treatment] pegylated interferon [Effect] irreversible decrease of visual acuity"}, {"id": "11335880_1_409", "context": "CONCLUSIONS: This case report showed that the clinical appearance of Hashimoto's disease after IFN-alpha therapy for chronic C hepatitis in our patient was associated with a specific genetic predisposition (DR5) for this pathology.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] our patient [Treatment] IFN-alpha [Effect] clinical appearance of Hashimoto's disease"}, {"id": "18472517_2_410", "context": "We present here a female patient who developed acute bilateral parotitis within minutes of i.v. enalaprilat injection and recovered within 24 hours of stopping the drug and with symptomatic treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a female patient [Treatment] i.v. enalaprilat injection [Effect] acute bilateral parotitis"}, {"id": "10907391_4_411", "context": "We describe 2 patients with prior amputation who experienced phantom limb pain (PLP) after receiving paclitaxel therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] 2 patients with prior amputation [Treatment] paclitaxel therapy [Effect] phantom limb pain (PLP)"}, {"id": "11191005_1_412", "context": "There is evidence that the angiotensin II receptor antagonist, losartan, increases urate excretion by reducing reabsorption of urate in the renal proximal tubule.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increases [Treatment] angiotensin II receptor antagonist, losartan [Effect] increases urate excretion; reducing reabsorption of urate in the renal proximal tubule."}, {"id": "11468878_1_413", "context": "Although no coagulation study was done and the Meckel's diverticulum is normally associated with bleeding, the particular intensity of the following hemorrhage may have been favored by metformin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] favored [Treatment] metformin [Effect] hemorrhage"}, {"id": "15468380_2_414", "context": "We describe 2 patients with severe erosive rheumatoid arthritis and rheumatoid vasculitis, respectively, in whom infliximab therapy was associated with peripheral neuropathy due to necrotizing vasculitis in one patient and to progression of preexisting mononeuritis multiplex in the other.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] one patient [Treatment] infliximab therapy [Effect] peripheral neuropathy [Adverse event] associated [Subject] preexisting mononeuritis multiplex in the other [Treatment] infliximab therapy [Effect] peripheral neuropathy"}, {"id": "3586163_2_415", "context": "Upper tract urothelial malignancy after cyclophosphamide therapy: a case report and literature review.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] cyclophosphamide therapy [Effect] Upper tract urothelial malignancy"}, {"id": "8864370_1_416", "context": "BACKGROUND: Methotrexate (MTX) may induce liver damage, which in some psoriatics will lead to fibrosis or cirrhosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Treatment] Methotrexate (MTX) [Effect] liver damage, which in some psoriatics will lead to fibrosis or cirrhosis"}, {"id": "19071894_5_417", "context": "The infection proceeded even after treatment with fluconazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] fluconazole [Effect] infection proceeded"}, {"id": "9861579_1_418", "context": "We report the case of intoxication of a 41-year-old female patient suffering from major depression with mirtazapine complicated by severe hypothermia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] a 41-year-old female patient [Treatment] mirtazapine [Effect] intoxication; hypothermia"}, {"id": "16816519_9_419", "context": "The bilateral ptosis markedly improved after 7 days of pyridoxine and pyridostigmine treatment and completely resolved after two weeks.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] improved [Treatment] pyridoxine and pyridostigmine treatment"}, {"id": "20065266_4_420", "context": "PURPOSE: The case of a patient who developed aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension simultaneously during treatment with trimethoprim-sulfamethoxazole is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] trimethoprim-sulfamethoxazole [Effect] aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension"}, {"id": "12432978_2_421", "context": "Seizures and extrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with interferon beta-1a and clomipramine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis [Treatment] interferon beta-1a and clomipramine [Effect] Seizures and extrapyramidal symptoms"}, {"id": "8961730_1_422", "context": "Psychotic disorder associated with isoniazid.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] isoniazid [Effect] Psychotic disorder"}, {"id": "8551001_3_423", "context": "The azathioprine dose was low (1 mg/kg) and pancytopenia occurred after 56 days therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] 56 days therapy; The azathioprine dose was low (1 mg/kg) [Effect] pancytopenia"}, {"id": "10442258_5_424", "context": "Findings on discontinuation and rechallenge supported the assumption that the hair loss was a side effect of the paroxetine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effect [Treatment] paroxetine. [Effect] hair loss"}, {"id": "12546343_5_425", "context": "The successful development and implementation of this protocol will have impact on patients who have anaphylactic reactions to MTX but require this medication for specific diseases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] have [Subject] patients [Treatment] MTX [Effect] anaphylactic reactions"}, {"id": "18445989_2_426", "context": "Clomiphene is a first line treatment for anovulation, a common cause of infertility.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Clomiphene"}, {"id": "3290702_2_427", "context": "A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] A new case [Treatment] human growth hormone [Effect] Creutzfeldt-Jakob disease"}, {"id": "16939867_2_428", "context": "This case study is the second report of localized purpura after prolonged lamotrigine treatment suggesting this may be an atypical lamotrigine-induced drug reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] lamotrigine [Effect] localized purpura; drug reaction"}, {"id": "19047493_1_429", "context": "Extrapyramidal symptoms are well-documented complications of therapy with haloperidol, even when small doses are used.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complications [Treatment] haloperidol; small doses [Effect] Extrapyramidal symptoms"}, {"id": "16580907_9_430", "context": "Although cetirizine has less potential for causing arrhythmias than other histamine 1 blockers, such an interaction should be considered, especially in patients with renal insufficiency who are receiving pilsicainide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causing [Subject] patients with renal insufficiency [Treatment] cetirizine [Effect] arrhythmias"}, {"id": "16948177_1_431", "context": "Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] rituximab therapy [Effect] Bronchiolitis obliterans with organizing pneumonia"}, {"id": "9792602_1_432", "context": "The case demonstrates that hypersensitivity reaction to pranlukast and resultant ATIN is possible, and that periodic urine testing in patients receiving pranlukast should be considered.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] pranlukast [Effect] hypersensitivity reaction"}, {"id": "12546343_4_433", "context": "Successful desensitization to high-dose methotrexate after systemic anaphylaxis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] high-dose methotrexate [Effect] systemic anaphylaxis. [Potential therapeutic event] to [Treatment] high-dose methotrexate [Effect] Successful desensitization"}, {"id": "7468565_4_434", "context": "The patient's clinical presentation, histologic features on liver biopsy and favorable course after stopping the drug suggest that barbiturates can be added to the list of agents which can cause submassive hepatic necrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] barbiturates [Effect] submassive hepatic necrosis"}, {"id": "19838099_1_435", "context": "Although there have been numerous reports of effusions, none have provided complete pleural fluid analysis; therefore, we report 2 patients with dasatinib-induced pleural effusion with complete pleural fluid analysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] 2 patients [Treatment] dasatinib [Effect] pleural effusion"}, {"id": "2523364_1_436", "context": "Morphea after bromocriptine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] bromocriptine therapy [Effect] Morphea"}, {"id": "12390172_2_437", "context": "PURPOSE: To describe the clinical and electrophysiological findings in a young boy with decreased vision possibly due to retinal damage by rifabutin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] a young boy [Treatment] rifabutin [Effect] decreased vision; retinal damage"}, {"id": "2196696_3_438", "context": "We reported a case of disulfiram-induced hepatitis with unique clinical features and compared our case with others in the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] disulfiram [Effect] hepatitis"}, {"id": "8739289_4_439", "context": "We report a patient receiving chronic lithium therapy who presented with a transient CDI occurring in the setting of underlying chronic NDI.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] patient [Treatment] chronic lithium therapy [Effect] transient CDI"}, {"id": "20009973_2_440", "context": "Here we report a patient with newly diagnosed acute promyelocytic leukemia who developed acute focal myositis, synovitis, and possible vasculitis, after receiving all-trans retinoic acid therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with newly diagnosed acute promyelocytic leukemia [Treatment] all-trans retinoic acid [Effect] acute focal myositis, synovitis, and possible vasculitis"}, {"id": "22550162_2_441", "context": "We report a case of methotrexate toxicity potentially induced by a drug interaction between methotrexate and omeprazole in a 25-year-old man with osteosarcoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 25-year-old man with osteosarcoma [Treatment] methotrexate and omeprazole [Effect] methotrexate toxicity"}, {"id": "18562412_1_442", "context": "Increasing the olanzapine dosage severely aggravated the symptoms of RLS.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] aggravated [Treatment] Increasing the olanzapine dosage [Effect] symptoms of RLS"}, {"id": "19512997_2_443", "context": "We report a case of 48-year-old woman with seizure disorder on divalproex sodium (Depakote) who presented with dyspnea.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] a case of 48-year-old woman with seizure disorder [Treatment] divalproex sodium (Depakote) [Effect] dyspnea"}, {"id": "19531696_2_444", "context": "To report a probable interaction between warfarin and marijuana smoking, resulting in increased international normalized ratio (INR) values and bleeding complications.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] interaction between warfarin and marijuana smoking [Effect] increased international normalized ratio (INR) values and bleeding complications"}, {"id": "19653965_2_445", "context": "Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] two patients with HIV infection [Treatment] lopinavir/ritonavir [Effect] Transient cardiac arrhythmias"}, {"id": "11688826_1_446", "context": "Interestingly, the use of carboplatin (CBDCA) and VDS in the subsequent treatment course was well tolerated indicating that the SIADH was most likely to have been induced by administration of CDDP.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] CDDP [Effect] SIADH"}, {"id": "18957000_1_447", "context": "Although heparin-dependent antibodies (HDAs) typically manifest with thrombocytopenia as in heparin-induced thrombocytopenia (HIT), they may also manifest with preserved platelet counts.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] manifest [Treatment] heparin-dependent antibodies (HDAs) [Effect] thrombocytopenia"}, {"id": "22010004_3_448", "context": "A 69-year-old white female whose anticoagulation treatment had been stable for 18 months with warfarin 2.5 mg daily (17.5 mg/wk) presented to an anticoagulation clinic with a critically elevated INR of greater than 12.3 after a dose increase in extended-release niacin (Niaspan) from 500 mg to 1000 mg daily the previous week.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] 69-year-old white female [Treatment] anticoagulation treatment had been stable for 18 months with warfarin 2.5 mg daily (17.5 mg/wk); dose increase in extended-release niacin (Niaspan) from 500 mg to 1000 mg daily the previous week [Effect] elevated INR of greater than 12.3"}, {"id": "17346586_1_449", "context": "The most serious dental side effect of bisphosphonate treatment (particularly when it is administered intravenously) is, paradoxically, osteonecrosis of the mandible or the maxilla represented by exposed nonhealing bone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effect [Treatment] bisphosphonate treatment (particularly when it is administered intravenously) [Effect] osteonecrosis of the mandible or the maxilla represented by exposed nonhealing bone"}, {"id": "18160579_1_450", "context": "Pericardial hemorrhage due to acetylsalicylic acid in a patient with essential thrombocythemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] acetylsalicylic acid [Effect] Pericardial hemorrhage"}, {"id": "7387219_2_451", "context": "These cases and a review of the literature suggested that hepatotoxicity, though rare, should be added to the list of adverse reactions to D-penicillamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse [Subject] These cases [Treatment] D-penicillamine [Effect] hepatotoxicity"}, {"id": "12962465_1_452", "context": "After four months, while receiving RH, he developed painful bilateral gynaecomastia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] receiving RH [Effect] painful bilateral gynaecomastia"}, {"id": "16580907_5_453", "context": "The plasma concentrations of both drugs were significantly increased during the coadministration, and the cetirizine concentration decreased on cessation of pilsicainide despite the fact that treatment with cetirizine was continued, which suggested that the fainting was induced by the pharmacokinetic drug interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] pilsicainide; cetirizine [Effect] fainting"}, {"id": "11573852_6_454", "context": "OBJECTIVE: To report a case of multiple episodes of seizure activity in an AIDS patent following amphotericin B infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] an AIDS patent [Treatment] amphotericin B infusion [Effect] multiple episodes of seizure activity"}, {"id": "9651465_3_455", "context": "The vomiting occurred on switching to different pancreatic enzymes preparations, ie, Creon 10, Viokase, and Pancrease MT 16.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] switching [Treatment] different pancreatic enzymes preparations, ie, Creon 10, Viokase, and Pancrease MT 16 [Effect] vomiting"}, {"id": "2357706_1_456", "context": "Although tardive dyskinesia is a known adverse reaction of sustained treatment with traditional neuroleptic agents, it was only rarely reported in association with sulpiride, a selective D2-receptor antagonist.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] sulpiride [Effect] tardive dyskinesia"}, {"id": "19047493_2_457", "context": "This report highlights a case of drug-induced dysphagia in a patient receiving haloperidol for obsessive nocturnal thoughts and auditory disturbances.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient [Treatment] haloperido [Effect] dysphagia"}, {"id": "15338554_3_458", "context": "In addition to disease refractoriness, rare instances of disease progression from chronic phase to blast crisis during imatinib therapy have recently been anecdotally reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] imatinib therapy [Effect] disease progression from chronic phase to blast crisis"}, {"id": "25540831_4_459", "context": "We report a typical case of transient serotonin syndrome secondary to tramadol-Citalopram combination.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Subject] a typical case [Treatment] tramadol-Citalopram combination [Effect] transient serotonin syndrome"}, {"id": "22550162_9_460", "context": "Although use of the Naranjo adverse reaction probability scale indicated a probable relationship (score of 6) between the patient's development of methotrexate toxicity and omeprazole use, we believe this was a drug-drug interaction case consistent with previous reports in the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] relationship [Subject] the patient [Treatment] methotrexate; and omeprazole use [Effect] methotrexate toxicity"}, {"id": "3620420_5_461", "context": "Systemic cyclosporin (10 mg/kg/day) resulted in resolution of the corneal ulceration within two weeks of beginning treatment, and the patient has remained in remission after 15 months of therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resulted [Subject] patient [Treatment] Systemic cyclosporin (10 mg/kg/day) [Effect] resolution of the corneal ulceration"}, {"id": "6578007_2_462", "context": "We report a 59-year-old patient with chronic myeloid leukemia, who developed severe interstitial lung fibrosis after short term and sequential treatment with melphalan and busulfan.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 59-year-old patient with chronic myeloid leukemia [Treatment] short term and sequential treatment with melphalan and busulfan [Effect] interstitial lung fibrosis"}, {"id": "12702914_1_463", "context": "Does the use of insulin in a patient with liver dysfunction increase water retention in the body, i.e. cause insulin oedema?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] use [Subject] a patient with liver dysfunction [Treatment] insulin [Effect] increase water retention in the body, i.e. cause insulin oedema?"}, {"id": "1624172_2_464", "context": "Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patients with chronic hepatitis C [Treatment] recombinant alpha interferon [Effect] Sustained hypothyroidism"}, {"id": "19512997_3_465", "context": "Withdrawal of Depakote resulted in resolution of the effusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Treatment] Withdrawal of Depakote [Effect] resolution of the effusion"}, {"id": "11428480_1_466", "context": "Adenosine-induced ventricular fibrillation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Adenosine [Effect] ventricular fibrillation"}, {"id": "23774436_1_467", "context": "Evaluation of initial and steady-state gatifloxacin pharmacokinetics and dose in pulmonary tuberculosis patients by using monte carlo simulations.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] in [Subject] pulmonary tuberculosis patients [Treatment] gatifloxacin"}, {"id": "14723711_5_468", "context": "We report two patients with acne vulgaris with a fourth type of minocycline-induced cutaneous pigmentation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] two patients with acne vulgaris [Treatment] minocycline [Effect] fourth type of; cutaneous pigmentation"}, {"id": "7720517_2_469", "context": "Budesonide is a synthetic glucocorticosteroid that is commonly used in topical treatment of asthma and rhinitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used in [Treatment] Budesonide"}, {"id": "3620420_1_470", "context": "Cyclosporin therapy in Mooren's ulcer.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] therapy [Treatment] Cyclosporin"}, {"id": "11359026_3_471", "context": "She developed neurotoxicity with an adjustment dosage of valacyclovir for a cutaneous zoster infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] She [Treatment] adjustment dosage of valacyclovir [Effect] neurotoxicity"}, {"id": "11642488_3_472", "context": "Nine eyes from 6 patients, 74 years to 90 years of age, referred by ophthalmologists for repair of cicatricial entropion after at least 2 years of twice-a-day application of dipivefrin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] Nine eyes from 6 patients, 74 years to 90 years of age [Treatment] at least 2 years of twice-a-day application of dipivefrin [Effect] cicatricial entropion"}, {"id": "15965422_3_473", "context": "We report 5 patients (3 patients with chronic hepatitis C treated with pegylated interferon alfa-2b in association with oral ribavirin and two patients with chronic myelocytic leukemia) who developed local cutaneous reactions at sites of injection after the administration of weekly subcutaneous injections of pegylated interferon alfa-2b at different doses.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two patients with chronic myelocytic leukemia [Treatment] administration of weekly subcutaneous injections of pegylated interferon alfa-2b at different doses [Effect] local cutaneous reactions at sites of injection [Adverse event] developed [Subject] 3 patients with chronic hepatitis C [Treatment] pegylated interferon alfa-2b in association with oral ribavirin [Effect] local cutaneous reactions at sites of injection"}, {"id": "20180933_2_474", "context": "Artemether-lumefantrine (AL) is first-line treatment for uncomplicated malaria in many African countries.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] first-line treatment [Treatment] Artemether-lumefantrine (AL)"}, {"id": "17329303_10_475", "context": "Functional regulation of certain neuroreceptors during risperidone treatment may lead to altered behavioural responses upon switching to methylphenidate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] lead [Treatment] risperidone; switching to methylphenidate [Effect] altered behavioural responses"}, {"id": "3508194_1_476", "context": "Transient leucopenia and thrombocytopenia associated with sodium nitroprusside infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] sodium nitroprusside infusion [Effect] Transient leucopenia and thrombocytopenia"}, {"id": "7789881_2_477", "context": "This unusual pattern of low-grade endometrial carcinoma adds to the spectrum of uterine neoplasia associated with tamoxifen therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] tamoxifen [Effect] unusual pattern of low-grade endometrial carcinoma adds to the spectrum of uterine neoplasia"}, {"id": "7420580_1_478", "context": "Inappropriate antidiuretic hormone secretion after high dose vinblastine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] high dose vinblastine [Effect] Inappropriate antidiuretic hormone secretion"}, {"id": "17373180_2_479", "context": "Osteomyelitis occurring during infliximab treatment of severe psoriasis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment [Treatment] infliximab [Effect] Osteomyelitis"}, {"id": "8452107_3_480", "context": "We describe a patient with transitional cell carcinoma of the renal pelvis who developed respiratory dysfunction and an abnormal chest x-ray with diffuse interstitial opacities while on chemotherapy with piritrexim, a methotrexate analog.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with transitional cell carcinoma of the renal pelvis [Treatment] chemotherapy with piritrexim, a methotrexate analog [Effect] respiratory dysfunction and an abnormal chest x-ray with diffuse interstitial opacities"}, {"id": "2690546_2_481", "context": "Amiodarone induced torsades de pointe.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Amiodarone [Effect] torsades de pointe"}, {"id": "2113320_1_482", "context": "A patient with Wegener's granulomatosis rapidly developed a circumferential subglottic stenosis while on a cyclophosphamide regimen that had caused resolution of systemic symptoms and pulmonary infiltrates.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient with Wegener's granulomatosis [Treatment] cyclophosphamide regimen [Effect] circumferential subglottic stenosis; resolution of systemic symptoms and pulmonary infiltrates"}, {"id": "8733532_1_483", "context": "A case is presented which illustrates a probably fatal interaction between minoxidil and a coagulation disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] between [Subject] A case [Treatment] minoxidil [Effect] fatal interaction"}, {"id": "11406880_1_484", "context": "Methadone-induced myoclonus in advanced cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Methadone [Effect] myoclonus"}, {"id": "11984077_1_485", "context": "Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Subject] a patient with dermatomyositis [Treatment] amifostine used with concurrent chemoradiotherapy [Effect] Life-threatening anaphylactoid reaction"}, {"id": "19260037_4_486", "context": "We conclude that while thrombocytopenia and schistocytosis can be seen in quinine-associated TTP/HUS, the pathophysiology seems to be distinct from that seen in most cases of idiopathic TTP (i.e., severely decreased ADAMTS13 with an inhibitor).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] quinine [Effect] thrombocytopenia and schistocytosis; TTP/HUS"}, {"id": "19690222_1_487", "context": "CONCLUSIONS: Spontaneous hemothorax is a rare phenomenon in conjunction with LMWH but should be considered in cases of acute respiratory distress following commencement of LMWH.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] considered [Treatment] LMWH [Effect] Spontaneous hemothorax; acute respiratory distress"}, {"id": "17068466_1_488", "context": "CONCLUSION: These cases suggest that moxifloxacin may interfere with the healing of corneal ulcers.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] interfere [Subject] These cases [Treatment] moxifloxacin [Effect] interfere with the healing of corneal ulcers"}, {"id": "2568058_4_489", "context": "Reinstitution of penicillamine treatment caused a recurrence thus proving a causal relationship between penicillamine and the described nail-changes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causal relationship [Treatment] penicillamine [Effect] nail-changes"}, {"id": "11672959_1_490", "context": "A 34-year-old lady developed a constellation of dermatitis, fever, lymphadenopathy and hepatitis, beginning on the 17th day of a course of oral sulphasalazine for sero-negative rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 34-year-old lady [Treatment] a course of oral sulphasalazine [Effect] a constellation of dermatitis, fever, lymphadenopathy and hepatitis"}, {"id": "18477279_3_491", "context": "He had been commenced on a course of fusidic acid at discharge in addition to his ongoing statin prescription and presented 4 weeks later with symptoms consistent with rhabdomyolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Treatment] a course of fusidic acid at discharge in addition to his ongoing statin prescription [Effect] symptoms consistent with rhabdomyolysis"}, {"id": "10456689_2_492", "context": "1.\nArtelinic acid (AL), a water-soluble artemisinin analogue for treatment of multidrug resistant malaria, is metabolized to the active metabolite dihydroqinghaosu (DQHS) solely by  CYP3A4/5.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Artelinic acid (AL), a water-soluble artemisinin analogue"}, {"id": "17331261_3_493", "context": "Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a patient with cystic fibrosis [Treatment] Inhaled tobramycin [Effect] recurrent eosinophilia and severe persistent bronchospasm"}, {"id": "15719254_4_494", "context": "The occurrence of BMTN in two children treated with RA in our unit is unlikely to be coincidental.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] two children [Treatment] RA [Effect] BMTN"}, {"id": "12665232_1_495", "context": "Comeoscleral perforation after pterygium excision and intraoperative mitomycin C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] pterygium excision and intraoperative mitomycin C [Effect] Comeoscleral perforation"}, {"id": "16237130_1_496", "context": "Capecitabine-induced multifocal leukoencephalopathy: a report of five cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] five cases [Treatment] Capecitabine [Effect] multifocal leukoencephalopathy"}, {"id": "15941649_3_497", "context": "Vigabatrin-induced visual field defects are at present the most important safety issue in the use of the drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Vigabatrin [Effect] visual field defects"}, {"id": "17667887_1_498", "context": "Serotonin syndrome in elderly patients treated for psychotic depression with atypical antipsychotics and antidepressants: two case reports.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] elderly patients [Treatment] atypical antipsychotics; antidepressants [Effect] Serotonin syndrome"}, {"id": "11903249_3_499", "context": "We report two new cases of sarcoidosis in two patients with hepatitis C virus infection treated with interferon alfa and ribavirin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] two patients with hepatitis C virus infection [Treatment] interferon alfa and ribavirin [Effect] sarcoidosis"}, {"id": "2523364_2_500", "context": "A 57-year-old man developed morphea while taking bromocriptine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] A 57-year-old man [Treatment] bromocriptine [Effect] morphea"}, {"id": "8739289_6_501", "context": "Potential mechanisms regarding the pathophysiology of lithium-associated CDI are discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] lithium [Effect] CDI"}, {"id": "18765315_2_502", "context": "Acute coronary syndromes complicating the first infusion of rituximab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicating [Treatment] the first infusion of rituximab [Effect] Acute coronary syndromes"}, {"id": "19690222_3_503", "context": "Spontaneous hemothorax following anticoagulation with low-molecular-weight heparin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] low-molecular-weight heparin [Effect] Spontaneous hemothorax following anticoagulation"}, {"id": "10715308_11_504", "context": "There were no incremental increases in myelosuppression, peripheral neuropathy, or renal, hepatic, or cardiac toxicity and no deaths related to tirapazamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] related [Treatment] tirapazamine [Effect] no incremental increases in myelosuppression, peripheral neuropathy, or renal, hepatic, or cardiac toxicity and no deaths"}, {"id": "10715308_3_505", "context": "A phase III trial, Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors (CATAPULT I), was designed to determine the efficacy and safety of tirapazamine plus cisplatin for the treatment of non-small-cell lung cancer (NSCLC).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] tirapazamine plus cisplatin"}, {"id": "17316160_3_506", "context": "Combination antimicrobial regimens (e.g., linezolid with rifampin) aimed at improving bacterial eradication and preventing resistance are often used; however, most data supporting this treatment strategy are not from randomized controlled trials.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] aimed [Treatment] Combination antimicrobial regimens (e.g., linezolid with rifampin) [Effect] improving bacterial eradication and preventing resistance"}, {"id": "17667887_10_507", "context": "Clinicians treating elderly patients with a combination of serotonergic antidepressants and atypical antipsychotics for psychotic depression should be aware of the potential for serotonin syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] be aware [Subject] elderly patients [Treatment] a combination of serotonergic antidepressants and atypical antipsychotics for psychotic depression [Effect] serotonin syndrome"}, {"id": "18472517_1_508", "context": "Enalaprilat induced acute parotitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Enalaprilat [Effect] acute parotitis"}, {"id": "18477279_6_509", "context": "We believe the most likely cause was hepatic inhibition of the CYP3A4 hepatic isoenzyme by fusidic acid resulting in an acute severe rise in plasma simvastatin level and extensive myocellular damage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] fusidic acid [Effect] an acute severe rise in plasma simvastatin level and extensive myocellular damage"}, {"id": "18160579_2_510", "context": "The authors describe pericardial hemorrhage, which is related to the use of low-dose acetylsalicylic acid in a patient with essential thrombocythemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] a patient with essential thrombocythemia [Treatment] low-dose acetylsalicylic acid [Effect] pericardial hemorrhage"}, {"id": "17083890_7_511", "context": "This complex pattern of nail and skin changes is accounted by synergy or an additive effect of chemotherapy agents on cellular proliferation of nail compartments.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] synergy or an additive effect [Treatment] chemotherapy agents [Effect] complex pattern of nail and skin changes"}, {"id": "12625995_1_512", "context": "Akathisia is a relatively rare side effect with the newer atypical antipsychotic agents, particularly clozapine, and is easily misdiagnosed in children.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] i [Treatment] clozapine [Effect] Akathisia"}, {"id": "1918672_1_513", "context": "In this case, discontinuing piroxicam, a nonsteroidal anti-inflammatory drug, and starting a palliative treatment plan helped resolve a patient's ulcers.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolve [Subject] a patient's [Treatment] discontinuing piroxicam, a nonsteroidal anti-inflammatory drug, and starting a palliative treatment"}, {"id": "9988365_2_514", "context": "Eosinophilia has been encountered from 0.2 to 61.7% in clozapine-treated patients, mostly with a transient course and spontaneous remission.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] encountered [Subject] patients [Treatment] clozapine [Effect] Eosinophilia"}, {"id": "3954165_2_515", "context": "We presented a patient with status asthmaticus treated with a combination of theophylline and prednisone who developed a perforated gastric ulcer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with status asthmaticus [Treatment] theophylline and prednisone [Effect] perforated gastric ulcer"}, {"id": "17157086_5_516", "context": "We speculate on a causal relationship between the assumption of the additives and the fatal hepatitis and envisage a synergy between the additives and montelukast, which per se has well been studied as a hepatotoxic drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] relationship [Treatment] montelukast [Effect] the fatal hepatitis"}, {"id": "17157086_1_517", "context": "Fatal liver failure following food supplements during chronic treatment with montelukast.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] food supplements during chronic treatment with montelukast [Effect] Fatal liver failure"}, {"id": "8627446_4_518", "context": "The nodules regressed after withdrawal of methotrexate therapy in one patient and were arrested with the addition of hydroxychloroquine in the other.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] after [Subject] one patient [Treatment] withdrawal of methotrexate therapy [Effect] regressed [Potential therapeutic event] with [Subject] one patient; the other [Treatment] the addition of hydroxychloroquine [Effect] arrested"}, {"id": "12661801_2_519", "context": "Treatment of carbimazole-induced agranulocytosis and sepsis with granulocyte colony stimulating factor.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] Treatment [Treatment] granulocyte colony stimulating factor"}, {"id": "3954165_1_520", "context": "A study following large patient groups on theophylline and a combination of theophylline and steroids might clarify the risk of ulcer formation in patients being treated with these medications for asthma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Subject] large patient groups [Treatment] theophylline and a combination of theophylline and steroids [Effect] ulcer"}, {"id": "9681092_10_521", "context": "The combination of cyclobenzaprine and fluoxetine resulted in significant QT prolongation in our patient that progressed to torsade de pointes after preoperative droperidol administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Subject] our patient [Treatment] The combination of cyclobenzaprine and fluoxetine; preoperative droperidol administration [Effect] significant QT prolongation; progressed to torsade de pointes"}, {"id": "7887138_2_522", "context": "INTRODUCTION-The aim of this case report is to present a 15-year follow-up of a patient with phenytoin (PHT) intoxication with unilateral gingival hyperplasia (GH).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] intoxication [Subject] a patient [Treatment] phenytoin [Effect] phenytoin (PHT) intoxication with unilateral gingival hyperplasia (GH)"}, {"id": "9039216_3_523", "context": "This severe illness was likely caused by minocycline, and we speculate that minocycline may have acted as a superantigen, causing lymphocyte over-activation and massive cytokine release.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] minocycline [Effect] severe illness"}, {"id": "15681911_3_524", "context": "RESULTS: Three patients who developed symptoms of inflammatory bowel disease (IBD) during rofecoxib exposure are described along with pathology findings.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Three patients [Treatment] rofecoxib exposure [Effect] symptoms of inflammatory bowel disease (IBD)"}, {"id": "15112258_2_525", "context": "Radiation recall refers to inflammatory reactions triggered by cytotoxic agents and develops in previously irradiated areas.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] triggered [Treatment] cytotoxic agents [Effect] Radiation recall; inflammatory reactions"}, {"id": "16507211_1_526", "context": "Herein, we describe 2 patients who developed unusual CD8+ cutaneous lymphoproliferative disorders after treatment with efalizumab and infliximab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 2 patients [Treatment] efalizumab and infliximab [Effect] CD8+ cutaneous lymphoproliferative"}, {"id": "12707728_1_527", "context": "Intrathecal methotrexate-induced acute cerebellar syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] methotrexate [Effect] acute cerebellar syndrome"}, {"id": "7468565_1_528", "context": "Barbiturate-induced submassive hepatic necrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Barbiturate [Effect] submassive hepatic necrosis"}, {"id": "9094821_1_529", "context": "The possible effects of tamoxifen upon the uterus are discussed in this article, in view of reports of tamoxifen associated with endometrial carcinoma and endometriosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] tamoxifen [Effect] endometrial carcinoma and endometriosis"}, {"id": "2549018_6_530", "context": "Three patients who had experienced neuroleptic-induced akathisia in the past reported that the symptoms of fluoxetine-induced akathisia were identical, although somewhat milder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] Three patients [Treatment] fluoxetine [Effect] akathisia [Adverse event] induced [Subject] Three patients [Treatment] neuroleptic [Effect] akathisia"}, {"id": "8700794_2_531", "context": "Intranasal desmopressin-induced hyponatremia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Intranasal desmopressin [Effect] hyponatremia"}, {"id": "9934637_4_532", "context": "Sunburn may sometimes be a major injury in psoralen users because high doses or inappropriate use of the drug may render the skin extremely sensitive.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] render [Subject] users [Treatment] psoralen users because high doses or inappropriate use [Effect] Sunburn; skin extremely sensitive"}, {"id": "2204409_2_533", "context": "Methotrexate-induced leukoencephalopathy is treatable with high-dose folinic acid: a case report and analysis of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatable [Treatment] high-dose folinic acid [Adverse event] induced [Treatment] Methotrexate [Effect] leukoencephalopathy"}, {"id": "18765315_5_534", "context": "We reviewed the records of 3 patients with lymphoproliferative disorders who experienced acute coronary syndromes associated with their initial infusion of rituximab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] 3 patients with lymphoproliferative disorders [Treatment] their initial infusion of rituximab [Effect] acute coronary syndromes"}, {"id": "14964753_8_535", "context": "Previous successful treatment with one ACE inhibitor does not rule out the vasculitis caused by the drug from the same group.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] ACE inhibitor [Effect] vasculitis"}, {"id": "11688826_3_536", "context": "We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following systemic chemotherapy with cisplatin (CDDP) and vindesine (VDS).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a patient with pulmonary adenocarcinoma [Treatment] systemic chemotherapy with cisplatin (CDDP) and vindesine (VDS) [Effect] the syndrome of inappropriate secretion of antidiuretic hormone (SIADH)"}, {"id": "2196696_2_537", "context": "Our patient had headache, mild fever, nausea, vomiting, rash, and eosinophilia after 3 weeks of disulfiram therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] after 3 weeks of disulfiram [Effect] headache, mild fever, nausea, vomiting, rash, and eosinophilia"}, {"id": "17316160_1_538", "context": "Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receiving [Subject] a critically ill patient [Treatment] concomitant linezolid and rifampin [Effect] Decreased serum linezolid levels"}, {"id": "8329789_2_539", "context": "OBJECTIVE: To report the first five cases of amphotericin B overdose with secondary cardiac complications in a pediatric population.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Subject] first five cases of; a pediatric population [Treatment] amphotericin B overdose [Effect] cardiac complications"}, {"id": "11573852_3_540", "context": "CONCLUSIONS: Amphotericin B seems to be the probable cause of the seizures.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Amphotericin B [Effect] seizures"}, {"id": "12707728_2_541", "context": "We describe a patient who developed acute cerebellar syndrome after prophylactic intrathecal methotrexate administration and recovered spontaneously.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] prophylactic intrathecal methotrexate administration [Effect] acute cerebellar syndrome"}, {"id": "11388112_1_542", "context": "Levofloxacin induced polymorphic ventricular tachycardia with normal QT interval.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Levofloxacin [Effect] polymorphic ventricular tachycardia with normal QT interval"}, {"id": "25540831_7_543", "context": "Most physicians are aware of serotonin syndrome secondary to antidepressants but do not think about other classes of medications such as analgesics.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] antidepressants [Effect] serotonin syndrome"}, {"id": "19071894_7_544", "context": "Renal toxicity signs, induced by amphotericin B, progression of infection after fluconazole, and likely in vivo resistance to this triazole made this case difficult to treat.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] amphotericin B [Effect] Renal toxicity signs [Adverse event] after [Treatment] fluconazole [Effect] infection"}, {"id": "11319599_2_545", "context": "We describe two patients with aspergillus arthritis of the knee joint following fludarabine-based non-myeloablative stem cell transplantation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] two patients [Treatment] fludarabine-based non-myeloablative stem cell transplantation [Effect] aspergillus arthritis of the knee joint"}, {"id": "8162401_1_546", "context": "A case of fluoxetine induced seizures, in a person with Down syndrome, is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a person with Down syndrome [Treatment] fluoxetine [Effect] seizures"}, {"id": "10405480_3_547", "context": "We report a case of acute generalized exanthematous pustulosis (AGEP) induced by salazosulfapyridine in a patient with ulcerative colitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced by [Subject] a patient with ulcerative colitis [Treatment] salazosulfapyridine [Effect] acute generalized exanthematous pustulosis (AGEP)"}, {"id": "10414481_1_548", "context": "Diclofenac-associated hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Diclofenac [Effect] hepatitis"}, {"id": "12729371_1_549", "context": "Angioimmunoblastic lymphadenopathy with dysproteinemia following doxycycline administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] doxycycline administration [Effect] Angioimmunoblastic lymphadenopathy with dysproteinemia"}, {"id": "12540009_1_550", "context": "Doxycycline-induced hypoglycemia in a nondiabetic young man.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a nondiabetic young man [Treatment] Doxycycline [Effect] hypoglycemia"}, {"id": "968449_7_551", "context": "Case 2 demonstrated after 40 months on chlorambucil the presence of a balanced translocation, t (1;5) (p36;q31) in 90% of the cells.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presence of [Subject] Case 2 [Treatment] 40 months on chlorambucil [Effect] a balanced translocation, t (1;5) (p36;q31) in 90% of the cells"}, {"id": "9792602_3_552", "context": "Within 6 months of pranlukast withdrawal, anemia resolved and urinary sediment and renal function normalized.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] withdrawal [Treatment] pranlukast [Effect] anemia resolved and urinary sediment and renal function normalized"}, {"id": "16221163_1_553", "context": "Sirolimus-associated hepatotoxicity in the kidney graft recipient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] kidney graft recipient. [Treatment] Sirolimus [Effect] hepatotoxicity"}, {"id": "12181031_1_554", "context": "Although vasculitis has been reported in the course of hairy cell leukaemia, it has only rarely been reported as the consequence of cladribine treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] consequence [Treatment] cladribine [Effect] vasculitis"}, {"id": "19275460_6_555", "context": "Despite aggressive medical management, including intravenous hydration and broad-spectrum antibiotics, the patient continued to become more confused, agitated, and despondent over the subsequent 24 hours.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] continued [Subject] patient [Treatment] intravenous hydration and broad-spectrum antibiotics [Effect] become more confused, agitated, and despondent over the subsequent 24 hours"}, {"id": "17763133_1_556", "context": "Cyclosporine is a potent inhibitor of simvastatin metabolism, and may therefore facilitate simvastatin-induced rhabdomyolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] facilitate [Treatment] Cyclosporine is a potent inhibitor of simvastatin metabolism"}, {"id": "20180933_1_557", "context": "The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receiving [Subject] African children [Treatment] artemether-lumefantrine crushed or dispersible tablets (Coartem)"}, {"id": "15827071_2_558", "context": "To report 2 cases of serotonin toxicity (ST) associated with concomitant use of linezolid and serotonergic drugs and review previously published case reports.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] 2 cases [Treatment] concomitant use of linezolid and serotonergic drugs [Effect] serotonin toxicity (ST)"}, {"id": "17952482_3_559", "context": "This case illustrates that the hemophagocytic syndrome associated with reactivation of EBV can occur as part of drug hypersensitivity reactions in RA patients taking sulfasalazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Treatment] sulfasalazine [Effect] the hemophagocytic syndrome associated with reactivation of EBV"}, {"id": "2357706_2_560", "context": "Tardive dyskinesia induced by sulpiride.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] sulpiride [Effect] Tardive dyskinesia"}, {"id": "9758325_1_561", "context": "Seizures occurred in two patients with probable Alzheimer's disease who were receiving long-term treatment with metrifonate, an irreversible acetylcholinesterase inhibitor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] two patients with probable Alzheimer's disease [Treatment] long-term treatment with metrifonate [Effect] Seizures"}, {"id": "11597289_16_562", "context": "High-dose antithrombin III was associated with an increased risk of hemorrhage when administered with heparin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increased [Treatment] High-dose antithrombin III; heparin [Effect] hemorrhage"}, {"id": "3513544_3_563", "context": "With the increasing use of Cyclosporine A in transplant patients, the incidence of herpes esophagitis may increase.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] incidence [Subject] transplant patients [Treatment] Cyclosporine A [Effect] herpes esophagitis may increase."}, {"id": "17473920_8_564", "context": "After starting nevirapine treatment, nine out of ten patients experienced symptoms of abstinence syndrome, and methadone dose had to be increased by 20% on average during the course of the study.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] nine out of ten patients [Treatment] nevirapine [Effect] abstinence syndrome"}, {"id": "19071894_4_565", "context": "Treatment was begun with amphotericin B-deoxycholate but renal toxicity signs led to its substitution by fluconazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] signs [Treatment] amphotericin B-deoxycholate [Effect] renal toxicity"}, {"id": "16531969_3_566", "context": "Post marketing studies of Interferon-beta (IFN beta) therapy in multiple sclerosis (MS) have demonstrated surprisingly high rates of hepatotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] demonstrated [Treatment] Interferon-beta [Effect] hepatotoxicity"}, {"id": "18715650_2_567", "context": "We describe the first case of disseminated salmonellosis in a patient treated with temozolomide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient [Treatment] temozolomide [Effect] disseminated salmonellosis"}, {"id": "16368918_1_568", "context": "OBJECTIVE: To describe a case of exacerbated mania potentially related to an interaction between lopinavir/ritonavir and valproic acid (VPA) and propose a mechanism of action for this interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] interaction between lopinavir/ritonavir and valproic acid [Effect] exacerbated mania"}, {"id": "6597713_4_569", "context": "The first reported case, in an adult, of cholestyramine induced hyperchloremic metabolic acidosis is a 70 year old female with a two year history of primary biliary cirrhosis confirmed by histologic and immunologic criteria.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 70 year old female with a two year history of primary biliary cirrhosis [Treatment] cholestyramine [Effect] hyperchloremic metabolic acidosis"}, {"id": "19423476_4_570", "context": "We report a case of fatal C. neoformans fungemia in a neutropenic patient with a history of chronic lymphocytic leukemia treated with alemtuzumab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated with [Subject] a neutropenic patient with a history of chronic lymphocytic leukemia [Treatment] alemtuzumab [Effect] fatal C. neoformans fungemia"}, {"id": "22550162_6_571", "context": "Aggressive hydration, urinary alkalinization, and leucovorin were continued during the period of elevated methotrexate levels, with the patient receiving a course of hemodialysis and a dose of carboxypeptidase G2.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] continued [Subject] the patient [Treatment] Aggressive hydration, urinary alkalinization, and leucovorin; elevated methotrexate; course of hemodialysis and a dose of carboxypeptidase G2"}, {"id": "2924444_1_572", "context": "Acute myocardial infarction due to coronary spasm associated with L-thyroxine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] L-thyroxine [Effect] Acute myocardial infarction due to coronary spasm"}, {"id": "12149193_7_573", "context": "Only patients on DT-PACE but not DCEP-T experienced an increased incidence of DVT.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] patients [Treatment] DT-PACE but not DCEP-T [Effect] an increased incidence of DVT"}, {"id": "17316160_5_574", "context": "To our knowledge, this is the first published report of a possible drug interaction in a critically ill patient receiving concomitant linezolid and rifampin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] a critically ill patient [Treatment] concomitant linezolid and rifampin [Effect] drug interaction"}, {"id": "8700794_4_575", "context": "Within 24 hours of fluid restriction and cessation of desmopressin, her symptoms and hyponatremia resolved.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Subject] her [Treatment] 24 hours of fluid restriction and cessation of desmopressin [Effect] symptoms and hyponatremia"}, {"id": "1450506_1_576", "context": "An adverse reaction to IFN was strongly suspected as the cause of CHF.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] IFN [Effect] CHF"}, {"id": "16164579_1_577", "context": "A 51-year old physically fit woman experienced angio-oedema and hypotensive shock after irbesartan ingestion requiring noradrenaline infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] A 51-year old physically fit woman [Treatment] irbesartan ingestion [Effect] angio-oedema and hypotensive shock"}, {"id": "15823103_3_578", "context": "Our report suggested that CBDCA hypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum-based chemotherapy, even in platinum-sensitive cases, because CBDCA hypersensitivity can occur even with low-dose CBDCA administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] correlated [Treatment] total dose of previously administered platinum agents [Effect] CBDCA hypersensitivity"}, {"id": "11978156_4_579", "context": "Lansoprazole-induced thrombocytopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Lansoprazole [Effect] thrombocytopenia"}, {"id": "15965422_2_580", "context": "Cutaneous necrosis as a result of interferon alfa is an infrequent complication with unknown pathogenesis, in which a cutaneous local immune-mediated inflammatory process might be involved.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] interferon alfa [Effect] Cutaneous necrosis"}, {"id": "9681092_1_581", "context": "Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] droperidol; cytochrome P450 [Effect] Torsade de pointes"}, {"id": "17952482_2_582", "context": "Sulfasalazine-induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein-Barr virus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Sulfasalazine [Effect] hypersensitivity syndrome and hemophagocytic syndrome"}, {"id": "11335880_4_583", "context": "OBJECTIVES: The authors described a case of Hashimoto's disease during interferon-alpha (IFN-alpha) treatment for chronic viral C hepatitis in a patient with the specific genetic susceptibility associated with the thyroid disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a patient with the specific genetic susceptibility associated with the thyroid disease [Treatment] interferon-alpha (IFN-alpha) treatment [Effect] Hashimoto's disease"}, {"id": "8739289_2_584", "context": "Nephrogenic diabetes insipidus (NDI) is a well-documented complication of lithium use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] lithium [Effect] Nephrogenic diabetes insipidus (NDI)"}, {"id": "15827071_1_585", "context": "Serotonin toxicity associated with concomitant use of linezolid.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] concomitant use of linezolid; Serotonin [Effect] Serotonin toxicity"}, {"id": "16221163_3_586", "context": "We report the case of a 30-year-old male after kidney transplantation, treated with steroids, cyclosporin A and SRL, with steroid-resistant acute rejection in anamnesis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] the case of a 30-year-old male [Treatment] kidney transplantation, treated with steroids, cyclosporin A and SRL [Effect] steroid-resistant acute rejection"}, {"id": "8933322_2_587", "context": "Infants are particularly susceptible to chronic nitrate-induced methemoglobinemia because of their low stomach acid production, large numbers of nitrite-reducing bacteria, and the relatively easy oxidation of fetal hemoglobin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] Infants [Treatment] nitrate [Effect] methemoglobinemia"}, {"id": "16580907_2_588", "context": "A 72-year-old woman with renal insufficiency who was taking oral pilsicainide (150 mg/d) complained of feeling faint 3 days after she was prescribed oral cetirizine (20 mg/d).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complained [Subject] A 72-year-old woman with renal insufficiency [Treatment] taking oral pilsicainide (150 mg/d); 3 days after she was prescribed oral cetirizine (20 mg/d) [Effect] feeling faint"}, {"id": "16615675_2_589", "context": "Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Chronic hydroxychloroquine [Effect] QT prolongation and refractory ventricular arrhythmia"}, {"id": "10610018_3_590", "context": "This increase when clozapine was switched to risperidone and vice versa is consistent with our previous report of elevated serum triglyceride levels in clozapine-treated patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] consistent [Subject] patients [Treatment] clozapine was switched to risperidone and vice versa"}, {"id": "12763355_2_591", "context": "Sensorimotor polyneuropathy with 5-aminosalicylic acid: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] a case [Treatment] 5-aminosalicylic acid [Effect] Sensorimotor polyneuropathy"}, {"id": "8329789_7_592", "context": "Hydrocortisone prophylaxis and verapamil therapy were the primary therapies used in patient 1 (the only survivor).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] therapies [Subject] patient 1 (the only survivor) [Treatment] Hydrocortisone prophylaxis and verapamil therapy"}, {"id": "160443_2_593", "context": "The clinical aspect closely resembled classical transient global amnesia but the episode after clioquinol lasted longer (24 hours to three days) and a more or less extensive retrograde amnesia persisted permanently.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] clioquinol [Effect] classical transient global amnesia; a more or less extensive retrograde amnesia"}, {"id": "12729371_2_594", "context": "We report a case of AILD in an 80-year-old male who presented with a generalized pruritic maculopapular eruption and fever following doxycycline administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] a case of AILD in an 80-year-old male [Treatment] doxycycline administration [Effect] generalized pruritic maculopapular eruption and fever"}, {"id": "16092915_2_595", "context": "OBJECTIVE: To our knowledge, this is the first published case report of an adolescent girl with a mitochondrial disorder and depression who displayed both new-onset psychotic and increased mood symptoms during treatment with risperidone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] an adolescent girl with a mitochondrial disorder and depression [Treatment] risperidone [Effect] new-onset psychotic and increased mood symptoms"}, {"id": "9733234_1_596", "context": "Young children undergoing cisplatin chemotherapy are known to be at risk for progressive sensorineural hearing loss.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Subject] Young children [Treatment] undergoing cisplatin chemotherapy [Effect] progressive sensorineural hearing loss"}, {"id": "12692521_1_597", "context": "Systemic capillary leak syndrome after granulocyte colony-stimulating factor (G-CSF).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] granulocyte colony-stimulating factor (G-CSF) [Effect] Systemic capillary leak syndrome"}, {"id": "16449538_2_598", "context": "CASE SUMMARIES: Two patients who received ifosfamide-containing chemotherapy developed NCSE.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two patients [Treatment] ifosfamide-containing chemotherapy [Effect] NCSE"}, {"id": "10456487_3_599", "context": "One of the monohydroxy-metabolites has been incriminated with tacrine-induced hepatotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] tacrine [Effect] hepatotoxicity"}, {"id": "20020238_1_600", "context": "BACKGROUND: To assess the nature, incidence, and risk factors of retinopathy associated with pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] chronic hepatitis C patients [Treatment] pegylated interferon and ribavirin combination therapy [Effect] retinopathy"}, {"id": "12149193_1_601", "context": "Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] myeloma patients [Treatment] doxorubicin; thalidomide [Effect] Thrombogenic activity"}, {"id": "15053046_2_602", "context": "Agranulocytosis is a rare adverse effect associated with prolonged vancomycin therapy, and is potentially serious, especially in end stage renal disease (ESRD) patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] end stage renal disease (ESRD) patients [Treatment] prolonged vancomycin therapy [Effect] Agranulocytosis"}, {"id": "8551001_4_603", "context": "Thiopurine methyltransferase deficiency occurs at a frequency of one in 300 and is associated with profound myelosuppression after a short course of azathioprine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] a short course of azathioprine [Effect] profound myelosuppression"}, {"id": "3967536_1_604", "context": "Hypotension and sinus arrest with nifedipine in pulmonary hypertension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] nifedipine [Effect] Hypotension and sinus arrest"}, {"id": "9709726_1_605", "context": "We describe children and adolescents with chronic hematologic and oncologic diseases who exhibited drug-seeking behavior or anticholinergic symptoms with the use of diphenhydramine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exhibited [Subject] children and adolescents with chronic hematologic and oncologic diseases [Treatment] diphenhydramine [Effect] drug-seeking behavior or anticholinergic symptoms"}, {"id": "8739289_1_606", "context": "Transient central diabetes insipidus in the setting of underlying chronic nephrogenic diabetes insipidus associated with lithium use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] lithium [Effect] Transient central diabetes insipidus"}, {"id": "8636829_1_607", "context": "A macrophage activation syndrome, possibly related to methotrexate toxicity, developed in a boy with systemic juvenile rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a boy with systemic juvenile rheumatoid arthritis [Treatment] methotrexate toxicity [Effect] macrophage activation syndrome"}, {"id": "6507240_1_608", "context": "Hyponatremia in patients treated with lorcainide, a new antiarrhythmic drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] patients [Treatment] lorcainide [Effect] Hyponatremia"}, {"id": "8186884_2_609", "context": "Electrical proarrhythmia with procainamide: a new ICD-drug interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] procainamide [Effect] Electrical proarrhythmia"}, {"id": "9681092_2_610", "context": "To report a case of QT prolongation associated with concomitant cyclobenzaprine and fluoxetine administration followed by torsade de pointes potentiated by droperidol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] concomitant cyclobenzaprine and fluoxetine administration [Effect] QT prolongation [Adverse event] potentiated [Treatment] droperidol [Effect] torsade de pointes"}, {"id": "6597713_3_611", "context": "It is presumed that her hyperchloremic metabolic acidosis was secondary to cholestyramine because of the similarity to pediatric reports; the rapid and lasting response to intravenous sodium bicarbonate; the absence of another etiology; normal serum potassium, chloride and bicarbonate despite continued spironolactone therapy after recovery.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] cholestyramine [Effect] hyperchloremic metabolic acidosis"}, {"id": "8551001_1_612", "context": "Azathioprine can cause severe myelosuppression.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Azathioprine [Effect] severe myelosuppression"}, {"id": "7789881_1_613", "context": "Secretory endometrial adenocarcinoma in a patient on tamoxifen for breast cancer: a report of a case.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] on [Subject] a patient [Treatment] tamoxifen for breast cancer [Effect] Secretory endometrial adenocarcinoma"}, {"id": "12452753_4_614", "context": "It was postulated that the allergic reaction was most likely caused by capecitabine or the intermediate metabolites based on the immediate reappearance of symptoms from the rechallenge, pharmacokinetic data, and well-tolerance of fluorouracil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] capecitabine or the intermediate metabolite [Effect] allergic reaction"}, {"id": "10465148_1_615", "context": "Anterior lumbosacral radiculopathy after intrathecal methotrexate treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] intrathecal methotrexate [Effect] Anterior lumbosacral radiculopathy"}, {"id": "19512997_1_616", "context": "Divalproex sodium-induced eosinophilic pleural effusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Divalproex sodium [Effect] eosinophilic pleural effusion"}, {"id": "10405480_1_617", "context": "A 26-year-old Japanese man, who had been receiving medical attention for ulcerative colitis for one year, presented with diffuse erythema and pustules on his face and trunk, malaise, and fever up to 39 degrees C one day after the administration of salazosulfapyridine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 26-year-old Japanese man, who had been receiving medical attention for ulcerative colitis for one year [Treatment] salazosulfapyridine [Effect] diffuse erythema and pustules on his face and trunk, malaise, and fever up to 39 degrees C"}, {"id": "11573852_1_618", "context": "Amphotericin B-induced seizures in a patient with AIDS.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with AIDS [Treatment] Amphotericin B [Effect] seizures"}, {"id": "2154663_2_619", "context": "Concomitant irradiation apparently enhanced the skin toxicity of aminoglutethimide or possibly aminoglutethimide had a radiosensitizing role in this patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] enhanced [Subject] this patient [Treatment] Concomitant irradiation; aminoglutethimide [Effect] skin toxicity"}, {"id": "8996514_1_620", "context": "CASE DESCRIPTION: A 59-year-old man with known neurocysticercosis developed a large cerebral infarction during praziquantel therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 59-year-old man with known neurocysticercosis [Treatment] during praziquantel therapy [Effect] a large cerebral infarction"}, {"id": "12181031_3_621", "context": "We describe a 73-year-old woman who developed serious systemic vasculitis with associated thrombocytopenia in the course of treatment with cladribine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 73-year-old woman [Treatment] cladribine [Effect] systemic vasculitis with associated thrombocytopenia"}, {"id": "17083890_8_622", "context": "All changes disappeared 4 months after the discontinuation of VAD chemotherapy, which further pointed out towards adriamycin and vincristine as possible etiologic agents.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] etiologic agents [Treatment] adriamycin and vincristine [Effect] All changes"}, {"id": "24679099_7_623", "context": "Because of further progression combination treatment of bevacizumab and irinotecan was started and again no liver toxicity was observed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Treatment] bevacizumab and irinotecan [Effect] liver toxicity"}, {"id": "3609047_2_624", "context": "Torsade de pointes represents a potential complication of chronic amiodarone therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] chronic amiodarone therapy [Effect] Torsade de pointes"}, {"id": "9988365_1_625", "context": "Eosinophilia caused by clozapine was observed in challenge, preceded by a faster neutrophil production and consecutive decrease (z = 2.27, p = 0.01).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] clozapine [Effect] Eosinophilia; preceded by a faster neutrophil production and consecutive decrease (z = 2.27, p = 0.01)"}, {"id": "17667887_3_626", "context": "The first case is a 69-year-old man who was admitted for depression with psychosis and treated with trazodone, risperidone, and sertraline.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] a 69-year-old man who was admitted for depression with psychosis [Treatment] trazodone, risperidone, and sertraline"}, {"id": "6221046_2_627", "context": "Multiple complications of propylthiouracil treatment: granulocytopenia, eosinophilia, skin reaction and hepatitis with lymphocyte sensitization.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complications [Treatment] propylthiouracil [Effect] granulocytopenia, eosinophilia, skin reaction and hepatitis with lymphocyte sensitization"}, {"id": "10456487_15_628", "context": "Whether concomitant fluvoxamine treatment reduces tacrine-induced hepatotoxicity needs further study.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] tacrine [Effect] hepatotoxicity [Potential therapeutic event] reduces [Treatment] concomitant fluvoxamine"}, {"id": "3718111_3_629", "context": "Severe hyperkalemia occurred in a patient with radiation pneumonitis and glaucoma shortly after beginning prednisone therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient with radiation pneumonitis and glaucoma [Treatment] prednisone [Effect] Severe hyperkalemia"}, {"id": "9651465_2_630", "context": "She was treated with Pancrease MT 16, but had consistent vomiting 1 to 2 hours after administration of enzymes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] enzymes [Effect] vomiting"}, {"id": "15701285_2_631", "context": "Following are two clinical case reports demonstrating profound cerebral edema associated with implantation of Gliadel wafers.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] two clinical case [Treatment] implantation of Gliadel wafers [Effect] profound cerebral edema"}, {"id": "15279668_4_632", "context": "At this point, a new antifungal agent had been commenced, suggesting a possible drug interaction enhancing the risk of known neurological toxicity with this regime.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suggesting [Treatment] a new antifungal agent [Effect] a possible drug interaction enhancing the risk of known neurological toxicity with this regime"}, {"id": "15941649_2_633", "context": "The knowledge concerning VGB-associated visual dysfunction in pediatric patients, particularly in those who have been exposed to VGB in utero is limited.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] pediatric patients [Treatment] VGB [Effect] visual dysfunction"}, {"id": "19097599_2_634", "context": "We herein described an additional patient with BCR-ABL (ela2) positive acute lymphoblastic leukemia who developed tumor lysis syndrome after 10-day treatment with imatinib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] patient with BCR-ABL (ela2) positive acute lymphoblastic leukemia [Treatment] 10-day treatment with imatinib [Effect] tumor lysis syndrome"}, {"id": "9792602_2_635", "context": "Tubulointerstitial nephritis induced by the leukotriene receptor antagonist pranlukast.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] pranlukast [Effect] Tubulointerstitial nephritis"}, {"id": "23471710_2_636", "context": "Two drugs commonly used in triple-drug therapy for treatment of a Helicobacter pylori infection, clarithromycin and omeprazole, have rarely been associated with hypoglycemia when given alone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] clarithromycin and omeprazole [Effect] hypoglycemia"}, {"id": "14660304_4_637", "context": "We describe the infectious toxicities experienced by the first two patients in our institution treated with dexamethasone (10 mg/m(2)/day for 4 weeks with gradual tapering) during induction according to the dexamethasone arm of BFM 2000 and review the relevant literature that suggests an increased risk of infectious complications with dexamethasone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced by [Subject] first two patients in our institution [Treatment] treated with dexamethasone (10 mg/m(2)/day for 4 weeks with gradual tapering) during induction according to the dexamethasone arm of BFM 2000 [Effect] infectious toxicities"}, {"id": "6510223_4_638", "context": "This case demonstrates that there is no cross reactivity between glyburide and chlorpropamide in producing hemolytic anemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] producing [Treatment] glyburide and chlorpropamide [Effect] hemolytic anemia"}, {"id": "10586009_1_639", "context": "Codeine intoxication in the neonate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] neonate [Treatment] Codeine [Effect] Codeine intoxication"}, {"id": "9760614_1_640", "context": "However, 1 eye had vitreous hemorrhage after repeated injections of tPA.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] repeated injections of tPA [Effect] 1 eye had vitreous hemorrhage"}, {"id": "1389744_2_641", "context": "Dilated cardiomyopathy associated with chronic overuse of an adrenaline inhaler.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] chronic overuse of an adrenaline inhaler [Effect] Dilated cardiomyopathy"}, {"id": "14530108_3_642", "context": "Surgeons and physicians should therefore be aware of the potential for RTA to occur with FK506 after any organ transplantation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Treatment] FK506 after any organ transplantation [Effect] RTA"}, {"id": "6826112_2_643", "context": "Thirty patients with hepatic reactions to cyclofenil, a non-steroidal drug with a stimulating effect on ovulation, are reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reactions [Subject] Thirty patients [Treatment] cyclofenil [Effect] hepatic"}, {"id": "19275460_3_644", "context": "Though serotonin syndrome is most often associated with ingestion of more than one serotonergic drug, many other mechanisms have been associated with serotonergic excess.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] ingestion of more than one serotonergic drug [Effect] serotonin syndrome"}, {"id": "2276822_1_645", "context": "Because of a hypersensitivity reaction, initial therapy with penicillin G and gentamicin was stopped and substituted with cefazolin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] penicillin G; gentamicin [Effect] hypersensitivity reaction"}, {"id": "15944830_4_646", "context": "Ophthalmologists should be aware of the ocular side effects of IFN therapy and carefully monitor patients for the possible occurrence of hypoalbuminemia and thrombocytopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] aware [Subject] patients [Treatment] IFN [Effect] ocular side effects; hypoalbuminemia and thrombocytopenia"}, {"id": "18562412_6_647", "context": "The third patient had been suffering from serious akathisia while on risperidone, and was cured after switching to olanzapine, but thereafter the patient suffered from RLS at nighttime.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suffering [Subject] The third patient [Treatment] risperidone [Effect] akathisia [Adverse event] suffered [Subject] The third patient [Treatment] switching to olanzapine [Effect] RLS at nighttime"}, {"id": "6510223_1_648", "context": "Chlorpropamide-induced hemolytic anemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Chlorpropamide [Effect] hemolytic anemia"}, {"id": "16099004_3_649", "context": "We report recrudescence of imported Plasmodium falciparum malaria following quinine treatment in the context of concurrent phenytoin use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] quinine treatment in the context of concurrent phenytoin use [Effect] Plasmodium falciparum malaria"}, {"id": "15719254_2_650", "context": "It is likely that RA contributed to the deterioration in renal function in these patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] contributed [Treatment] RA [Effect] deterioration in renal function"}, {"id": "6303138_1_651", "context": "Marked sinus tachycardia resulting from the synergistic effects of marijuana and nortriptyline.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] marijuana and nortriptyline [Effect] Marked sinus tachycardia"}, {"id": "17373180_1_652", "context": "Infliximab and its serious adverse effects are discussed, and other cases of osteomyelitis with infliximab use are also reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] infliximab [Effect] osteomyelitis"}, {"id": "14723711_1_653", "context": "A new type of minocycline-induced cutaneous hyperpigmentation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] minocycline [Effect] cutaneous hyperpigmentation"}, {"id": "9491301_3_654", "context": "Stroke is an infrequent but recognized complication of heroin addiction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] heroin addiction [Effect] Stroke"}, {"id": "2461837_1_655", "context": "Although this type of hyperpigmentation has been previously seen in patients with cancer who are receiving bleomycin, this is, to our knowledge, the first reported case of bleomycin-induced hyperpigmentation in an AIDS patient and should be added to the growing list of cutaneous eruptions seen in these patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an AIDS patient [Treatment] bleomycin [Effect] hyperpigmentation"}, {"id": "6625005_1_656", "context": "Case report of withdrawal dyskinesia associated with amoxapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] Case [Treatment] amoxapine [Effect] withdrawal dyskinesia"}, {"id": "21350204_2_657", "context": "Concern exists that preadmission warfarin use may be associated with an increased risk of intracerebral hemorrhage in patients with ischemic stroke receiving intravenous tissue plasminogen activator, even in those with an international normalized ratio <1.7.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] patients with ischemic stroke [Treatment] receiving intravenous tissue plasminogen activator; preadmission warfarin [Effect] increased risk of intracerebral hemorrhage"}, {"id": "7035691_1_658", "context": "Transient anuria following administration of angiotensin I-converting enzyme inhibitor (SQ 14225) in a patient with renal artery stenosis of the solitary kidney successfully treated with renal autotransplantation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a patient with renal artery stenosis of the solitary kidney [Treatment] angiotensin I-converting enzyme inhibitor (SQ 14225) [Effect] Transient anuria [Potential therapeutic event] treated [Subject] a patient with renal artery stenosis of the solitary kidney [Treatment] renal autotransplantation"}, {"id": "9517515_1_659", "context": "Development of essential thrombocythemia in a patient treated with interferon alfa and pentostatin for hairy cell leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Development [Subject] a patient [Treatment] interferon alfa and pentostatin [Effect] essential thrombocythemia"}, {"id": "12399645_1_660", "context": "A case of SIADH induced by mizoribin administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] A case [Treatment] mizoribin administration [Effect] SIADH"}, {"id": "15053046_4_661", "context": "The agranulocytosis was rapidly resolved by granulocyte colony-stimulating factor (G-CSF) therapy and by the discontinuation of vancomycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Treatment] granulocyte colony-stimulating factor (G-CSF) therapy and by the discontinuation of vancomycin [Effect] agranulocytosis"}, {"id": "11406880_3_662", "context": "A patient that received methadone for cancer-associated pain developed myoclonus as a side effect.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient [Treatment] methadone [Effect] myoclonus"}, {"id": "9224230_1_663", "context": "These cases were considered unusual in light of the short delay of their onset after initiation of immunosuppressive therapy and their fulminant course: 3 of these patients died of PCP occurring during the first month of treatment with prednisone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] died [Subject] 3 of these patients [Treatment] first month of treatment with prednisone [Effect] PCP"}, {"id": "16816519_5_664", "context": "Five days after the fourth dose of vincristine, she presented with bilateral ptosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] she [Treatment] Five days after the fourth dose of vincristine [Effect] bilateral ptosis"}, {"id": "19249953_7_665", "context": "As it had been 10 months since her last dosage adjustment of diltiazem, it was unlikely that the statin-induced rhabdomyolysis was precipitated by diltiazem.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitated [Treatment] diltiazem [Effect] statin-induced rhabdomyolysis"}, {"id": "278642_2_666", "context": "After the chlorambucil was discontinued, the wbc count began to slowly rise and the patient developed clinical AML.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] the patient [Treatment] chlorambucil [Effect] wbc count began to slowly rise; clinical AML"}, {"id": "16816519_7_667", "context": "She received 3.8 mg cumulative dose of vincristin before development of ptosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] She [Treatment] 3.8 mg cumulative dose of vincristin [Effect] ptosis"}, {"id": "2429270_3_668", "context": "In addition, the tachycardia persisted and was repeatedly spontaneously reinitiated for prolonged periods after procainamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] procainamide [Effect] tachycardia persisted and was repeatedly spontaneously reinitiated for prolonged periods"}, {"id": "9527943_2_669", "context": "One patient had a lower average heart rate and two patients had lower average mean blood pressure values during propranolol treatment, none of which was clinically significant.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] two patients [Treatment] propranolol [Effect] lower average mean blood pressure values [Adverse event] during [Subject] One patient [Treatment] propranolol [Effect] lower average heart rate"}, {"id": "7685228_2_670", "context": "We have successfully overcome severe neutropenia in an RA patient treated with gold salts, using granulocyte colony-stimulating factor (G-CSF), reducing the duration of neutropenia and risk of infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] overcome [Subject] an RA patient treated with gold salts [Treatment] granulocyte colony-stimulating factor (G-CSF) [Effect] reducing the duration of neutropenia and risk of infection [Adverse event] in [Treatment] gold salts [Effect] severe neutropenia"}, {"id": "10907391_1_671", "context": "A third patient experienced disabling neurotoxicity in the extremity of a prior ulnar nerve and tendon transposition after receiving paclitaxel.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] A third patient [Treatment] paclitaxel [Effect] disabling neurotoxicity in the extremity of a prior ulnar nerve and tendon transposition"}, {"id": "12702914_5_672", "context": "While 40 mg/day of prednisolone improved hepatic dysfunction dramatically, her diabetic milieu deteriorated seriously.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] deteriorated [Treatment] 40 mg/day of prednisolone [Effect] diabetic milieu deteriorated [Potential therapeutic event] improved [Treatment] 40 mg/day of prednisolone"}, {"id": "15463865_2_673", "context": "Acute renal insufficiency is known to occur in patients who are taking ciprofloxacin, particularly the elderly.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Subject] patients; elderly [Treatment] ciprofloxacin [Effect] Acute renal insufficiency"}, {"id": "95811_1_674", "context": "A 61-year-old man developed clinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus (LE) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of procainamide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 61-year-old man [Treatment] 26 months of procainamide therapy [Effect] clinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus (LE) cell preparation, and diffuse proliferative glomerulonephritis"}, {"id": "10510017_4_675", "context": "We report the successful treatment of heparin-induced thrombocytopenia and subsequent hemorrhagic complications postoperatively in a 2-year-old child with Danaparoid (orgaran).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 2-year-old child [Treatment] heparin [Effect] thrombocytopenia and subsequent hemorrhagic complications [Potential therapeutic event] treatment [Subject] a 2-year-old child [Treatment] Danaparoid (orgaran)"}, {"id": "18775393_2_676", "context": "Laryngeal dyspnea in relation to an interaction between acenocoumarol and topical econazole lotion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] relation [Treatment] acenocoumarol; topical econazole lotion [Effect] Laryngeal dyspnea"}, {"id": "24927617_2_677", "context": "A 46-year old man with a chronic hepatitis C virus infection received triple therapy with ribavirin, pegylated interferon and telaprevir.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] received [Subject] A 46-year old man with a chronic hepatitis C virus infection [Treatment] triple therapy with ribavirin, pegylated interferon and telaprevir"}, {"id": "17176478_2_678", "context": "Leishmania infantum leishmaniasis in corticosteroid--treated patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Treatment] corticosteroid [Effect] Leishmania infantum leishmaniasis"}, {"id": "15028328_3_679", "context": "The patient developed occipital infarcts and was found to have extremely elevated levels of PPA in his blood and dialysis fluid.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] The patient [Treatment] extremely elevated levels of PPA [Effect] occipital infarcts"}, {"id": "17329303_2_680", "context": "As atypical antipsychotics are increasingly used in the treatment of childhood behavioural disorders either as monotherapy or in combination with other medications, there is a need to know more about their safety, in particular during switching to and from methylphenidate treatment, as antipsychotics and methylphenidate have opposing effects on dopaminergic neurotransmission.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] atypical antipsychotics; as monotherapy or in combination with other medications"}, {"id": "15468380_1_681", "context": "Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] infliximab therapy [Effect] Sensory neuropathy revealing necrotizing vasculitis"}, {"id": "17710018_2_682", "context": "Because etoposide-induced pulmonary toxicity is an uncommon but serious adverse event, clinicians must be vigilant about the possibility of it, so that the optimal treatment can start as soon as possible.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] etoposide [Effect] pulmonary toxicity"}, {"id": "17959575_12_683", "context": "On March 13 the patient was again admitted for worsening CHF and was started on continuous dobutamine infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] started on [Subject] the patient was again admitted for worsening CHF [Treatment] continuous dobutamine infusion"}, {"id": "22550162_1_684", "context": "Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] omeprazole [Effect] methotrexate toxicity [Potential therapeutic event] use [Subject] methotrexate-experienced patient [Treatment] carboxypeptidase G2 [Adverse event] toxicity [Treatment] methotrexate [Effect] toxicity"}, {"id": "16688722_2_685", "context": "We report a 53-year-old-man who developed rippling muscle disease (RMD) 2 months after starting simvastatin therapy for hypercholesterolemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 53-year-old-man [Treatment] 2 months after starting simvastatin therapy [Effect] rippling muscle disease (RMD)"}, {"id": "6597713_1_686", "context": "After taking cholestyramine II sachets twice daily for two months she presented with lethargy, confusion and drowsiness.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] After [Subject] she [Treatment] cholestyramine II sachets twice daily for two months [Effect] lethargy, confusion and drowsiness"}, {"id": "2429270_2_687", "context": "Escape atrial complexes, which occurred following junctional premature complexes, failed to initiate tachycardia in the control state but tachycardia was always reinitiated by an identical escape sequence after procainamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reinitiated [Treatment] procainamide [Effect] tachycardia"}, {"id": "12149193_2_688", "context": "Ten percent of newly diagnosed myeloma patients treated with any type of chemotherapy develop deep venous thrombosis (DVT).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] myeloma patients [Treatment] any type of chemotherapy [Effect] deep venous thrombosis (DVT)"}, {"id": "12399645_3_689", "context": "In summary, we report herein the first case of SIADH believed to be an adverse effect of mizoribin, which may therefore needed to be added to the list of drugs which can induce SIADH.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse effect [Subject] the first case [Treatment] mizoribin [Effect] SIADH"}, {"id": "3115809_3_690", "context": "Isoniazid and ethambutol as a cause of optic neuropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Isoniazid and ethambutol [Effect] optic neuropathy"}, {"id": "12452753_3_691", "context": "Fluorouracil for allergic reactions to capecitabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] capecitabine [Effect] allergic reactions [Potential therapeutic event] for [Treatment] Fluorouracil"}, {"id": "4018433_2_692", "context": "Administration of pyridoxine to an infant after a long period of convulsions was followed by acute hypotonia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] followed [Subject] an infant [Treatment] pyridoxine [Effect] acute hypotonia"}, {"id": "11059196_1_693", "context": "Acute pancreatitis in a child with idiopathic ulcerative colitis on long-term 5-aminosalicylic acid therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a child with idiopathic ulcerative colitis [Treatment] long-term 5-aminosalicylic acid therapy [Effect] Acute pancreatitis"}, {"id": "11597289_2_694", "context": "High-dose antithrombin III in severe sepsis: a randomized controlled trial.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] in [Treatment] High-dose antithrombin III"}, {"id": "7459812_1_695", "context": "Fatal interstitial pneumonitis following high-dose intermittent chlorambucil therapy for chronic lymphocyte leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] high-dose intermittent chlorambucil therapy [Effect] Fatal interstitial pneumonitis"}, {"id": "647693_3_696", "context": "These findings suggest that the corneal and retinal changes are the result of a toxic effect of tamoxifen when used in the doses and duration described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] tamoxifen [Effect] corneal and retinal changes"}, {"id": "20171144_1_697", "context": "Common adverse events (frequency 10%) of lacosamide doses up to 600 mg/day include nonspecific central nervous system effects (e.g., dizziness, ataxia, diplopia, and somnolence).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] include [Treatment] lacosamide doses up to 600 mg/day [Effect] nonspecific central nervous system effects (e.g., dizziness, ataxia, diplopia, and somnolence)"}, {"id": "17667887_2_698", "context": "We report two cases of serotonin syndrome in elderly patients during treatment of psychotic depression with atypical antipsychotics and antidepressants.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] elderly patients [Treatment] atypical antipsychotics and antidepressants [Effect] serotonin syndrome"}, {"id": "8452107_1_699", "context": "Piritrexim-induced pulmonary toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Piritrexim [Effect] pulmonary toxicity"}, {"id": "15338554_6_700", "context": "Progression of chronic myeloid leukemia to blast crisis during treatment with imatinib mesylate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] imatinib mesylate [Effect] Progression of chronic myeloid leukemia to blast crisis"}, {"id": "19648225_3_701", "context": "Presentation of three palliative care patients who were given ketamine as an analgesic and subsequently developed significant and debilitating urological symptoms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] three palliative care patients [Treatment] ketamine [Effect] urological symptoms"}, {"id": "19058340_1_702", "context": "A 52 year-old male patient diagnosed of ankylosing spondylitis presented with an iron deficiency anemia after a ten-month treatment of methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] A 52 year-old male patient diagnosed of ankylosing spondylitis [Treatment] a ten-month treatment of methotrexate [Effect] an iron deficiency anemia"}, {"id": "19423476_6_703", "context": "The international literature regarding opportunistic infections after immunosuppressive therapy with alemtuzumab with particular attention on fungal infections has also been reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] immunosuppressive therapy with alemtuzumab [Effect] opportunistic infections"}, {"id": "9681092_13_704", "context": "Clinicians should be aware of the dysrhythmic potential of cyclobenzaprine and fluoxetine, monitor for other cytochrome P450 inhibitors, and avoid concomitant drugs known to prolong the QT interval.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] potential [Treatment] cyclobenzaprine and fluoxetin [Effect] dysrhythmic"}, {"id": "10405480_2_705", "context": "Acute generalized exanthematous pustulosis induced by salazosulfapyridine in a patient with ulcerative colitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with ulcerative colitis [Treatment] salazosulfapyridine [Effect] Acute generalized exanthematous pustulosis"}, {"id": "17627694_1_706", "context": "CONCLUSION: Acetic acid is corrosive and may cause vagina bleeding.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Acetic acid [Effect] vagina bleeding"}, {"id": "16244351_3_707", "context": "We report a case admitted with a first-detected, symptomatic paroxysmal atrial fibrillation in a healthy patient after self-medication with vardenafil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a healthy patient [Treatment] vardenafil [Effect] symptomatic paroxysmal atrial fibrillation"}, {"id": "7362333_1_708", "context": "Propranolol: an unrecognized cause of central nervous system dysfunction in patients undergoing cardiopulmonary bypass.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] patients undergoing cardiopulmonary bypass [Treatment] Propranolol [Effect] central nervous system dysfunction"}, {"id": "15681911_1_709", "context": "CONCLUSIONS: Symptoms and pathologic changes of colitis are associated with exposure to rofecoxib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] rofecoxib [Effect] Symptoms and pathologic changes of colitis"}, {"id": "16507380_13_710", "context": "A possible drug-drug interaction between IFN alfa 11 MU TIW and gemfibrozil 600 mg BID was reported in a patient undergoing treatment for IFN-induced hypertriglyceridemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Subject] a patient [Treatment] drug-drug interaction between IFN alfa 11 MU TIW and gemfibrozil 600 mg BID [Effect] IFN-induced hypertriglyceridemia"}, {"id": "12181031_2_711", "context": "Systemic vasculitis complicating hairy cell leukaemia treatment with cladribine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment [Treatment] cladribine [Effect] Systemic vasculitis"}, {"id": "11126885_2_712", "context": "Quinine is universally used for the very common symptom of night leg cramps.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used [Treatment] Quinine"}, {"id": "8864370_3_713", "context": "However, continued low-dose MTX led, in spite of normal liver tests, 8 years after the last biopsy to liver failure and death in 1 of our patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] led [Treatment] low-dose MTX [Effect] liver failure and death"}, {"id": "11597289_5_714", "context": "Antithrombin III may provide protection from multiorgan failure and improve survival in severely ill patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] provide protection [Subject] severely ill patients [Treatment] Antithrombin III; multiorgan failure"}, {"id": "7235792_3_715", "context": "In the second case, five cardiac arrests due to ventricular tachycardia and fibrillation occurred during several hours after beginning a trial of bretylium maintenance therapy for complex ventricular ectopy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] In the second case [Treatment] several hours after beginning a trial of bretylium maintenance therapy [Effect] five cardiac arrests due to ventricular tachycardia and fibrillation"}, {"id": "8739289_3_716", "context": "The association of central diabetes insipidus (CDI) with lithium use is rare.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] lithium [Effect] central diabetes insipidus (CDI)"}, {"id": "17426073_2_717", "context": "However, a new episode of neutropenia, with a WBC count of 2.8 x 10(3)/mm3 and ANC of 0.448 x 10(3)/mm3, occurred 11 days after teicoplanin initiation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] 11 days after teicoplanin initiation [Effect] neutropenia, with a WBC count of 2.8 x 10(3)/mm3 and ANC of 0.448 x 10(3)/mm3"}, {"id": "7448830_4_718", "context": "In a phase II study of hycanthone in patients with breast cancer we have recently observed severe hepatotoxicity, even at lower doses, which resulted in two drug-related deaths.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Subject] patients with breast cancer [Treatment] hycanthone [Effect] hepatotoxicity"}, {"id": "11008259_3_719", "context": "This is the first report of non-convulsive status epilepticus provoked by tiagabine in adolescent patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] provoked [Subject] adolescent patients [Treatment] tiagabine [Effect] non-convulsive status epilepticus"}, {"id": "180258_2_720", "context": "Two patients are described who developed sensory neuropathy after the ingestion of 30.6 and 114 g metronidazole respectively.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] Two patients [Treatment] the ingestion of 30.6 and 114 g metronidazole [Effect] sensory neuropathy"}, {"id": "15463865_3_721", "context": "We report two young patients with cystic fibrosis who presented with acute renal insufficiency after 2-3 weeks of oral ciprofloxacin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] two young patients with cystic fibrosis [Treatment] 2-3 weeks of oral ciprofloxacin therapy [Effect] acute renal insufficiency"}, {"id": "15827071_8_722", "context": "A 37-year-old male with multiple myeloma received citalopram 40 mg/day and trazodone 150 mg/day for anxiety-related disorders.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Subject] A 37-year-old male with multiple myeloma [Treatment] citalopram 40 mg/day and trazodone 150 mg/day"}, {"id": "11335880_3_723", "context": "Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease [Treatment] interferon-alpha [Effect] Hashimoto's disease"}, {"id": "9039216_2_724", "context": "Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse reaction to minocycline.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse reaction [Treatment] minocycline [Effect] Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis"}, {"id": "16092915_1_725", "context": "CONCLUSIONS: This observation of \"on-off\" risperidone treatment suggests that risperidone may have worsened both psychiatric and physical manifestations of the mitochondrial disorder in this adolescent.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] have worsened [Subject] mitochondrial disorder in this adolescent [Treatment] risperidone [Effect] psychiatric and physical manifestations"}, {"id": "11008259_2_726", "context": "The events of non-convulsive status epilepticus subsided following reduction in tiagabine dosages.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] reduction in tiagabine dosages [Effect] non-convulsive status epilepticus subsided"}, {"id": "17426073_1_727", "context": "CONCLUSIONS: For all patients with vancomycin-induced neutropenia, possible cross-reactivity of teicoplanin should be monitored.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patients [Treatment] vancomycin [Effect] neutropenia"}, {"id": "19058340_2_728", "context": "Methotrexate induced sprue-like syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Methotrexate [Effect] sprue-like syndrome"}, {"id": "22010004_9_729", "context": "Because of the described effects of niacin on the coagulation cascade and the possibility for pharmacokinetic interactions, there is a potential for synergistic coagulopathy when combined with warfarin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] potential [Treatment] niacin; combined with warfarin therapy [Effect] synergistic coagulopathy"}, {"id": "8186884_3_730", "context": "The failure of therapy with disopyramide and mexiletine to reproduce this observation suggests either a previously unreported electrophysiologic effect of, or idiosyncratic response to, procainamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] response [Treatment] procainamide [Effect] electrophysiologic effect"}, {"id": "15944830_5_731", "context": "The former patient had complained once that his visual acuity had decreased after the termination of IFN therapy, and the latter patient complained twice during IFN therapy that his visual acuity had decreased.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] The former patient [Treatment] IFN [Effect] visual acuity had decreased [Adverse event] during [Subject] patient [Treatment] IFN therapy [Effect] visual acuity had decreased"}, {"id": "11573852_4_732", "context": "Despite administration of phenytoin and lorazepam, the seizures persisted and occurred only during amphotercin B administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] amphotercin B [Effect] seizures"}, {"id": "11247558_3_733", "context": "We describe a patient who presented with bloody diarrhoea after 15 mg meloxicam daily for 10 days for osteoarthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient who presented with bloody diarrhoea; osteoarthritis [Treatment] 15 mg meloxicam daily for 10 days [Effect] bloody diarrhoea"}, {"id": "7235792_2_734", "context": "In the first patient, two episodes of ventricular tachycardia requiring cardioversion occurred in close temporal sequence with administering bretylium.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] first patient [Treatment] close temporal sequence with administering bretylium [Effect] two episodes of ventricular tachycardia requiring cardioversion"}, {"id": "3030084_1_735", "context": "Transient phenytoin induced IgA deficiency and permanent IgE increase.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] phenytoin [Effect] IgA deficiency and permanent IgE increase"}, {"id": "15701285_1_736", "context": "Cerebral edema associated with Gliadel wafers: two case studies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Gliadel wafers [Effect] Cerebral edema"}, {"id": "8305778_4_737", "context": "Following the development of restless leg syndrome, therapy with clonazepam 0.5 mg qhs was initiated.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] therapy [Treatment] clonazepam 0.5 mg qhs"}, {"id": "15362597_2_738", "context": "We present a case of a diabetic patient taking glyburide who was prescribed ciprofloxacin and developed prolonged hypoglycemia, which persisted for over 24 hours.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a case of a diabetic patient taking glyburide [Treatment] ciprofloxacin [Effect] prolonged hypoglycemia, which persisted for over 24 hours"}, {"id": "12399645_4_739", "context": "We describe a 74-year-old man with rheumatoid arthritis (RA) who developed syndrome of inappropriate secretion of antidiuretic hormone (SIADH) 1.5 months after commencement of mizoribin prescription when his arthritis was improved.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 74-year-old man with rheumatoid arthritis (RA) [Treatment] 1.5 months after commencement of mizoribin prescription [Effect] syndrome of inappropriate secretion of antidiuretic hormone (SIADH)"}, {"id": "16682062_2_740", "context": "To our knowledge, this is the first case of ivermectin-induced severe liver disease published in the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ivermectin [Effect] severe liver disease"}, {"id": "10348150_3_741", "context": "This is the first case of hydroxyurea-induced acute interstitial pneumonitis reported in the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] hydroxyurea [Effect] acute interstitial pneumonitis"}, {"id": "17301517_1_742", "context": "A 32-year-old man with a family history of type 2 diabetes mellitus presented with circulatory collapse and deep coma after 9 days of treatment with perospirone hydrochloride, a recently developed atypical antipsychotic agent available only in Japan.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 32-year-old man with a family history of type 2 diabetes mellitus [Treatment] 9 days of treatment with perospirone hydrochloride [Effect] circulatory collapse and deep coma"}, {"id": "16615675_3_743", "context": "CONCLUSION: The chronic use of HCQ for rheumatic diseases, or as an anti-malarial drug, should be balanced against the risk of developing potentially lethal cardiac arrhythmias.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] against [Treatment] chronic use of HCQ [Effect] lethal cardiac arrhythmias"}, {"id": "3400849_1_744", "context": "Myoclonic spasms following intrathecal morphine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] intrathecal morphine [Effect] Myoclonic spasms"}, {"id": "6324592_2_745", "context": "This is the first report of a disulfiram-like reaction with cefmenoxime.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] cefmenoxime [Effect] disulfiram-like reaction"}, {"id": "22010004_2_746", "context": "To report a case of a probable interaction between warfarin and extended-release niacin that may have led to synergistic coagulopathy and to inform health care providers of a need for more frequent monitoring of international normalized ratio (INR) in patients taking these drugs concomitantly.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] led [Treatment] warfarin and extended-release niacin [Effect] synergistic coagulopathy"}, {"id": "19838099_2_747", "context": "Dasatinib-induced pleural effusions: a lymphatic network disorder?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Dasatinib [Effect] pleural effusions"}, {"id": "9819544_3_748", "context": "This article reports the case of an otherwise healthy patient who experienced permanent sensorineural hearing loss after a brief course of naproxen and reviews the literature on NSAID-related permanent sensorineural hearing loss.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] an otherwise healthy patient [Treatment] a brief course of naproxen [Effect] permanent sensorineural hearing loss"}, {"id": "9695308_1_749", "context": "Administration of steroid and decreasing the dose of PTU produced a good clinical response and the ANCA disappeared.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] produced [Treatment] steroid; PTU [Effect] a good clinical response and the ANCA disappeared"}, {"id": "18562412_5_750", "context": "The second patient exhibited sudden PLMS following olanzapine injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] The second patient [Treatment] olanzapine injection [Effect] sudden PLMS"}, {"id": "11428480_2_751", "context": "However, adenosine shortens the antegrade refractoriness of accessory atrioventricular connections and may cause acceleration of the ventricular rate during atrial fibrillation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] adenosine [Effect] acceleration of the ventricular rate during atrial fibrillation"}, {"id": "19249953_5_752", "context": "A cardiology consultation performed on the day of admission determined that a markedly elevated creatine kinase-myocardial band isoenzyme level and borderline-high troponin I level were diagnostic of rhabdomyolysis secondary to statin use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] statin [Effect] elevated creatine kinase-myocardial band isoenzyme level and borderline-high troponin I level; rhabdomyolysis"}, {"id": "9651465_1_753", "context": "METHODS: Double-blind, placebo-controlled titrated oral challenges with pancreatic enzymes resulted in definite vomiting within 1 to 1.5 hours after challenges with Viokase and Pancrease MT 16, but not with placebo.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted in [Treatment] Viokase and Pancrease MT 16 [Effect] vomiting"}, {"id": "25204404_2_754", "context": "Abiraterone acetate, an androgen biosynthesis inhibitor, prolongs survival in men with metastatic castration-resistant prostate cancer (mCRPC) in the pre- and post-chemotherapy setting as demonstrated by the pivotal phase III studies COU-AA-301 and COU-AA-302.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prolongs survival [Subject] men with metastatic castration-resistant prostate cancer (mCRPC) [Treatment] Abiraterone acetate, an androgen biosynthesis inhibitor"}, {"id": "12455453_2_755", "context": "Reduction of methylprednisolone dosage rather than insulin therapy resulted in better control of glycemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resulted [Treatment] Reduction of methylprednisolone dosage rather than insulin therapy"}, {"id": "17725438_1_756", "context": "Here, we report a case of RFP-induced hypothyroidism without underlying thyroid disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] RFP [Effect] hypothyroidism without underlying thyroid disease"}, {"id": "14964753_9_757", "context": "Here we report ramipril-induced cutaneous vasculitis in a patient who required steroid therapy to control it.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient [Treatment] ramipril [Effect] cutaneous vasculitis"}, {"id": "8186884_1_758", "context": "A 78-year-old man with a transvenous cardioverter defibrillator system developed frequent shocks during oral procainamide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 78-year-old man with a transvenous cardioverter defibrillator system [Treatment] during oral procainamide therapy [Effect] frequent shocks"}, {"id": "11590881_2_759", "context": "A 53 year old Greenlandic male was admitted twice over a period of 4 years with a new complete right bundle branch block after ingestion of 10 g and 4 g of carbamazepine respectively.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 53 year old Greenlandic male [Treatment] ingestion of 10 g and 4 g of carbamazepine [Effect] was admitted twice over a period of 4 years with a new complete right bundle branch block"}, {"id": "15112258_14_760", "context": "In contrast, other common agents for the most part trigger cutaneous inflammation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] trigger [Treatment] other common agents for the most part [Effect] cutaneous inflammation"}, {"id": "10619721_1_761", "context": "In both patients the rippling phenomena worsened with pyridostigmine treatment but markedly improved after immunosuppression with azathioprine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] worsened [Subject] both patients [Treatment] pyridostigmine [Effect] rippling phenomena"}, {"id": "8175330_2_762", "context": "We present findings from three patients who experienced a psoriasiform eruption apparently due to the antiepileptic agents sodium valproate and carbamazepine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Subject] three patients [Treatment] antiepileptic agents sodium valproate and carbamazepine [Effect] psoriasiform eruption"}, {"id": "3620420_4_763", "context": "We report here such a case with bilateral Mooren's ulcer that failed to respond to local therapy with topical corticosteroids, silver nitrate, and conjunctival resection, as well as systemic immunosuppression with corticosteroids, cyclophosphamide, and azathioprine.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] respond [Subject] a case with bilateral Mooren's ulcer [Treatment] local therapy with topical corticosteroids, silver nitrate, and conjunctival resection, as well as systemic immunosuppression with corticosteroids, cyclophosphamide, and azathioprine"}, {"id": "12635752_2_764", "context": "Successful treatment with carbimazole of a hyperthyroid pregnancy with hepatic impairment after propylthiouracil administration: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] Successful treatment [Treatment] carbimazole [Adverse event] after [Treatment] propylthiouracil [Effect] a hyperthyroid pregnancy with hepatic impairment"}, {"id": "8638872_1_765", "context": "Jaundice induced by streptokinase.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] streptokinase [Effect] Jaundice"}, {"id": "16355099_4_766", "context": "When thrombosis develops during heparin treatment, it is important to suspect HITTs and to assay for the associated antibodies, regardless of the actual platelet count.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develops [Treatment] heparin [Effect] thrombosis; HITTs"}, {"id": "3620420_8_767", "context": "The results in this case suggest that cyclosporin is an effective agent in patients with severe sight threatening Mooren's ulcer.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] effective [Subject] patients with severe sight threatening Mooren's ulcer [Treatment] cyclosporin [Effect] is an effective agent"}, {"id": "8329789_9_768", "context": "CONCLUSIONS: Amphotericin B overdose can be fatal in children and infants.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] be [Subject] children and infants [Treatment] Amphotericin B overdose"}, {"id": "369675_1_769", "context": "Five and one-half years after the diagnosis of myeloma, while in remission on cyclophosphamide therapy, the patient experienced severe abdominal right lower quadrant pain due to a large cecal lymphoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] diagnosis of myeloma; patient [Treatment] cyclophosphamide therapy [Effect] severe abdominal right lower quadrant pain; large cecal lymphoma"}, {"id": "9681211_2_770", "context": "Leukaemoid monocytosis in M4 AML following chemotherapy and G-CSF.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] chemotherapy and G-CSF [Effect] Leukaemoid monocytosis in M4 AML"}, {"id": "9426968_1_771", "context": "Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a patient with chronic active hepatitis C [Treatment] alpha-interferon [Effect] Vitiligo"}, {"id": "1759924_2_772", "context": "We report a case of fulminant neuroleptic malignant syndrome in a man aged 70 developing within 12 hours of starting six-hourly intravenous metoclopramide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developing [Subject] a man aged 70 [Treatment] six-hourly intravenous metoclopramide [Effect] fulminant neuroleptic malignant syndrome"}, {"id": "17331261_1_773", "context": "CASE PRESENTATION: We report a patient with CF who developed recurrent eosinophilia and severe persistent bronchospasm following repeated administration of preservative-free tobramycin by inhalation, beginning at 16 months of age.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with CF; beginning at 16 months of age [Treatment] repeated administration of preservative-free tobramycin by inhalation [Effect] recurrent eosinophilia and severe persistent bronchospasm"}, {"id": "9491301_1_774", "context": "Ballistic movements due to ischemic infarcts after intravenous heroin overdose: report of two cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] two cases [Treatment] intravenous heroin overdose [Effect] Ballistic movements due to ischemic infarcts"}, {"id": "7468565_3_775", "context": "A case of barbiturate-induced submassive hepatic necrosis is presented and the literature is reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] A case [Treatment] barbiturate [Effect] submassive hepatic necrosis"}, {"id": "3967572_5_776", "context": "With combined use, clinicians should be aware, when phenytoin is added, of the potential for reexacerbation of pulmonary symptomatology due to lowered serum theophylline concentrations.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] phenytoin is added; theophylline [Effect] reexacerbation of pulmonary symptomatology"}, {"id": "2549018_3_777", "context": "Fluoxetine-induced akathisia: clinical and theoretical implications.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Fluoxetine [Effect] akathisia"}, {"id": "16001348_1_778", "context": "Lansoprazole-associated collagenous colitis: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Lansoprazole [Effect] collagenous colitis"}, {"id": "2863342_2_779", "context": "We discuss a variety of bronchopulmonary complications of IBD and their association with sulfasalazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] sulfasalazine [Effect] a variety of bronchopulmonary complications of IBD"}, {"id": "15961942_2_780", "context": "OBJECTIVE: To report the late development of immune-mediated diabetes mellitus after completion of alfa-interferon therapy for hepatitis C in an Asian patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] an Asian patient [Treatment] alfa-interferon [Effect] the late development of immune-mediated diabetes mellitus"}, {"id": "10715308_10_781", "context": "The tirapazamine-plus-cisplatin regimen was associated with mild to moderate adverse events, including acute, reversible hearing loss, reversible, intermittent muscle cramping, diarrhea, skin rash, nausea, and vomiting.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] tirapazamine-plus-cisplatin regimen [Effect] mild to moderate adverse events, including acute, reversible hearing loss, reversible, intermittent muscle cramping, diarrhea, skin rash, nausea, and vomiting"}, {"id": "12665232_2_782", "context": "To the best of our knowledge, corneoscleral melting in the first postoperative week after a single intraoperative application of mitomycin C has not been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] a single intraoperative application of mitomycin C [Effect] corneoscleral melting"}, {"id": "3259776_2_783", "context": "Thrombo-embolic complication after streptokinase therapy of pulmonary emboli.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] streptokinase [Effect] Thrombo-embolic complication"}, {"id": "7986915_1_784", "context": "Amebic abscess of the spleen complicated by metronidazole-induced neurotoxicity: case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] case [Treatment] metronidazole [Effect] neurotoxicity; Amebic abscess of the spleen complicated"}, {"id": "16521231_3_785", "context": "Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] infliximab [Effect] Subfulminant hepatitis B"}, {"id": "18715650_1_786", "context": "Disseminated salmonellosis in a patient treated with temozolomide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient [Treatment] temozolomide [Effect] Disseminated salmonellosis"}, {"id": "16221163_2_787", "context": "The aim of our paper was to describe hepatotoxicity of sirolimus (SRL) in a kidney graft recipient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a kidney graft recipient [Treatment] sirolimus (SRL) [Effect] hepatotoxicity"}, {"id": "3744305_1_788", "context": "Idiosyncratic pulmonary reactions to nitrofurantoin are not unusual, often presenting as eosinophilic pneumonia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] nitrofurantoin [Effect] Idiosyncratic pulmonary reactions; eosinophilic pneumonia"}, {"id": "17937473_3_789", "context": "The NZ Pharmacovigilance Centre has received 7 additional reports of severe infections in patients with RA taking leflunomide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] patients with RA [Treatment] leflunomide [Effect] severe infections"}, {"id": "6102186_5_790", "context": "In addition, loading with one low oral dose of serine produced psychotic symptoms 5 h later which lasted 3-6 h.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] loading [Treatment] one low oral dose of serine; 5 h later [Effect] psychotic symptoms"}, {"id": "16939867_1_791", "context": "Localized purpura associated with lamotrigine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] lamotrigine [Effect] Localized purpura"}, {"id": "20065266_1_792", "context": "Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim-sulfamethoxazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient [Treatment] trimethoprim-sulfamethoxazole [Effect] Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension"}, {"id": "16352777_3_793", "context": "Torsemide appears to also be a part of a long list of agents that can cause pancreatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Torsemide [Effect] pancreatitis"}, {"id": "2863342_1_794", "context": "Sulfasalazine has been associated with bronchopulmonary complications of inflammatory bowel disease (IBD) in adults.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] adults [Treatment] Sulfasalazine [Effect] bronchopulmonary complications of inflammatory bowel disease (IBD)"}, {"id": "10348150_1_795", "context": "Hydroxyurea-induced acute interstitial pneumonitis in a patient with essential thrombocythemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with essential thrombocythemia [Treatment] Hydroxyurea [Effect] interstitial pneumonitis"}, {"id": "16001348_9_796", "context": "The reported case represents an unusual association between medication with the proton pump inhibitor lansoprazole and the development of collagenous colitis suggesting the importance of evaluation of drug use in patients with microscopic colitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Subject] patients with microscopic colitis [Treatment] proton pump inhibitor lansoprazole [Effect] collagenous colitis"}, {"id": "644545_3_797", "context": "The temporal sequence of the respiratory insufficiency and the histopathology, when compared to the previous examples in the literature, suggest that cyclophosphamide was aetiologically responsible for the lung disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] responsible [Treatment] cyclophosphamide [Effect] lung disease"}, {"id": "16001348_2_798", "context": "A 57-year-old man developed chronic, watery diarrhea four weeks after Helicobacter pylori eradication therapy including lansoprazole followed by lansoprazole monotherapy for gastroesophageal reflux disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 57-year-old man [Treatment] four weeks after Helicobacter pylori eradication therapy including lansoprazole followed by lansoprazole monotherapy for gastroesophageal reflux disease [Effect] chronic, watery diarrhea"}, {"id": "10327035_2_799", "context": "We believe that this represents an unusual case of moderate-dose MTX-induced neurotoxicity in a patient with gastric cancer, which has not previously been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patient with gastric cancer [Treatment] moderate-dose MTX [Effect] neurotoxicity"}, {"id": "18672645_1_800", "context": "The patient expired after seven cycles of treatment had been completed because of pulmonary fibrosis and the drug toxicity of bleomycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] The patient [Treatment] seven cycles of treatment; drug toxicity of bleomycin [Effect] expired"}, {"id": "12149193_8_801", "context": "A statistical association between the incidence of DVT and combination chemotherapy including doxorubicin (P =.02) was observed; this association was confirmed on multivariate analysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] combination chemotherapy including doxorubicin (P =.02) [Effect] DVT"}, {"id": "2417800_3_802", "context": "Bleomycin pneumonitis potentiated by oxygen administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] by [Treatment] oxygen administration [Effect] Bleomycin pneumonitis"}, {"id": "12455453_1_803", "context": "After five and six weeks of continuous oral administration of methylprednisolone, the boys developed steroid diabetes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] boys [Treatment] After five and six weeks of continuous oral administration of methylprednisolone [Effect] steroid diabetes"}, {"id": "18775393_1_804", "context": "CONCLUSION: This report describes a case of a probable interaction between topical econazole lotion 1% and acenocoumarol that resulted in overanticoagulation and a life-threatening laryngeal hematoma in this elderly patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Subject] elderly patient [Treatment] a probable interaction between topical econazole lotion 1% and acenocoumarol [Effect] overanticoagulation and a life-threatening laryngeal hematoma"}, {"id": "15529178_1_805", "context": "Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] etanercept [Effect] Pulmonary lymphohistiocytic reactions"}, {"id": "16459502_2_806", "context": "Disseminated tuberculous lesions post intravesical BCG therapy are rare but need to be identified and treated quickly.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] post [Treatment] BCG [Effect] Disseminated tuberculous lesions"}, {"id": "14712320_5_807", "context": "Rhabdomyolysis can occur with all statins when used alone and particularly when combined with other drugs that are themselves myotoxic or that elevate the concentration of the statin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Treatment] statins; other drugs that are themselves myotoxic or that elevate the concentration of the statin [Effect] Rhabdomyolysis"}, {"id": "4044222_2_808", "context": "Amiodarone-induced dysthyroidism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Amiodarone [Effect] dysthyroidism"}, {"id": "6108450_2_809", "context": "Two patients with imminent gangrene of the extremities caused by ergot-induced arteriospasm underwent mechanical dilatation of the arteries when conventional measures such as anticoagulation, vasodilation, and sympathetic blockade produced no improvement.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ergot [Effect] arteriospasm [Adverse event] caused [Subject] Two patients [Treatment] ergot [Effect] imminent gangrene of the extremities"}, {"id": "18765315_1_810", "context": "Acute coronary syndromes can be associated with the infusion of rituximab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] infusion of rituximab [Effect] Acute coronary syndromes"}, {"id": "9466030_2_811", "context": "Approximately 15 min after the first administration of nebulised morphine the patient became markedly bradypneic (respiratory rate: 4-5 bpm), hypotensive (BP 70/40 mmHg), and responded only partially to command.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] became [Subject] patient [Treatment] nebulised morphine [Effect] markedly bradypneic (respiratory rate: 4-5 bpm), hypotensive (BP 70/40 mmHg), and responded only partially to command"}, {"id": "2549018_1_812", "context": "Akathisia appeared to be a common side effect of fluoxetine and generally responded well to treatment with the beta-adrenergic antagonist propranolol, dose reduction, or both.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] responded [Treatment] beta-adrenergic antagonist propranolol"}, {"id": "9934637_1_813", "context": "An unusual cause of burn injury: unsupervised use of drugs that contain psoralens.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] use of drugs that contain psoralens. [Effect] burn injury"}, {"id": "11984077_3_814", "context": "The patient suffered a life-threatening anaphylactoid reaction to amifostine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suffered [Subject] patient [Treatment] amifostine [Effect] life-threatening anaphylactoid reaction"}, {"id": "16313549_2_815", "context": "We report three cases of severe hypocalcaemia associated with i.v. bisphosphonate treatment in patients with multiple myeloma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] patients with multiple myeloma [Treatment] i.v. bisphosphonate treatment [Effect] severe hypocalcaemia"}, {"id": "1829999_2_816", "context": "We report a case of exfoliative dermatitis clearly linked to intravenous and intraperitoneal administration of tobramycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] linked [Subject] a case [Treatment] intravenous and intraperitoneal administration of tobramycin [Effect] exfoliative dermatitis"}, {"id": "95811_2_817", "context": "Glomerulonephritis in procainamide induced lupus erythematosus: report of a case and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] procainamide [Effect] Glomerulonephritis; lupus erythematosus"}, {"id": "8645078_4_818", "context": "Patients treated with captopril who develop \"atypical cholangitis\" should be suspected of having captopril-associated liver damage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] Patients [Treatment] captopril [Effect] atypical cholangitis; liver damage"}, {"id": "10586009_2_819", "context": "We report a case of codeine intoxication in the neonate, in which the drug was prescribed for cough control during an emergency department visit.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] prescribed [Subject] in the neonate; for cough control during an emergency department visit [Treatment] codeine [Effect] intoxication"}, {"id": "17763133_2_820", "context": "Discontinuation of simvastatin and cyclosporine resulted in resolution of rhabdomyolysis and normalization of renal function.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resulted [Treatment] Discontinuation of simvastatin and cyclosporine [Effect] normalization of renal function"}, {"id": "15028328_2_821", "context": "Phenylpropanolamine (PPA) recently has been publicly implicated as a cause of stroke and other neurologic events.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Phenylpropanolamine (PPA) [Effect] stroke and other neurologic events"}, {"id": "22010004_1_822", "context": "Critically elevated INR in a patient on warfarin after increase in extended-release niacin dose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient [Treatment] warfarin; increase in extended-release niacin dose [Effect] elevated INR"}, {"id": "17329303_5_823", "context": "He developed severe hyperactivity and agitation on taking methylphenidate after the discontinuation of risperidone treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] He [Treatment] methylphenidate after the discontinuation of risperidone [Effect] hyperactivity and agitation"}, {"id": "12390172_4_824", "context": "We suggest that objective evaluation of retinal function with electrophysiological methods should be performed in patients with visual disturbance during treatment with rifabutin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] rifabutin [Effect] visual disturbance"}, {"id": "3290702_1_825", "context": "A clinically atypical, neuropathologically verified case of Creutzfeldt-Jakob disease is described in a 32-year-old New Zealand woman with idiopathic hypopituitarism who had been treated in late adolescence (1970 to 1973) with human growth hormone processed from pooled cadaveric pituitary glands.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] described [Subject] a 32-year-old New Zealand woman with idiopathic hypopituitarism [Treatment] human growth hormone [Effect] Creutzfeldt-Jakob disease"}, {"id": "16099004_2_826", "context": "Quinine remains a reliable treatment for falciparum malaria in most parts of the world.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Quinine"}, {"id": "17068466_3_827", "context": "Severe corneal toxicity after topical fluoroquinolone therapy: report of two cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] topical fluoroquinolone therapy [Effect] corneal toxicity"}, {"id": "12452753_6_828", "context": "She developed a generalized rash and itching, sore throat, and dizziness approximately 4 hours after the first dose of capecitabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] approximately 4 hours after the first dose of capecitabine [Effect] a generalized rash and itching, sore throat, and dizziness"}, {"id": "8162401_2_829", "context": "Seizures associated with fluoxetine therapy are uncommon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] fluoxetine therapy [Effect] Seizures"}, {"id": "10337682_1_830", "context": "A 14-year-old girl with newly diagnosed SLE developed a pruritic bullous eruption while on prednisone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 14-year-old girl with newly diagnosed SLE [Treatment] prednisone [Effect] a pruritic bullous eruption"}, {"id": "8175330_1_831", "context": "Sodium valproate and carbamazepine, antiepileptic drugs that are associated with a relatively low rate of adverse cutaneous reactions, should be added to the growing list of drugs that produce psoriasiform eruptions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] Sodium valproate and carbamazepine [Effect] adverse cutaneous reactions"}, {"id": "10715308_1_832", "context": "Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] in [Treatment] Tirapazamine plus cisplatin"}, {"id": "1829999_1_833", "context": "Exfoliative dermatitis secondary to tobramycin sulfate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary to [Treatment] tobramycin sulfate. [Effect] Exfoliative dermatitis"}, {"id": "20110001_3_834", "context": "Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] a patient [Treatment] imatinib mesylate [Effect] Kaposi's sarcoma"}, {"id": "6303138_2_835", "context": "A young patient experienced marked sinus tachycardia while smoking marijuana and receiving therapeutic doses of nortriptyline.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] young patient [Treatment] nortriptyline [Effect] sinus tachycardia"}, {"id": "3501467_2_836", "context": "Hypogammaglobulinemia associated with gold therapy: evidence for a partial maturation blockade of B cells.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] gold therapy [Effect] Hypogammaglobulinemia; a partial maturation blockade of B cells"}, {"id": "6614033_3_837", "context": "Experience with five patients in whom impaired renal function developed early during amphotericin B therapy is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] five patients [Treatment] amphotericin B therapy [Effect] impaired renal function"}, {"id": "15529178_2_838", "context": "This report details the pulmonary pathologic findings in four patients with rheumatoid arthritis, who developed new onset of pulmonary signs and symptoms with alveolar infiltrates temporally related to the institution of etanercept therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related to [Subject] four patients with rheumatoid arthritis [Treatment] institution of etanercept therapy [Effect] developed new onset of pulmonary signs and symptoms with alveolar infiltrates"}, {"id": "17331261_2_839", "context": "CONCLUSION: Hypersensitivity reaction should be considered in patients who develop recurrent eosinophilia and deterioration of pulmonary function following the use of tobramycin by inhalation or by intravenous administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] patients [Treatment] use of tobramycin by inhalation or by intravenous administration [Effect] recurrent eosinophilia and deterioration of pulmonary function"}, {"id": "16449538_4_840", "context": "NCSE, an epileptic disorder in which typical convulsive activity is absent, has previously been reported in only 4 patients receiving ifosfamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] 4 patients [Treatment] ifosfamide [Effect] NCSE"}, {"id": "18487000_3_841", "context": "We describe a case of life-threatening hyponatremia associated with sibutramine use in an obese woman.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] obese woman [Treatment] sibutramine [Effect] hyponatremia"}, {"id": "19448237_1_842", "context": "Polymyoclonus seizure resulting from accidental injection of tranexamic acid in spinal anesthesia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] accidental injection of tranexamic acid in spinal anesthesia [Effect] Polymyoclonus seizure"}, {"id": "14712320_3_843", "context": "Hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) have been associated with myopathy and rhabdomyolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) [Effect] myopathy and rhabdomyolysis"}, {"id": "4051280_2_844", "context": "Propranolol-induced hypertension in treatment of cocaine intoxication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Propranolol [Effect] hypertension"}, {"id": "10970989_1_845", "context": "This is the second report of lactic acidosis in a patient on stavudine and lamivudine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] on [Subject] a patient [Treatment] stavudine and lamivudine [Effect] lactic acidosis"}, {"id": "7035691_2_846", "context": "We report on a patient with renal artery stenosis who had only 1 kidney and in whom acute renal impairment developed with transient anuria after the administration of captopril.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient with renal artery stenosis who had only 1 kidney [Treatment] the administration of captopril [Effect] acute renal impairment developed with transient anuria"}, {"id": "11795358_1_847", "context": "However, in the mid-to-late 1980s, a series of letters to the editor and case reports announced an association between tamoxifen therapy in women with breast cancer and the development of endometrial carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] women with breast cancer [Treatment] tamoxifen [Effect] endometrial carcinoma"}, {"id": "17763133_3_848", "context": "Simvastatin-induced rhabdomyolysis following cyclosporine treatment for uveitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] cyclosporine treatment; Simvastatin [Effect] rhabdomyolysis"}, {"id": "12663440_2_849", "context": "Based on our previous demonstration that quinine could be used clinically to reverse P-glycoprotein-mediated resistance, we designed a multicenter, randomized trial aiming to determine whether quinine would improve the survival of adult patients (15-60 years old) with de novo acute myelogenous leukemia (AML).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] improve [Subject] adult patients (15-60 years old) [Treatment] quinine [Effect] reverse P-glycoprotein-mediated resistance"}, {"id": "16816519_1_850", "context": "Vincristine induced cranial polyneuropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Vincristine [Effect] cranial polyneuropathy"}, {"id": "17697264_1_851", "context": "Here we describe another case of VOD occurring after LT, but in which the causative role was played by azathioprine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Treatment] azathioprine [Effect] VOD"}, {"id": "19260037_2_852", "context": "A retrospective review of TTP patients with quinine-associated thrombotic microangiopathy (TMA) for whom ADAMTS13 was measured before plasma exchange was performed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] TTP patients [Treatment] quinine [Effect] thrombotic microangiopathy (TMA)"}, {"id": "18306483_1_853", "context": "Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patients with disseminated extranodal marginal zone B cell lymphoma [Treatment] Rituximab-CHOP [Effect] interstitial pneumonitis"}, {"id": "2234880_2_854", "context": "Nitrendipine is an experimental calcium channel blocking agent that also appears to cause the side effect of drug-induced gingival hyperplasia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Nitrendipine is an experimental calcium channel blocking agent [Effect] gingival hyperplasia"}, {"id": "18950384_1_855", "context": "The present study describes a patient who had unusual weight fluctuation under corticosteroid and psychotropic treatment such as mianserin and aripiprazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] patient [Treatment] corticosteroid and psychotropic treatment such as mianserin and aripiprazole [Effect] unusual weight fluctuation"}, {"id": "12625995_2_856", "context": "Clozapine-induced akathisia in children with schizophrenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] children with schizophrenia [Treatment] Clozapine [Effect] akathisia"}, {"id": "10715308_4_857", "context": "Patients with previously untreated NSCLC were randomized to receive either tirapazamine (390 mg/m(2) infused over 2 hours) followed 1 hour later by cisplatin (75 mg/m(2) over 1 hour) or 75 mg/m(2) of cisplatin alone, every 3 weeks for a maximum of eight cycles.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receive [Subject] Patients with previously untreated NSCLC [Treatment] either tirapazamine (390 mg/m(2) infused over 2 hours) followed 1 hour later by cisplatin (75 mg/m(2) over 1 hour) or 75 mg/m(2) of cisplatin alone, every 3 weeks for a maximum of eight cycles"}, {"id": "11720625_3_858", "context": "Drug interactions between macrolide antibiotics such as erythomycin and pharmacologic agents that prolong the QT interval have been known to cause TdP. However, clarithromycin is thought to be less frequently associated with drug induced TdP, because it inactivates hepatic cytochrome P-450 to a lesser extent than erythromycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Drug interactions between macrolide antibiotics such as erythomycin and pharmacologic agents that prolong the QT interval [Effect] TdP"}, {"id": "20180933_5_859", "context": "In a randomised, investigator-blinded, multicentre phase III efficacy trial, 899 infants and children with acute uncomplicated Plasmodium falciparum malaria received six doses of AL according to body weight over 3 days either as crushed tablets (Coartem) or as dispersible tablets.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] received [Subject] 899 infants and children with acute uncomplicated Plasmodium falciparum malaria [Treatment] six doses of AL according to body weight over 3 days either as crushed tablets (Coartem) or as dispersible tablets"}, {"id": "1389744_1_860", "context": "A patient presented with dilated cardiomyopathy after many years of overusing an adrenaline inhaler.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A patient [Treatment] many years of overusing an adrenaline inhaler [Effect] dilated cardiomyopathy"}, {"id": "6625005_2_861", "context": "Occurrence of withdrawal dyskinesia indicates that the neuroleptic effects of amoxapine may be clinically significant.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Occurrence [Treatment] amoxapine [Effect] withdrawal dyskinesia"}, {"id": "10442258_1_862", "context": "Hair loss associated with paroxetine treatment: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a case [Treatment] paroxetine [Effect] Hair loss"}, {"id": "15760792_4_863", "context": "RESULTS: In a 22-year-old Thai woman with Graves' disease, tinnitus, hearing impairment in the left ear (with progression to the right ear), and vertigo developed after 3 years of therapy with PTU.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 22-year-old Thai woman with Graves' disease [Treatment] after 3 years of therapy with PTU [Effect] tinnitus, hearing impairment in the left ear (with progression to the right ear), and vertigo"}, {"id": "6578007_1_864", "context": "Additive pulmonary toxicity with melphalan and busulfan therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] melphalan and busulfan therapy [Effect] Additive pulmonary toxicity"}, {"id": "16682062_3_865", "context": "We report the case of a 20-year-old woman originally from Cameroon who was infected by the L. loa parasite and developed severe hepatitis, identified 1 month after a single dose of ivermectin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 20-year-old woman originally from Cameroon who was infected by the L. loa parasite [Treatment] 1 month after a single dose of ivermectin [Effect] severe hepatitis"}, {"id": "8739289_5_866", "context": "To the best of our knowledge, this is the first case of lithium-associated CDI and NDI presenting concurrently.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] lithium [Effect] CDI and NDI"}, {"id": "11795358_2_867", "context": "In this healthy population, the relative risk of developing endometrial carcinoma in the tamoxifen arm was 2.54, although when stratified by age, in women over 50, the risk grew to 4.01.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developing [Subject] healthy population [Treatment] tamoxifen [Effect] endometrial carcinoma"}, {"id": "7235792_4_868", "context": "Paradoxical ventricular tachycardia and fibrillation after intravenous bretylium therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] intravenous bretylium [Effect] Paradoxical ventricular tachycardia and fibrillation"}, {"id": "11978156_5_869", "context": "OBJECTIVE: To describe a case of thrombocytopenia associated with the administration of lansoprazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a case [Treatment] lansoprazole [Effect] thrombocytopenia"}, {"id": "3115809_1_870", "context": "A patient developed optic neuropathy while being treated with isoniazid and ethambutol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient [Treatment] isoniazid and ethambutol [Effect] optic neuropathy"}, {"id": "18622319_3_871", "context": "This case describes a 52-year-old white woman who developed a spontaneous nasal septal perforation after given the antiangiogenic drug, bevacizumab, for metastatic ovarian cancer treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 52-year-old white woman [Treatment] antiangiogenic drug, bevacizumab [Effect] a spontaneous nasal septal perforation"}, {"id": "2104570_5_872", "context": "Two cases are reported of patients who developed a hematologic malignancy several years after intravesical chemotherapy of superficial bladder cancer with etoglucid, doxorubicin, and mitomycin C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two cases are reported of patients [Treatment] etoglucid, doxorubicin, and mitomycin C; several years after intravesical chemotherapy of superficial bladder cancer with etoglucid, doxorubicin, and mitomycin C [Effect] hematologic malignancy"}, {"id": "17937473_1_873", "context": "Eleven patients developed infection requiring hospitalization while taking leflunomide including: lower respiratory tract infections (3), cellulitis (2), disseminated herpes zoster (2), probable TB liver (1), abdominal sepsis (1), mycotic aneurysm (1) and gastroenteritis (1).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Eleven patients [Treatment] leflunomide [Effect] infection; lower respiratory tract infections (3), cellulitis (2), disseminated herpes zoster (2), probable TB liver (1), abdominal sepsis (1), mycotic aneurysm (1) and gastroenteritis (1)"}, {"id": "11247558_2_874", "context": "Symptoms and endoscopic lesions quickly regressed within 1 week of meloxicam withdrawal.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] regressed [Treatment] within 1 week of meloxicam withdrawal"}, {"id": "14712320_1_875", "context": "Potential drug interaction between simvastatin and danazol causing rhabdomyolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causing [Treatment] drug interaction between simvastatin and danazol [Effect] rhabdomyolysis"}, {"id": "1450506_2_876", "context": "Multiple myeloma complicated by congestive heart failure following first administration of recombinant alpha-interferon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] first administration of recombinant alpha-interferon [Effect] Multiple myeloma complicated by congestive heart failure"}, {"id": "15823103_1_877", "context": "Carboplatin hypersensitivity induced by low-dose paclitaxel/carboplatin in multiple platinum-treated patients with recurrent ovarian cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] multiple platinum-treated patients with recurrent ovarian cancer [Treatment] low-dose paclitaxel/carboplatin [Effect] Carboplatin hypersensitivity"}, {"id": "2104570_2_878", "context": "Two cases are reported of patients who developed a hematologic malignancy several years after intravesical chemotherapy of superficial bladder cancer with etoglucid, doxorubicin, and mitomycin C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] patients [Treatment] several years after intravesical chemotherapy; with etoglucid, doxorubicin, and mitomycin C [Effect] a hematologic malignancy"}, {"id": "11573852_2_879", "context": "CASE SUMMARY: A 46-year-old African-American man experienced recurrent grand mal seizures during intravenous infusion of amphotericin B, then petit mal seizures as the infusion was stopped and the drug concentrations decreased with time.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] A 46-year-old African-American man [Treatment] intravenous infusion of amphotericin B [Effect] recurrent grand mal seizures"}, {"id": "16948177_2_880", "context": "Moreover, these findings suggest that the incidence of BOOP following rituximab therapy may be higher than has been previously appreciated.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] rituximab therapy [Effect] BOOP"}, {"id": "1624172_4_881", "context": "Two cases of hypothyroidism in patients with chronic hepatitis C treated with recombinant alpha interferon are reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] Two cases [Treatment] recombinant alpha interferon [Effect] hypothyroidism"}, {"id": "15760792_2_882", "context": "OBJECTIVE: To report the case of a young woman with Graves' disease in whom ototoxicity developed because of propylthiouracil (PTU)-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] young woman with Graves' disease [Treatment] propylthiouracil (PTU) [Effect] ototoxicity developed"}, {"id": "11468878_2_883", "context": "An obese patient, not diabetic, treated with metformin for some weeks, was referred to us with severe inferior digestive hemorrhage, diagnosed with Meckel's diverticulum.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] diagnosed [Subject] An obese patient, not diabetic [Treatment] metformin for some weeks [Effect] severe inferior digestive hemorrhage; Meckel's diverticulum"}, {"id": "2690546_1_884", "context": "Although a lot of amiodarone-induced torsades de pointe have been published, a review of all these cases and the underlying risk-factors has never been made.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] amiodarone [Effect] torsades de pointe"}, {"id": "15823103_2_885", "context": "However, one patient exhibited severe hypersensitivity reactions including cardiac arrest and apnea, and another four patients developed eruptions, hypotension, and tachycardia soon after administration of CBDCA.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] administration [Subject] one patient [Treatment] CBDCA [Effect] severe hypersensitivity reactions including cardiac arrest and apnea [Adverse event] administration [Subject] four patients [Treatment] CBDCA [Effect] eruptions, hypotension, and tachycardia"}, {"id": "17329303_3_886", "context": "This report is about three cases of children who developed severe adverse reactions during switching from risperidone to methylphenidate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] three cases of children [Treatment] during switching from risperidone to methylphenidate [Effect] adverse reactions"}, {"id": "10414481_2_887", "context": "This patient, who had a history of osteoarthritis, had severe hepatitis 5 weeks after being started on diclofenac for increasing pain in the joints.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] This patient, who had a history of osteoarthritis [Treatment] 5 weeks after being started on diclofenac [Effect] hepatitis"}, {"id": "16816519_4_888", "context": "She received chemotherapy according to the previously described modified St. Jude total therapy studies XIII.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] received [Subject] She [Treatment] chemotherapy"}, {"id": "9039216_1_889", "context": "A 17-year-old female patient who had been taking oral minocycline (50 mg twice daily) for 3 weeks for acne developed an eruption that progressed to an exfoliative dermatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 17-year-old female patient [Treatment] oral minocycline (50 mg twice daily) for 3 weeks [Effect] eruption; an exfoliative dermatitis"}, {"id": "12880504_3_890", "context": "Risperidone-induced obsessive-compulsive symptoms in two children.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] two children [Treatment] Risperidone [Effect] obsessive-compulsive symptoms"}, {"id": "11642488_2_891", "context": "CONCLUSIONS: Cicatrization in the substantia propria of the conjunctiva by excessive lymphocytic infiltration after topically administered antiglaucoma drugs including dipivefrin is a possible mechanism of action for entropion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] mechanism of action [Treatment] antiglaucoma drugs including dipivefrin [Effect] entropion"}, {"id": "2429270_1_892", "context": "A patient with the Wolff-Parkinson-White syndrome presented with incessant orthodromic atrioventricular tachycardia following initiation of procainamide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] A patient with the Wolff-Parkinson-White syndrome [Treatment] initiation of procainamide therapy [Effect] incessant orthodromic atrioventricular tachycardia"}, {"id": "12439602_3_893", "context": "Hypersensitivity to carboplatin is a rare but real complication of therapy and should be considered in patients presenting with hyperacute changes on ECG whilst receiving carboplatin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Subject] patients presenting with hyperacute changes on ECG [Treatment] carboplatin therapy [Effect] Hypersensitivity to carboplatin"}, {"id": "3115809_2_894", "context": "A well-recognized complication of ethambutol use is optic neuropathy, but the potential ocular toxicity of isoniazid is often overlooked.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] ethambutol [Effect] optic neuropathy [Adverse event] toxicity [Treatment] isoniazid [Effect] ocular toxicity"}, {"id": "11554897_4_895", "context": "PURPOSE: To report that acute lamotrigine poisoning may result in severe encephalopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] acute lamotrigine poisoning [Effect] severe encephalopathy"}, {"id": "6108450_1_896", "context": "Reversal of ergotamine-induced arteriospasm by mechanical intra-arterial dilatation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ergotamine [Effect] arteriospasm"}, {"id": "17667887_9_897", "context": "There have been several case reports of serotonin syndrome from similar combinations of antidepressant and atypical antipsychotic treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] combinations of antidepressant and atypical antipsychotic treatment [Effect] serotonin syndrome"}, {"id": "18991509_2_898", "context": "We report the first case of a human immunodeficiency virus type 1 (HIV-1)-infected individual receiving combination antiretroviral therapy, which included ritonavir, who developed Cushing syndrome with profound complications after epidural triamcinolone injections.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a human immunodeficiency virus type 1 (HIV-1)-infected individual [Treatment] combination antiretroviral therapy, which included ritonavir; epidural triamcinolone injections [Effect] Cushing syndrome"}, {"id": "6324592_1_899", "context": "Disulfiram-like reactions with newer cephalosporins: cefmenoxime.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] cefmenoxime [Effect] Disulfiram-like reactions"}, {"id": "11590881_4_900", "context": "We recommend routine follow up by ECG of patients over the age of 50 treated with carbamazepine.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] of [Subject] patients over the age of 50 [Treatment] routine follow up by ECG"}, {"id": "3149484_1_901", "context": "A 10-year-old girl with Lennox-Gastaut syndrome who received intravenous lorazepam for atypical absence status seizures is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Subject] A 10-year-old girl with Lennox-Gastaut syndrome [Treatment] intravenous lorazepam"}, {"id": "10485779_10_902", "context": "Ritonavir can inhibit the metabolism of fentanyl significantly, so caution should be exercised if fentanyl is given to patients receiving ritonavir medication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caution [Subject] patients receiving ritonavir medication [Treatment] fentanyl [Effect] metabolism of fentanyl significantly"}, {"id": "8739289_7_903", "context": "This case emphasizes the importance of the evaluation of lithium-associated polyuria with a direct measurement of plasma vasopressin, interpreted with simultaneous plasma and urine osmolality to secure the correct diagnosis and ensure appropriate therapeutic management.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] This case [Treatment] lithium [Effect] polyuria"}, {"id": "17710018_1_904", "context": "A patient with chronic myelomonocytic leukemia developed drug-induced pulmonary toxicity after using low dose oral etoposide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient with chronic myelomonocytic leukemia [Treatment] using low dose oral etoposide [Effect] pulmonary toxicity"}, {"id": "10442258_2_905", "context": "Alopecia and hair loss are rare side effects of psychotropic drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effects [Treatment] psychotropic drugs [Effect] Alopecia and hair loss"}, {"id": "11126885_1_906", "context": "Occult quinine-induced thrombocytopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] quinine [Effect] thrombocytopenia"}, {"id": "19296063_3_907", "context": "We report the case of a 17-year-old male who developed chest pain, elevated cardiac biomarkers, and acute left ventricular dysfunction following a single dose of methylphenidate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a 17-year-old male [Treatment] a single dose of methylphenidate [Effect] chest pain, elevated cardiac biomarkers, and acute left ventricular dysfunction"}, {"id": "9925865_2_908", "context": "In patients with swallowing dysfunction and pneumonia, a history of mineral oil use should be obtained and a diagnosis of ELP should be considered in the differential diagnoses if mineral oil use has occurred.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] considered [Subject] In patients with swallowing dysfunction and pneumonia [Treatment] a history of mineral oil use [Effect] ELP"}, {"id": "15053046_1_909", "context": "Agranulocytosis induced by vancomycin in an ESRD patient on CAPD.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] ESRD patient on CAPD [Treatment] vancomycin [Effect] Agranulocytosis"}, {"id": "16682062_1_910", "context": "First case of ivermectin-induced severe hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ivermectin [Effect] severe hepatitis."}, {"id": "2549018_4_911", "context": "The authors suggest that fluoxetine-induced akathisia may be caused by serotonergically mediated inhibition of dopaminergic neurotransmission and that the pathophysiology of fluoxetine-induced akathisia and tricyclic antidepressant-induced \"jitteriness\" may be identical.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] fluoxetine [Effect] akathisia may be caused by serotonergically mediated inhibition of dopaminergic neurotransmission"}, {"id": "19755414_10_912", "context": "The use of telithromycin in patients receiving multiple doses of oxycodone for pain relief may increase the risk of opioid adverse effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increase the risk [Subject] patients receiving multiple doses of oxycodone for pain relief [Treatment] telithromycin [Effect] opioid adverse effects"}, {"id": "17195428_1_913", "context": "A case of metoclopramide-induced oculogyric crisis in a 16-year-old girl with cystic fibrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 16-year-old girl with cystic fibrosis [Treatment] metoclopramide [Effect] oculogyric crisis"}, {"id": "16099004_4_914", "context": "Supported by a subtherapeutic quinine level, we hypothesise that a drug interaction with phenytoin may compromise the efficacy of quinine in the treatment of malaria.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] compromise [Treatment] phenytoin; quinine [Effect] efficacy of quinine"}, {"id": "16688722_1_915", "context": "Sporadic rippling muscle disease unmasked by simvastatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] unmasked [Treatment] simvastatin [Effect] Sporadic rippling muscle disease"}, {"id": "16449538_1_916", "context": "An objective causality assessment by use of the Naranjo probability scale revealed that NCSE due to ifosfamide was probable.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] ifosfamide [Effect] NCSE"}, {"id": "15719254_1_917", "context": "Cis-retinoic acid (RA) may further increase the risk of developing BMTN.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developing [Treatment] Cis-retinoic acid (RA) [Effect] BMTN"}, {"id": "12546343_3_918", "context": "He was later skin tested to confirm allergy to MTX.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Subject] He [Treatment] MTX [Effect] allergy"}, {"id": "11319599_1_919", "context": "Indolent aspergillus arthritis complicating fludarabine-based non-myeloablative stem cell transplantation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicating [Treatment] fludarabine [Effect] Indolent aspergillus arthritis"}, {"id": "19296063_1_920", "context": "A case of acute cardiomyopathy and pericarditis associated with methylphenidate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] methylphenidate [Effect] acute cardiomyopathy and pericarditis"}, {"id": "9527943_3_921", "context": "STUDY DESIGN: Case reports are presented of three premature infants (mean gestational age 27 weeks) cared for in the intensive care nursery in whom clinically significant septal hypertrophy and left ventricular outflow tract obstruction developed during dexamethasone treatment for bronchopulmonary dysplasia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] three premature infants (mean gestational age 27 weeks) cared for in the intensive care nursery [Treatment] during dexamethasone treatment for bronchopulmonary dysplasia [Effect] clinically significant septal hypertrophy and left ventricular outflow tract obstruction"}, {"id": "2063999_1_922", "context": "A case of the Rett syndrome with acute encephalopathy induced during calcium hopantenate treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] A case of the Rett syndrome [Treatment] calcium hopantenate treatment [Effect] acute encephalopathy"}, {"id": "25540831_1_923", "context": "Transient serotonin syndrome caused by concurrent use of tramadol and selective serotonin reuptake inhibitor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] concurrent use of tramadol and selective serotonin reuptake inhibitor [Effect] Transient serotonin syndrome"}, {"id": "16507380_3_924", "context": "Adverse events associated with IFN alfa-2b use are primarily constitutional symptoms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] IFN alfa-2b [Effect] primarily constitutional symptoms"}, {"id": "7474364_2_925", "context": "Sustained-release procainamide-induced reversible granulocytopenia after myocardial infarction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Sustained-release procainamide [Effect] reversible granulocytopenia"}, {"id": "9681211_3_926", "context": "We describe a patient with M4 AML treated with standard chemotherapy followed by G-CSF who developed marked monocytosis on day 8 of G-CSF therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with M4 AML [Treatment] standard chemotherapy followed by G-CSF [Effect] marked monocytosis"}, {"id": "7797283_2_927", "context": "Esophageal candidiasis was diagnosed at endoscopy in two patients receiving omeprazole therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] two patients [Treatment] omeprazole therapy [Effect] Esophageal candidiasis"}, {"id": "17660778_1_928", "context": "Bisphosphonate induced osteochemonecrosis of the jaw mimicking a tumour.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Bisphosphonate [Effect] osteochemonecrosis of the jaw"}, {"id": "15338554_4_929", "context": "OBJECTIVES: To describe the clinicopathologic features of 3 patients with CML who rapidly progressed from chronic phase to blast crisis while taking imatinib and to perform a review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] progressed [Subject] 3 patients with CML [Treatment] imatinib [Effect] from chronic phase to blast crisis"}, {"id": "8627446_3_930", "context": "Although they had only a few nodules at diagnosis, the nodules increased in number and size 3 to 4 months after the start of methotrexate therapy in both patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a few nodules at diagnosis [Treatment] methotrexate therapy [Effect] the nodules increased in number and size"}, {"id": "16449538_3_931", "context": "CONCLUSIONS: Among the many presentations of ifosfamide neurotoxicity, clinicians should consider NCSE as a possible explanation for changes in consciousness in a patient receiving this agent.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] a patient [Treatment] ifosfamide [Effect] neurotoxicity; NCSE; changes in consciousness"}, {"id": "6507240_3_932", "context": "It is concluded that SIADH is an important side effect of lorcainide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effect [Treatment] lorcainide therapy [Effect] SIADH"}, {"id": "16221163_8_933", "context": "Hepatoxicity is a rare complication of SRL therapy and may be connected with some diagnostic and/or therapeutic problems.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] is [Treatment] SRL therapy [Effect] Hepatoxicity"}, {"id": "19260037_1_934", "context": "A previous study of patients with \"quinine-associated TTP/HUS\" found that ADAMTS13 activities were not abnormal in 12/12 patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] 12/12 patients [Treatment] quinine [Effect] ADAMTS13 activities were not abnormal; TTP/HUS"}, {"id": "9695308_3_935", "context": "A teenage girl with crescentic glomerulonephritis had antineutrophil cytoplasmic antibody (ANCA) detected after she had received propylthiouracil (PTU) for hyperthyroidism without cutaneous vasculitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] A teenage girl with crescentic glomerulonephritis [Treatment] propylthiouracil (PTU) [Effect] antineutrophil cytoplasmic antibody (ANCA)"}, {"id": "11468878_3_936", "context": "Digestive hemorrhage caused by a Meckel's diverticulum in a metformin-treated patient: is there any connection?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] patient [Treatment] metformin [Effect] Digestive hemorrhage caused by a Meckel's diverticulum"}, {"id": "18492617_1_937", "context": "Our findings reveal that even in patients without a history of seizures, pregabalin can cause a cortical negative myoclonus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] patients without a history of seizures [Treatment] pregabalin [Effect] cortical negative myoclonus"}, {"id": "8551001_5_938", "context": "We describe the first documented case of azathioprine-induced severe myelosuppression due to thiopurine methyltransferase deficiency in autoimmune liver disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] azathioprine [Effect] severe myelosuppression"}, {"id": "15823103_4_939", "context": "We report five cases of carboplatin (CBDCA) hypersensitivity after weekly low-dose paclitaxel (60 mg/m2)/CBDCA (area under the concentration curve = 2) therapy in patients with recurrent ovarian cancer receiving multiple platinum-based chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] patients with recurrent ovarian cancer [Treatment] weekly low-dose paclitaxel (60 mg/m2)/CBDCA (area under the concentration curve = 2) therapy; multiple platinum-based chemotherapy [Effect] carboplatin (CBDCA) hypersensitivity"}, {"id": "22550162_3_940", "context": "The patient was placed on omeprazole after his first cycle of high-dose methotrexate for stress ulcer prophylaxis, and it was discontinued before the start of the first day of the patient's second round of high-dose methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prophylaxis [Subject] The patient [Treatment] methotrexate"}, {"id": "19249953_6_941", "context": "Because the patient had been taking lovastatin for the past 12 years, the possibility that the rhabdomyolysis may have been caused by a drug interaction between lovastatin and a concomitant drug was evaluated.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] the patient [Treatment] lovastatin [Effect] rhabdomyolysis"}, {"id": "8104147_1_942", "context": "Ibopamine-induced reversible leukopenia during treatment for congestive heart failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Ibopamine [Effect] leukopenia"}, {"id": "7474364_1_943", "context": "A 71-year-old man with paroxysmal atrial fibrillation who had a previous anterior myocardial infarction exhibited granulocytopenia 8 days following the administration of oral sustained-release procainamide (750 mg/day).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exhibited [Subject] A 71-year-old man with paroxysmal atrial fibrillation who had a previous anterior myocardial infarction [Treatment] oral sustained-release procainamide (750 mg/day) [Effect] granulocytopenia"}, {"id": "18957000_2_944", "context": "Clinicians should be cognizant of this possibility and consider a diagnosis of HDAs in patients with ongoing thrombosis who are receiving heparin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] patients [Treatment] heparin [Effect] HDAs; thrombosis"}, {"id": "17725438_2_945", "context": "Rifampin-induced hypothyroidism without underlying thyroid disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Rifampin [Effect] hypothyroidism without underlying thyroid disease"}, {"id": "3149484_2_946", "context": "Paradoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizures.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitation [Subject] child with atypical absence seizures [Treatment] lorazepam [Effect] Paradoxical precipitation of tonic seizures"}, {"id": "2568058_2_947", "context": "Peculiar nail-changes in a 70-year-old woman with rheumatoid arthritis occurring after approximately 1 year of penicillamine treatment are described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 70-year-old woman with rheumatoid arthritis [Treatment] penicillamine [Effect] Peculiar nail-changes"}, {"id": "14964753_1_948", "context": "Cutaneous vasculitis secondary to ramipril.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] ramipril [Effect] Cutaneous vasculitis"}, {"id": "15463865_5_949", "context": "Multiple mechanisms for ciprofloxacin-induced nephrotoxicity have been proposed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ciprofloxacin [Effect] nephrotoxicity"}, {"id": "25295553_4_950", "context": "Pregabalin was added to clozapine in 2 patients with schizophrenia, who both suffered from severe anxiety symptoms.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] in [Subject] 2 patients with schizophrenia, who both suffered from severe anxiety symptoms [Treatment] Pregabalin was added to clozapine"}, {"id": "3718111_2_951", "context": "Severe hyperkalemia as a complication of timolol, a topically applied beta-adrenergic antagonist.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] timolol; a topically applied beta-adrenergic antagonist [Effect] Severe hyperkalemia"}, {"id": "8329789_1_952", "context": "Amphotericin B overdose in pediatric patients with associated cardiac arrest.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] pediatric patients [Treatment] Amphotericin B overdose [Effect] cardiac arrest"}, {"id": "15279668_3_953", "context": "Of particular interest is that toxicity only occurred during the second course of FLA and sixth course of Ara-C containing chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] second course of FLA and sixth course of Ara-C containing chemotherapy [Effect] toxicity"}, {"id": "15112258_8_954", "context": "The literature search found 12 cases of radiation recall caused by gemcitabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] 12 cases [Treatment] gemcitabine [Effect] radiation recall"}, {"id": "9491301_4_955", "context": "Two heroin addicts, aged 34 and 19 years, developed ballistic movements after intravenous heroin overdose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two heroin addicts, aged 34 and 19 years [Treatment] intravenous heroin overdose [Effect] ballistic movements"}, {"id": "9988365_3_956", "context": "Successful challenge with clozapine in a history of eosinophilia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] with [Treatment] clozapine"}, {"id": "16352777_1_957", "context": "CASE SUMMARY: A 57-year-old female with cardiomyopathy and \"sulfa\" (trimethoprim/sulfamethoxazole) allergy documented as pancreatitis presented with symptoms consistent with pancreatitis after use of furosemide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after use [Subject] A 57-year-old female with cardiomyopathy and \"sulfa\" (trimethoprim/sulfamethoxazole) allergy [Treatment] furosemide [Effect] pancreatitis"}, {"id": "6510223_2_958", "context": "Acute intravascular hemolysis developed when a diabetic patient, previously treated with glyburide, was started on another oral sulfonylurea drug, chlorpropamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] a diabetic patient [Treatment] chlorpropamide [Effect] Acute intravascular hemolysis"}, {"id": "17505739_1_959", "context": "Intravitreal triamcinolone may have had an influence on the exacerbation of retinochoroiditis in the posterior pole of the patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] influence [Subject] the patient [Treatment] Intravitreal triamcinolone [Effect] exacerbation of retinochoroiditis in the posterior pole"}, {"id": "8961730_2_960", "context": "We evaluated a patient who developed a psychotic disorder after 4 months of isoniazid prophylaxis for a positive tuberculosis tine test.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] patient [Treatment] 4 months of isoniazid prophylaxis [Effect] psychotic disorder"}]}